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Miniaturizing High Throughput Droplet Assays For Ultrasensitive
Molecular Detection On A Portable Platform
Abstract

Digital droplet assays – in which biological samples are compartmentalized into millions of femtoliter-volume
droplets and interrogated individually – have generated enormous enthusiasm for their ability to detect
biomarkers with single-molecule sensitivity. These assays have untapped potential for point-of-care
diagnostics but are mainly confined to laboratory settings due to the instrumentation necessary to serially
generate, control, and measure millions of compartments. To address this challenge, we developed an
optofluidic platform that miniaturizes digital assays into a mobile format by parallelizing their operation. This
technology has three key innovations: 1. the integration and parallel operation of hundred droplet generators
onto a single chip that operates >100x faster than a single droplet generator. 2. the fluorescence detection of
droplets at >100x faster than conventional in-flow detection using time-domain encoded mobile-phone
imaging, and 3. the integration of on-chip delay lines and sample processing to allow serum-to-answer device
operation. By using this time-domain modulation with cloud computing, we overcome the low framerate of
digital imaging, and achieve throughputs of one million droplets per second. To demonstrate the power of this
approach, we performed a duplex digital enzyme-linked immunosorbent assay (ELISA) in serum to show a
1000x improvement over standard ELISA and matching that of the existing laboratory-based gold standard
digital ELISA system. This work has broad potential for ultrasensitive, highly multiplexed detection, in a
mobile format. Building on our initial demonstration, we explored the following: (i) we demonstrated that the
platform can be extended to >100x multiplexing by using time-domain encoded light sources to detect colorcoded beads that each correspond to a unique assay, (ii) we demonstrated that the platform can be extended
to the detection of nucleic acid by implementing polymerase chain reaction, and (iii) we demonstrated that
sensitivity can be improved with a nanoparticle-enhanced ELISA. Clinical applications can be expanded to
measure numerous biomarkers simultaneously such as surface markers, proteins, and nucleic acids.
Ultimately, by building a robust device, suitable for low-cost implementation with ultrasensitive capabilities,
this platform can be used as a tool to quantify numerous medical conditions and help physicians choose
optimal treatment strategies to enable personalized medicine in a cost-effective manner.
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ABSTRACT
MINIATURIZING HIGH THROUGHPUT DROPLET ASSAYS FOR ULTRASENSITIVE
MOLECULAR DETECTION ON A PORTABLE PLATFORM
Venkata Yelleswarapu
David Issadore

Digital droplet assays – in which biological samples are compartmentalized into millions
of femtoliter-volume droplets and interrogated individually – have generated enormous
enthusiasm for their ability to detect biomarkers with single-molecule sensitivity. These
assays have untapped potential for point-of-care diagnostics but are mainly confined to
laboratory settings due to the instrumentation necessary to serially generate, control,
and measure millions of compartments. To address this challenge, we developed an
optofluidic platform that miniaturizes digital assays into a mobile format by parallelizing
their operation. This technology has three key innovations: 1. the integration and parallel
operation of hundred droplet generators onto a single chip that operates >100x faster
than a single droplet generator. 2. the fluorescence detection of droplets at >100x faster
than conventional in-flow detection using time-domain encoded mobile-phone imaging,
and 3. the integration of on-chip delay lines and sample processing to allow serum-toanswer device operation. By using this time-domain modulation with cloud computing,
we overcome the low framerate of digital imaging, and achieve throughputs of one
million droplets per second. To demonstrate the power of this approach, we performed a
duplex digital enzyme-linked immunosorbent assay (ELISA) in serum to show a 1000x
improvement over standard ELISA and matching that of the existing laboratory-based
gold standard digital ELISA system. This work has broad potential for ultrasensitive,
highly multiplexed detection, in a mobile format. Building on our initial demonstration, we
iv

explored the following: (i) we demonstrated that the platform can be extended to >100x
multiplexing by using time-domain encoded light sources to detect color-coded beads
that each correspond to a unique assay, (ii) we demonstrated that the platform can be
extended to the detection of nucleic acid by implementing polymerase chain reaction,
and (iii) we demonstrated that sensitivity can be improved with a nanoparticle-enhanced
ELISA. Clinical applications can be expanded to measure numerous biomarkers
simultaneously such as surface markers, proteins, and nucleic acids. Ultimately, by
building a robust device, suitable for low-cost implementation with ultrasensitive
capabilities, this platform can be used as a tool to quantify numerous medical conditions
and help physicians choose optimal treatment strategies to enable personalized
medicine in a cost-effective manner.
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CHAPTER 1: INTRODUCTION
1.1 Need for ultrasensitive, multiplexed assays in diagnostics
Effective healthcare relies on the ability to treat patients based on symptoms that
differentiate healthy patients from those that are at risk for certain conditions or are in a
state of disease. Since treatment can be expensive, and comes with side effects, it is
paramount that diagnosis must be accurate. Diagnostic sensitivity measures the
proportion of correctly classified patients with disease as having a disease, while
specificity measures the proportion of healthy patients who receive a negative result.
While these are binary measures, predictive values give probabilities that these
classifications are truly accurate. Diagnosis can be done by checking physiological
features such as heart rate; removing tissue and checking for any abnormalities; various
forms of imaging; and liquid biopsies. Of these, liquid biopsy1,2 shows immense potential
since measuring basic physiological features do not provide enough information to
classify patients accurately, while techniques like needle biopsy can be expensive,
painful, and time consuming3. In addition, tests that require lab-grade facilities require
patients to travel, creating a burden on how frequently these tests can be administered.
Liquid biopsies focus on sampling body fluids and testing these for target
biomarkers that may indicate the condition of the patient4–7. Liquid biopsies can be more
practical than techniques like surgery, magnetic resonance imaging, CT scans, etc.
since a blood draw can be administered routinely, is inexpensive, less painful, and time
efficient. The convenience also makes it possible to track patients through multiple
stages of screening and treatment to verify that treatment is working effectively. In
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addition to blood, samples as saliva, sputum, urine, and cerebral spinal fluid also contain
vast resources for biomarkers.
One technique that is employed is to search for the presence of target material
that would only be present if a patient is infected. This strategy works in infectious
diseases like HIV8,9, where a single virus particle circulating in blood indicates infection;
or cancers where rare tumor cells start to appear in the bloodstream that would
otherwise not be there10. Conditions where the target concentration is extremely low –
~a few particles/mL of sample – require large patient sample volumes, since detecting
rare molecules in a finger prick of blood would also mean that there is a high probability
that the finger prick would not even contain the target. Therefore, it is crucial to collect
volumes as large as 10mL and screen this entire sample for rare circulating tumor cells,
or virus particles to catch them at early stages. In addition, drug treatments that may not
have completely eradicated cancer or HIV can be monitored frequently, which is not
practical via tissue biopsy or imaging.9,11,12

By monitoring frequently, any signs of

remission can be addressed immediately before cancer cells can metastasize or
infectious pathogens spread latently to other regions of the body.
While detecting rare targets that are only present in diseased conditions is ideal,
this may not be practical due to specificity issues, or lack of knowledge of physiological
conditions. Instead, biomarkers that are normally present in healthy individuals can
either increase or decrease in response to changing physiology, which can also be
measured to indicate disease13–15. For example, in traumatic brain injury (TBI),
biomarkers panels have not been fully established that link specific proteins or nucleic
acids to conditions like concussion. Instead, if it is observed that cytokines or exosomes
are responding to a TBI condition, it is useful to measure the concentrations of these
2

over several time points before classifying a patient for treatment4. Therefore, liquid
biopsies also can be a strategy for drug discovery since large panels of biomarkers
between known healthy and diseased patients can be studied to find biomarkers with the
most fold change, and then use these in diagnosis.
In order to catch early onset of certain diseases, ultrasensitive detection is
necessary16. miRNA and proteins previously thought to be of little importance can in fact
have a lot of information in them17. Since traditional assays cannot measure these low
concentrations accurately, the “right” biomarkers for disease may never be found without
the proper tools. As ultrasensitive assays are being developed, proteins once thought to
not provide any value in diagnostics such as PSA in prostate cancer, have shown
promising diagnostic value when measured at lower limits of detections17. Furthermore,
ultrasensitive detection enables trace molecules that could not be measured to now
provide valuable information.
Ultrasensitive technology is driving development of biomarker panels as miRNA,
mRNA, exosomes, and proteins are being mapped onto various conditions such as
pancreatic cancer10, HIV188, Alzheimer’s19, cancers, TB, cytokines20. In pancreatic
cancer, a single base mutation in the KRAS gene could be detected in the background
of ~200,000 copies of nonmutated genes, enabling incredible sensitivity to catch
mutations early in blood10. In HIV, capsid protein p24 measurements showed similar
limit of detection to nucleic acid amplification8,18. With 2000 p24 molecules per HIV
particle as opposed to two copies of RNA, ultrasensitive immunoassays could potentially
replace the need for more equipment-dependent polymerase chain reaction (PCR). For
Alzheimer’s, measurements of change in Neurofilament light chain (NfL) proteins over a
ten year period showed predictive value compared to just the absolute quantity19. This
3

study highlights that while detecting concentrations is important, the rate of change is
critical, which is only possible if inexpensive, convenient assays are available for use in
the clinic. Blood tests for tuberculosis are currently in development that combine four
host proteins measurements with machine learning with 80% sensitivity and 65%
specificity when compared with TB-like diseases21, showing potential for blood-based
diagnostics but also lots of room to improve. Lastly, measurement of multiple cytokines
have implications in diseases ranging from brain injuries, cancers, and infection.20
Clinical studies have also shown that one biomarker is not enough to classify
patient groups. Complex diseases mean that heterogenous patients will display different
biomarker levels, which will also vary over time in the same individual. To make this
even more complicated, cells are heterogeneous and using a single biomarker as a
diagnostic often risks having low specificity22. Diagnosing cancer improves significantly
when combining biomarkers that may not be related to each other or one’s that may
follow separate trends among patients23. TBI measurements have shown that some
biomarkers change immediately in response to an insult, while others respond later2425,
indicating diagnosis can also indicate the progression of disease. While DNA and RNA
changes are routinely measured with sequencing technologies, they might not paint
entire picture without proteins and epigenetic information that can further illustrate what
is happening on a physiological level26.
Lastly, laboratory facilities are important for developing new technologies, but if
these new powerful technologies can never be implemented in resource-poor areas or in
the field, there will be less impact for the diagnostic value. In order to develop
meaningful point-of-care technologies, the ASSURED (affordable, sensitive, specific,
user-friendly, rapid and robust, equipment free, and deliverable to users) criteria lists out
4

several features that make technologies adaptable in the field27. Therefore, an ideal
device would follow these ASSURED criteria, offer ultrasensitive detection, contain
sample prep on chip, and be able to detect a panel of biomarkers to maximize its impact.

1.2 Current techniques for diagnostics
Blood based diagnostics enables several advantages discussed above, but also
has a unique opportunity for diseases where other techniques often find the symptoms
too late4–7. For example, in cases like Tuberculosis, while sputum and cell culture are
known to be the widely adopted methods for clinical testing, a problem arises in getting
access to sputum. For young children, it becomes difficult to force them to cough up
large amounts of sputum and then grow these cultures out for over a week28. Similarly,
in cases like pancreatic cancer, imaging is often too late to find tumors before they have
already metastasized, so the survival rate is ~5% despite major advances in imaging
techniques29.
Blood-based tests that have shown practical uses in the clinic, as well as point of
care assays that can be purchased without the need for a medical expert. These range
in complexity from laboratory facility limited equipment that can scan for many
biomarkers but require a trained expert to run; to simple at home blood prick tests that
change color to indicate the disease status. The simplest of blood based diagnostics are
those based on paper, or later flow assays30–32

33.

These assays change color or create

an easy to read qualitative mark in the presence of a biomarker – and are used widely in
at home self-care tests for pregnancy and diabetes. Some come with portable readers
that can somewhat quantify the color change or other properties by having optical or
electrochemical biosensors. However, these types of devices require that a sample is
concentrated, abundant in a small sample volume, and does not require precise
5

quantification of change in levels. Nonetheless, several companies have built
commercial platforms such as Alere (HIV/AIDS), Claros Diagnostics (urological,
infectious disease), Cepheid (respiratory infections), Daktari (HIV/AIDS), Abbott i-STAT
(coagulation, blood chemistry, cardiac markers) to address these needs34. While
techniques have been developed to concentrate molecules in targets with paper or other
materials, or even purify serum or plasma from the rest of the blood 35, these tests still do
not have the sensitivity for ultrasensitive detection.
In order to achieve more quantitative measurements, techniques such as flow
cytometry exist, where cells or beads that capture target biomarkers are then labeled
with fluorescent tags and pass through multiple lasers, each then read out by
photodetectors after emitted light passes through many optical elements36,37. These
types of systems have great precision since the lasers generate sharp excitation
wavelengths, optical elements separate emission light into multiple wavelengths, which
are then read out by sensitive photodetectors. Flow cytometers can thus cover a large
dynamic range, measure multiple colors simultaneously and even detect the size and
makeup of particles from the side and forward scatter. Recently, imaging flow cytometry
combines images of particles and implements machine learning to combine what is
fluorescently detected with image data, allowing more precise morphological
measurements to be taken38. Combined with sorting, these workflows offer flexibility,
precision, and accuracy. However, flow cytometry suffers from low adoptability in
resource-poor settings due to their size, cost, training required, and the low throughput
nature since the particles are often filed one by one through a focused laser spot.
In order to address fluorescent readouts that require expensive equipment,
several other approaches to biosensors have been built that are based on graphene 39,
6

plasmonic sensors40, micro-Hall detectors41, and nanopore sequencing42. While these
biosensors have shown great promise in multiple human samples for various diseases,
the specialized nature of fabricating them makes them hard to scale up, manufacture,
and replicate in various lab settings. Therefore, simplicity is also a requirement that
ensures simple fabrication strategies, limited steps for protocols, and limited use of
complex engineering techniques if a chip is to be manufactured en masse for portable
environments.

1.3 Digital Assays
While the above assays have made enormous strides in liquid biopsies, many
still lack the sensitivity for detecting single molecules in the background of billions of
nontarget molecules. Trying to detect single molecules in bulk volumes is nearly
impossible since nonspecificity and diffusion of fluorescent molecules will generate only
a weak signal. Trying to detect one molecule in a 100 µL sample (as is often used for
traditional assays) means that the target molecule can diffuse into the entire space. If
any fluorescence is to be measured from the molecule, or any reaction that amplifies the
reaction such as polymerase chain reaction (PCR) or enzyme-linked immunosorbent
assay (ELISA), the product to be measured would diffuse in this vast space (Fig 1.1a).
The concentration of a single molecule in that space would be 2 *10 -20 M, which would
make it extremely difficult to distinguish between a true positive and a blank sample.43
Additionally, what if there are billions of other off target molecules in the sample? Since
typical Kd of antibodies are in the range of µM to nM range44, this would mean that even
with the specificity of a sandwich ELISA, the 2 *10-20 M protein concentration would
result in a false positives or false negatives even with the strongest binding affinities.
This also does not improve significantly if there is amplification since the same amplified
7

molecules can diffuse freely, so the signal would not be concentrated. In addition, any
generated signal would be hard to quantize into single molecules since the difference
between zero, one, two, ten, so on in 100 µL would look nearly identical in most
detection strategies (Fig 1.1a). The reason conventional assays such as qPCR and
ELISA are unable distinguish between individual copy numbers it that the initial
concentration is calculated by using calibrator curves. These calibrator curves are used
as a reference, but the threshold settings used to compare the values are either
empirically or subjectively determined, causing a major source for variation. In addition,
in large samples low target copies are dominated by background signal that is much
larger than the fluorescence of a single target copy45 (Fig 1.1a).

Figure 1.1 Conventional Analog vs Digital Assays. a. In conventional analog assays,
the change between a negative sample and those with trace amounts of target
molecules are hard to distinguish. b. When the sample is compartmentalized either into
droplets or static arrays, the effective concentration increases by many orders of
magnitude, and the fluorescent substrate is concentrated. In addition, these
compartments contain a single target molecule or none, allowing them to be counted for
absolute quantification as opposed to compared to standards. c. The limit of detection of
8

state-of-the-art ELISA assays can be above the clinical range needed, making it
impossible to measure physiological concentrations of these relevant proteins.
Quanterix’s digital ELISA, has shown up to 104 increase in several proteins by using
digital assays.
To overcome the challenges of conventional ELISA assays,digital approaches
have been developed.. While different strategies have been employed for portioning a
sample (“digitize”), the result is that the individual molecules are confined into solutions
that are on the order of ~fL in volume. Thus the same molecule that was in 100 µL, when
placed into fL volumes would be 2nM, or 1011 more concentrated. The resulting higher
concentration means molecules are confined and more easily observed, with the
additional benefit that by partitioning a volume into these tiny compartments, most will
only contain either one or zero target molecules based on distribution based on Poisson
statistics46 (Fig 1.1a). In addition, the background competition is also significantly
reduced, reducing signal from background molecules. Rather than relying on quantifying
the change in fluorescence, digital assays measure endpoints. If a compartment is
fluorescent, it signifies a single molecule. Counting the number of fluorescent
compartments gives a count of total target molecules without the need for standards or
an analog readout, making this technique robust. Digital assays have demonstrated
enormous improvements in sensitivity with over 104-fold improvements in several
biomarkers (Fig 1.1b). There are three main methods to perform digital assays: static
arrays, electrowetting on dielectric (EWOD) surfaces to manipulate droplets, and
continuous flow droplets.
1.3.1 Static Arrays
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Static array digital assays use compartments that are separated by physical
barriers or by dispersing liquid into emulsions separated by a continuous phase of oil,
and are often the simplest to build due to the lack of moving fluids. The sample is placed
into these compartments through gravity, centrifuging sample into tiny wells, applying
pressure on top of wells to force the sample into the thousands of wells, or using fluidic
paths to seal wells and ducts after loading reagents. Several strategies use self
compartmentalization47 or reagent introduction into wells that are then sealed and
observe such as the SlipChip48. One particular strategy that has been developed into a
commercial platform is the Quanterix’s Single Molecule Array (Simoa)

49,

which began

as with etched glass fiber wells and evolved to manufacturing using Bluray technology to
create multiple 250k wells regions on a disc50. This technique is used for bead-based
protein capture, where beads that have captured single protein molecules and are
labelled with enzyme will cause a well to fluorescence. A CCD camera measures
fluorescence and calibrates for crosstalk into empty wells, and detect multiple colored
beads simultaneously.
Other techniques create water in oil emulsions, which contain the sample and
reagents which are then injected into a reservoir chip that acts as a viewing platform,
where these emulsions spread out in a monolayer and can be observed for fluorescence
over time51. The advantages of static arrays are that they are often image based, since
the endpoint of the reaction is measured after the reagents are sealed into an array. This
allows for long integration times that can be overlaid with several optical filters to
generate images for multiple color, that can be used to identify multiple biomarkers.
Image based detection can potentially enable lower grade cameras such as cell phone
cameras if the number of compartments fit the pixel resolution of the camera – again
10

demonstrating the tradeoff between hardware complexity and dynamic range of a target
biomarker to be measured. Static arrays are often simpler to build since the fluid sits
inside wells without moving, and do not require precise pumps but still require machines
like centrifuges, careful pipetting, etc. The main drawback of static arrays is that they are
limited by the number of compartments that can be imaged to fit onto a chip. Therefore,
the sample volume is limited since it must fit in the volume of the compartments, thus
sacrificing dynamic range. To address this issue, techniques such as the Simoa can
measure multiple targets in a single well by correcting for Poisson encapsulation
probabilities to back calculate the initial concentration. In addition, once the wells
become increasingly full, the overall fluorescence from the entire array can be measured
and compared to a calibration curve to measure both digital and analog52.
1.3.2 Digital Microfluidics based on Electrowetting on Dielectrics (DMF on EWOD)
Certain reactions call for the complex steps that include introduction of reagents
and wash steps that cannot be addressed if the compartments are isolated. While picoinjectors for continuous flow droplet systems and workflows exist for exchanging liquids
between steps in arrays, these still do not allow the user to manipulate the volumes with
much control. Digital Microfluidics (DMF)36,38,53 was developed to have precise control
over how droplets move and have complex liquid handling protocols automated by
addressing each droplet individually. The spatial position is controlled through
electrowetting by having insulating layers on electrodes that separate them from the
liquid on top. While electrowetting on dielectric surfaces is most common, approaches
also exist that use acoustic waves, magnetic force, optical wetting, and thermal
gradients. Furthermore, the droplets can be sandwiched on both sides, or be open so
that color and fluorescent properties can be measured from the open side. Once
11

programmed, these multistep protocols obviate the need for human intervention since
the spatial position can be controlled precisely. The advantages of this technique include
monitoring droplets over time and keeping track of location of each droplet and mixing
conditions. Applications where such precision are required include chemical synthesis,
However, the dynamic range again is limited since typical assays run up to tens
of droplets in parallel, and the droplets tend to be larger in size (µL to 100 nL)54. Since
the force applied to move the droplets is on the order of seconds, operations on DMF
are typically in the Hz range, which limit how quickly reactions occur54. Additionally,
fabrication often involves more complex steps compared to soft lithography of droplet
microfluidics, or well based approaches for static arrays. Thus, the dynamic range is
smaller, and multiplexing becomes more complicated to scale, making the system low
throughput. This makes DMF more difficult as a diagnostic platform since a wide range
of biomarkers and dynamic range from rare to concentration targets cannot be
measured simultaneously.
1.3.3 Continuous flow high throughput droplet systems
Continuous flow high-throughput droplet systems use thousands to millions of
droplets that are generated, incubated while a reaction takes place, and then observed
after. These droplets can be manipulated through merging, sorting, splitting55; or used to
create complex particles such as two faced Janus particles or cured using several
chemical approaches like UV to create nanoparticles54,56. In diagnostics, the tiny
volumes afford better heating, mixing, increasing the concentration of particles,
encapsulating primarily one or zero target molecules for strong signal to background
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separation, and allow lower reagent consumption for running millions of experiments in
parallel.57–61
Continuous flow droplets offer several advantages over arrays and DMF, in that
millions of droplets can be measured – enabling large dynamic range and sensitivity with
no limit on sample size. In addition, the liquid-liquid interface as opposed to walls also
provides benefits. With the proper surfactants, these interfaces can reduce enzymes,
nucleic acids, and targets from sticking to surfaces and thus reducing sensitivity62. Since
these droplets are encapsulated in oil, they are at a lower risk of drying from exposed
air, since static arrays in several oils have shown to exchange gases and evaporated
out51. In addition, since the channels where droplets travel through after they are
generated are not fouled, the risk of contamination also reduces since the dispersed
liquid inside the compartment never makes contact with walls, which also allows chips to
be reused63,64.
1.3.4 Applications of Digital Assays
Diagnostic digital assays are primarily used to amplify nucleic acids through
PCR, or proteins through ELISA. If droplets need to be analyzed further in cases such as
single cell sequencing applications, or to process only droplets of interest to save
reagent costs, the droplets can be sorted for further downstream analysis.
Table 1.1 – Digital PCR Technologies
Ref.

Throughput

Droplet
Volume

Method of
Thermal

Method of
Detection

125 to 250 k/s
based on 4-8s
exposure

50 pL

Thermoelectric
Cooler, Copper, Si
wafer, PDMS

Wide field 21 MP
DSLR camera

On Chip
Heating
Hatch51
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Schaerli65

Flow rates
~160ul/h;

40um to
150um; 33.5
pL to 1.76nL

Peltier module with
copper rod at
center; spatial

Droplets were
collected, opened for
gel electrophoresis

4.7*106/mL
Beer66

Generate 1k/s
and then stop
while it cycles.

10 pL

Peltier temporal
heating

Nikon microscope w/
5k fps camera.

Kiss67

500/s

65 pl; observed
14k droplets
per cycle at 11
points

Spatial heating; two
heaters at 95 and
65c zone; 55 s
cycles/ 35 min

Droplets flash frozen
and analyzed on gel
and fluorescence
microscope

Terazono68

2.2k/3.5 min

20-30um
droplets made
with micropipetting 1030uL at a time

Single monolayer
of droplets heated
w/ IR laser; 3.5min
for 50 cycles

Inverted microscope,
laser,

Biorad

1.92 mL can
be loaded on
thermocycler
at once

1 nL; 1 k/s

Off chip
thermocycler

Dual laser

Raindance

400 µL sets

5 pL; 1 k/s

Rane69

1M/110 min;
10uL per
110min

8 pL; 1-2
ms/droplet

Peltier heater with
water cooling

Custom built optical
dual fluorescence

Li et al 70

27,000

314 pL

Peltier heater with
copper chamber,
PWA chip, and
glass; 10 min… 30
min for entire
procedure at 39C

Wide field image
microscopy

39C on flat metal
adapter; plate
reader with
temperature
controlled at 25°C.
1 hr at 39C, 30 min
at 42C

Leica DMI 6000 B
epi-fluorescence

Labdisk player with
built in heater; 30
min for entire thing

Stroboscopic setup
for droplet dia only;
fluorescence
imaging with Lavion

Off Chip
Heating

Dual laser

Isothermal

Static array

SlipChip48

Schuler71

1550 reaction
wells

Volume
calculated
from given
dimensions:
~30000

9 nL each;
1550 wells/hr

0.9048 nL;
volume of
chamber where
droplets form is
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microscope (Leica
Microsystems,
Germany) with a 5X
/ 0.15 NA objective
and L5 filter

Kang72

120um dia
droplets;

27 µL

100 kHz

10 kHz

bioanalyzer

Red/Green colors;

Rotating cuvette with
mini confocal
detector for
DNAzyme detection

Digital PCR: Digital PCR can quantify specific nucleic acid targets, including
DNA, miRNA, and mRNA, by compartmentalizing large volumes into tiny droplets that
are then thermocycled for the nucleic acids to amplify (Table 1.1). Several approaches
exist for RNA amplification, where a heating step is dedicated to first creating cDNA73,74.
As the DNA amplifies in the droplets, dyes such as EvaGreen or quenched probes come
apart in the presence of amplified DNA, causing a fluorescence readout7576. Studies
have shown that when compared directly with qPCR, ddPCR results are more precise
and reproducible. Digital PCR demonstrates much lower variance than qPCR when
targets are at low abundance targets, in highly contaminated sample, or when the fold
change difference between samples is 2-fold or lower (variance between 7%-30% for
ddPCR compared to 60-87% for qPCR in replicates)7711. Endpoint reactions do not
depend on primer efficiency if the final fluorescence is achieved in positive droplets,
while in qPCR the fluorescence of the sample can vary significantly based on acceptable
primer pairs (90 to 110%). Absolute quantification relies on counting positive droplets,
and do not rely on standards for comparison, although most assays run them as quality
check78.
Digital PCR can also be multiplexed such that a single test volume can be tested
for multiple nucleic acids simultaneously79

80.

Multiplexing can be achieved by adding

additional dyes for each target, however, this becomes limited by the optics and
hardware, making each addition more expensive and crosstalk among dyes a larger
15

issue as more colors are added. Therefore, commercial techniques often use “higher
order multiplexing” where the endpoint fluorescence amplitude is used to differentiate
target strands.79,80 In “amplitude based multiplex assay”, different concentrations of
probes are used such that the end point fluorescence depends on this concentration and
can identify which target strand is amplified. In order to expand this to multicolor, multiple
dyes can increase the number of genes targeted. To scale up practically, each target
also has different probe concentrations such that even within one dye, multiple levels of
final endpoint fluorescence can be generated based on the probe concentration per
specific target. Other techniques also use the fact that since longer strands can
potentially bind more EvaGreen, they should be more fluorescent, so while probe
concentration remains the same, the endpoint fluorescence will now depend on the
target strand length. However, multiplexing comes with a host of issues including probe
specificity, competition with other primers, and differential PCR efficiencies 79,80. Digital
PCR has made its mark on the field for nucleic acid detection and has been adopted for
ultrasensitive measurements on nucleic acids, generating $318 million in 2017 and
projected to reach $1.2B by 2025 (Allied Market Research, 2019).
Table 1.2 – Digital ELISA Technologies
Ref.

Guan81

LOD

0.88 µM

Volume /
compart
ments

Device

4.2 pL/
200k

PDMS

Method

material
-Single β-Gal in droplets
-Measured rate of fluorescence
production

Obayashi82

7.0 fM

44 fL/
7600*120

CYTOP
on

chamber

glass
coverslip
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-Noted only 2.5% of the substrate
was consumed in 20 min with ALP
and β-Gal

Rissin44

6 fg/mL

50 fL /
50k

Glass
wells

Microarray with bead based
dELISA

wells

Silicone
gasket/oil

50 fL /
50k

Simoa

-Measured number of p24 proteins

array

-Converted to virion count

(200aM)

Chang83

100 vir/mL

wells
by dividing 2000 p24 proteins/virion
Verified with RNA extracted
Shim84

1.2 pg/mL

32 fL /
20k drops

(43 fM)

PDMS

-Static array with

Glass

around 20k droplets analyzed
-Low dynamic range
-No false positives reported

Leirs85

4 fM in buffer

38 fL /
62.5k
wells

Patterned
Teflon-Af

-Detected nucleoprotein
from flu virus

on glass
slides

in nasopharyngeal swabs
to show dELISA in clinical sample

Wilson86

3.8 fg/mL

McGuigan49

(200 aM)

Kan87

IL-10

40 fL
/216k
wells

Cyclic
Olefin
Polymer

-Fully automated

25-50k
beads

Bluray
Printing

from Quanterix Simoa HD-1

commercial digital ELISA

Analyzer
Yelleswarapu88

3.7 fg/mL
(300 aM)

22.5 pL /
10M
droplets

PDMS
and Glass

-Integrated mobile platform
with parallelized droplet

3D stack
7.0 fg/mL

generation and detection

1M beads

(350 aM)

with cloud computing

Digital ELISA: In addition to nucleic acids, proteins have enormous potential in
measuring the physiological conditions, but traditional ELISA techniques cannot
generate the single molecule sensitivity due to background fluorescence of blank
samples. To overcome this obstacle, digital ELISA confines single molecules into
partitions by first using a bead-based ELISA approach, where antibody-functionalized
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beads capture a single protein from the sample by setting the concentration of beads
higher than the number of proteins. The unbound sample is washed away, and the
captured protein is then labelled with a detection antibody, washed to remove unbound
detection antibodies, and then labeled with an enzyme43,89. When these enzymes are
present in a partition, the inactive substrate turns fluorescent, and the fluorescent dye
and bead are measured together to count the total protein molecules (Figure 1.1a,
Table 1.2). In PCR, specificity comes from the primers that can bind to very specific
target sequences. In ELISA however, any enzyme that is not washed away properly and
remains in a well not bound to a bead will cause a false positive. Therefore, there are
two critical requirements for developing a successful digital ELISA assay: the sandwich
assay between the protein and antibodies must be strong and not dissociate during
subsequent wash steps, else it will result in false negatives. Second, excess labeling
enzyme must be completely washed away, else it will result in false positives44. In bulk, a
single molecule in 100 µL is 2 *10-20M, thus even the best antibodies with low Kd in the
nM range would be unable to compete with background protein molecules in serum or
plasma that would create false positives from non-specificity issues. But when confined
in fL volumes, the 1011 higher concentration now allows combinations of antibodies that
are in the µM to nM range8578443,89. The bead based approach of capturing a target
molecule and labeling it an enzyme can also be accomplished with nucleic acids90,91. A
powerful advantage of ELISA comes from its simplicity without the need for
thermocyclers – and if the same sensitivity of target molecules in a 100 µL sample can
be mathced – digital ELISA offers great potential for simpler ultrasensitive detection
compared to digital PCR.

In addition, multiplexing can be achieved by using color

encoded beads with different combinations of dye that each capture a specific protein;
creating a higher order multiplexing strategy similar to multiplex digital PCR2192.
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Single Cell Sequencing: More complicated approaches with digital assays also
exist that can identify large amounts of heterogeneity. Personalized medicine aims to
find these differences in heterogeneity and optimize treatment options. Since droplets
allows millions of experiments to be done simultaneously, digital assays with single cell
sequencing has evolved to measure cells from large tissues in entire organisms to find
variations in how genes are expressed. One popular technique termed “Drop-seq”53
analyzes mRNA from individual cells by compartmentalizing a single cell, lysis buffer and
primer barcoded beads into droplets. As cells are lysed, mRNA can bind to the primers.
All the droplets are broken to release beads, which go through a reverse transcription
process to generate cDNA. This DNA can be amplified and sequenced to measure a
large panel of mRNA from single cells. Tabula Muris is an example of taking all of the
resulting information that was generated from commercial platforms such as Biorad’s
digital PCR, 10x Genomics, and sequencing93. These types of parallel assays generate
enormous amounts of biological data. The interpretation of this data is still in nascent
stages as researchers are using data mining algorithms to eventually map out how
genes, proteins, and physiology are all linked to classify patients in different states.
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1.4 Point of Care Diagnostics
While digital assays have proven ultrasensitive detection has enormous
advantages for early detection and in general understanding physiological conditions,
most of these techniques rely on bulky, expensive equipment. Point of care devices
eliminate equipment that cannot be used in the field and instead rely on simpler tests
that often have a qualitative readout such as a color or turbidity change 94. The simplest
of these are based on paper and use the wicking motion of liquid to flow liquid over a
region where a reaction takes place95. The most common are lateral flow assays, where
antibodies are printed onto a region, and after the sample is introduced, can change
color in the presence of a target biomarker. These have been successfully
commercialized for pregnancy tests, while other electrochemical sensors are used for
glucose measurements with a prick of blood96. Point of care devices excel in conditions
that have concentrated biomarkers in a small volume, allowing qualitative measurements
to provide satisfactory information.
However, most point of care devices cannot provide the quantitative information
and the ability to detect rare molecules necessary for many diagnostic applications.
Diseases like HIV, cancer, and traumatic brain injury are hard to diagnose using PoC
devices since the small fold changes or limit of detection required cannot be achieved
through later flow assays97,98. Several groups have used inexpensive CMOS cameras
with LEDs, and 3d printed casing where a reaction on a microfluidic chip can be
observed99. A large subset of these have transitioned to the use of smartphone-based
readouts, due to their powerful cameras, built in LEDs, computation power, and
connection to the cloud to transmit data and results100,101. In addition, smartphone-based
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systems have been combined with brightfield, fluorescence imaging, spectroscopy,
phase imaging, and multicolor techniques to demonstrate the power of a handheld
device that is ubiquitous around the world102. By combining smartphone-based
technology with techniques like machine learning, powerful image analysis and
diagnostics have emerged103.
Several groups, including our own, have combined the power of smartphone
technology with digital assays to achieve ultrasensitive detection in a mobile platform104.
Most groups use static arrays where compartments are made on a simple chip and an
LED excitation source is separated from the emission through optical filters. Slip Chip is
an example of a microfluidic platform that uses arrays with isothermal amplification, and
counts the total number of fluorescent compartments105. Other readouts such as a
rotating cuvette with a laser diode readout was also used for a smaller footprint device,
termed the Integrated Comprehensive Droplet Digital Detection106. While many portable
techniques have been developed, they often lack the dynamic range, sensitivity, or
integration required for a point of care device with ultrasensitive detection.

21

1.5 Challenges with current systems
Current digital systems often require that the input sample must be purified or
diluted. If the sample is not processed or enriched, volumes required could be as large
as 10mL to interrogate for sparse targets that would otherwise be missed if sampling
only 100 µL. For example, in the case of pancreatic cancer, there can be as few as onethree pancreatic cancer cells in the background of billions of other particles in 1 mL of
blood107,108. Therefore, to get a confident readout, it is best multiple mL of blood.
However, most commercial techniques such as Biorad’s digital PCR system, or
Quanterix’s Simoa often use 100uL of sample as an input for a test. If a large sample is
broken up into 100uL aliquots, this would increase the reagent cost and time cost. This
becomes an even larger issue in cases like single cell sequencing, where the library
prep and costs for processing these large samples for extremely rare cells would be
resource intensive. In addition, many of the technologies developed for digital assays
took what was available in flow cytometry and applied the same principles to droplets109.
The inherently low throughput nature of generating droplets one by one for analysis for
up to 10mL of sample is highly impractical since measuring this volume would take
nearly 10h per sample, assuming a 10kHz processing time and 40 µm diameter droplets.
Therefore, parallelization from sample preparation, enrichment, droplet generation,
incubation, detection and analysis is mandatory to make digital assays appealing for the
most challenging, yet highest impact, applications.
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Figure 1.2: Miniaturizing bulky equipment into an integrated, portable platform. a.
The Biorad Digital PCR workflow requires first centrifuging sample to separate plasma or
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serum. The sample is then used for the droplet generator, where it is transferred to a
plate sealer, and then moved to a droplet detector that is connected to a computer. b,c.
In order to compress the systems, we have envisioned an ideal device that has a
membrane sample processor to first filter out molecules based on size or magnetic
sorting. Downstream of the membrane is a 3D chip where droplets are generated,
incubated, and detected in parallel. Using a smartphone-based readout with peristaltic
pumps, equipment is inexpensive without sacrificing robustness or sensitivity. A true
sample in to results out can be displayed on a cell phone with multiplexed, ultrasensitive
measurements.
The ASSURED criteria sets the standards for an ideal point-of-care device, and
the addition of ultra-sensitivity would be a feature that further extends what could be
possible in a portable device. Assay sensitivity, reproducibility, specificity and dynamic
range are criteria that can act as quantifiable measures for an ideal device. First, a limit
of detection for nucleic acids have already been shown with up to 1:200,000 specificity
for single mutated KRAS genes in the background of unmutated genes, showing the
capability of digital PCR.

10110

Similarly, zM concentrations of enzymes can accurately be

detected through digital ELISA – making droplets ideal platforms due to their inherent
robustness and endpoint measurements. Next, specificity in PCR comes from base pair
bonding, while in ELISA comes from the binding events between the antibodies and the
proteins. A major advantage of amplification inside droplets is that millions of dye
molecules can be detected in a small volume – obviating the need for expensive lenses,
optical setups, and lasers that are traditionally required for flow cytometry-based
approaches.
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One of the main tradeoffs in commercially available ultrasensitive assays and
those that have been implemented in the field, is that dynamic range is often sacrificed
for simplicity111. This means that static arrays with a small number compartments can be
implemented on simple devices in the field, making more complicated scenarios where
multiple biomarkers are at varied concentrations over a 103 range becomes difficult to
measure without serially diluting samples. However, diluting samples does not always
produce a linear effect due to matrix effects112, which can complicate the attempt to
serially dilute and run multiple digital assays. If the same sample is broken up into 10 3
droplets as opposed to 106, a positive partition will have a lower signal to background. In
addition, lower number droplet assays often employ the use of the Most Probable
Number (MPN) algorithm that back calculates the initial concentration based on empty
droplets due to statistical filling of positive droplets113. This means that the absolute
quantification of digital assays is lost with a limited number of partitions.
In addition, having the ability to process millions of droplets enables key
applications in areas like copy number variation genotyping, detecting of sparse cell free
DNA in large samples of blood, low-level viral load and pathogens, and preparing for
next generation sequencing libraries.113 Applications that require multiplexing are also
highly limited if the 10k droplets in an assay workflow have to be split by 10 biomarkers
and then back calculated, which loses the strengths of digital assays. Furthermore, next
gen sequencing and techniques that employ barcoding mechanisms for cells or DNAtagged antibodies require millions of droplets to cast a wide net for the inherent
variability in biological systems114. Since current workflows that can process such large
quantities are too expensive and bulky, an ideal device would also be able to process
droplets at ultra high-throughput.
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Sample prep would have to be integrated such that machines such as
centrifuges that require lab facilities are not needed. Next, while many microfluidic chips
are small, they often rely on expensive syringe pumps to control flow, or a computer to
analyze the results – making them not truly portable. In other scenarios, these
microfluidic chips also rely on microscopes, lasers, and optical components that must be
fixed precisely, or the imaging becomes impaired. Therefore, another feature of an ideal
device is that it is robust to the precision needed for many microfluidic platforms, without
requiring expensive pumps or detection platforms. Integration is also critical, since
having users transfer samples, collect droplets, and reinject them results in loss and
variability between runs. Therefore, a sample to readout device with ultrasensitive
detection while being portable can unlock the potential of digital assay from lab facilities
to a wider group of researchers and clinicians.

26

CHAPTER 2: ULTRA-HIGH THROUGHPUT DETECTION (1 MILLION DROPLETS /
SECOND) OF FLUORESCENT DROPLETS USING A CELL PHONE CAMERA AND
TIME DOMAIN ENCODED OPTOFLUIDICS
This chapter is a slightly modified version of a manuscript published in Lab on a Chip:
VR. Yelleswarapu, H. Jeon, S. Yadavali, D. Issadore, Ultra-High Throughput Detection
(1 Million Droplets / Second) of Fluorescent Droplets Using a Cell Phone Camera and
Time Domain Encoded Optofluidics, Lab on a Chip, DOI: 10.1039/C6LC01489E, 2017.
V. Y. conceived and performed all experiments in this study, coded the Matlab software,
created the Android app, as well as prepared the manuscript and figures.

2.1 Abstract
Droplet-based assays — in which ultra-sensitive molecular measurements are
made by performing millions of parallel experiments in picoliter droplets — have
generated enormous enthusiasm due to their single molecule resolution and robustness
to reaction conditions. These assays have enormous untapped potential for point of care
diagnostics but are currently confined to laboratory settings due to the instrumentation
necessary to serially generate, control, and measure tens of millions of droplets. To
address this challenge, we have developed the microdroplet Megascale Detector (µMD)
that can generate and detect the fluorescence of millions of droplets per second (1000x
faster than conventional approaches) using only a conventional cell phone camera. The
key innovation of our approach is borrowed from the telecommunications industry,
wherein we modulate the excitation light with a pseudorandom sequence that enables
individual droplets to be resolved that would otherwise overlap due to the limited frame
rate of digital cameras. Using this approach, the µMD measures droplets at a rate of 10 6
droplets/sec (ɸ = 166 mL/hr) in 120 parallel microfluidic channels and achieves a limit of
detection LOD = 1 µM Rhodamine dye, sufficient for typical droplet based assays. We
27

incorporate this new droplet detection technology with our previously reported
parallelized droplet production strategy, incorporating 120 parallel droplet makers and
only one set of continuous and droplet phase inputs and one output line. By miniaturizing
and integrating droplet based diagnostics into a handheld format, the µMD platform can
translate ultra-sensitive droplet based assays into a self-contained platform for practical
use in clinical and industrial settings.

2.2 Introduction
Droplet-based assays, in which microscale emulsions are used as isolated
compartments to run many independent chemical reactions, have demonstrated
enormous utility in recent years as a platform for the ultrasensitive detection of small
molecules, proteins, and nucleic acids115–122. The sensitivity of droplet-based assays
arises from the 106x reduction in volume from conventional assays (>µL) to the volume
of individual microscale droplets (pL). However, the enormous increase in sensitivity
comes at the expense of cumbersome instrumentation and time-consuming, not fully
automated processing (T >> 1 hour for current commercial systems123) to generate,
incubate, and measure millions of droplets — including pumps, optics, thermal cyclers,
and multiple microfluidic chips. Primarily, this processing time is currently limited by the
inherently low throughput rate (<104 droplets/sec) in which microscale droplets are
serially generated and fluorescently detected69,124–126. (Fig. 1a)
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Figure 2.1. μMD Implementation. a. Conventional digital assays are
currently confined to laboratory settings due to the instrumentation necessary to
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serially generate, control, and measure tens of millions of droplets, with typical
droplet throughput limited to f ≅ 1 kHz. For a 107 droplet experiment, the
experiment time is T ~ 2.8 hours. b. Our μMD can generate and detect the
fluorescence of millions of droplets per second, by parallelizing both the
generation of droplets and the detection of droplets to achieve f = 1 MHz,
resulting in T = 10 seconds for a 107 droplet experiment. c. The µMD consists of
a cell phone, a custom 3D printed piece that contains inexpensive optics, an
LED, and a disposable microfluidic chip. d. Using conventional excitation that is
constant in time, as a droplet travels through a microfluidic channel, it is imaged
as a streak that has a length Lstreak = v*Texp, where v is the droplet’s velocity and
Texp is the camera’s exposure time, that sets the minimum distance between
droplets. e. Neighboring droplets closer than Lstreak have streaks that overlap and
cannot be resolved. f. The µMD breaks the tradeoff relationship between droplet
spacing and flow velocity v. The LED excitation is modulated
One promising direction to scale-up droplet production and detection has been the
development of platforms that make it possible to operate many microfluidic droplet
generators and detectors in parallel127–131. Many promising technologies have been
proposed in this area132–135. (Table 1) Imaging platforms have been designed that can
measure as many as 1 million droplets simultaneously19. In-flow detection systems, in
which droplets pass one-by-one through an optical detector can measure a far greater
number of droplets than is possible using static imaging, and have the advantage that
droplets can be sorted downstream of the detector55,136–138. In recent years, microfluidicbased techniques have been proposed to detect droplets without the need for expensive
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lenses, cameras, and lasers, which were conventionally necessary for in-flow detection.
In one particularly promising approach, hybrid CMOS/microfluidic chips have been
reported that can detect droplets flowing in parallel channels, achieving high throughput
detection

(254x103

droplets/sec) using

no

lenses139.

However,

these

hybrid

CMOS/microfluidic approaches are limited by the expense of incorporating centimeter
sized post-processed CMOS chips (> $10/chip)27 into a disposable microfluidic
component. Alternatively, devices have been developed in which the light coming from a
fluorescent droplet is modulated using microfabricated apertures, enabling parallel
streams of micro-scale droplets or cells to be detected using only a single
photodetector129,140–143. (Table 1) These approaches, however, are limited to a
throughput < 5k droplets/sec, resulting in > 30 minutes to read out each 10 million
droplet-based

assay,

and

require

specialized

optics,

electronics,

lithographically defined apertures on the microfluidic chip.
Table 1 - Technologies to Perform Digital Assays
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and

micro-

Building on this previous work, we have developed a new approach to
miniaturizing droplet based assays that can achieve a throughput of 106 droplets/sec,
1000x faster than conventional methods, using a conventional smartphone camera and
inexpensive disposable chips. (Fig. 1b) By harnessing ultra-bright LEDs with the
sensitivity

and

computing

power

of

smartphone

based

imaging

and

cloud

computing134,144, we were able to implement our platform as a self-contained mobile
device. (Fig. 1c) The key innovation of our approach is modulation of the excitation light
in time with a pseudorandom sequence that enables individual droplets to be resolved
that would otherwise overlap due to the limited frame rate of digital cameras. Using
conventional excitation that is constant in time, as a droplet travels through a microfluidic
channel and moves across the camera’s field of view, it is imaged as a streak 145 whose
length Lstreak = v*Texp is a function of the droplet’s velocity v and the camera’s exposure
time Texp. (Fig. 1d) This streak length Lstreak sets the minimum distance that must be
maintained between droplets for them to be resolved. To illustrate this point, for droplets
that have a diameter ddrop = 35 µm that are traveling through a typical microfluidic
channel (40 µm wide and 35 µm tall) at ɸ = 5 mL/hr, using a typical camera with 1/Texp =
60 frames per second (FPS), the minimum separation is Lstreak = 472*ddrop. Droplets that
are separated by less than Lstreak are imaged as overlapping streaks that cannot be
resolved. (Fig. 1e)
The key innovation of our approach breaks the tradeoff relationship between
droplet spacing and flow velocity v, allowing the throughput and dynamic range to be
dramatically increased. To this end, we modulate the LED excitation with a
pseudorandom sequence at a rate >10x faster than the exposure time of the camera,
encoding the droplet streak with a pattern that allows it to be resolved using correlation32

based detection amongst neighboring droplets with a separation as small as 3.5*ddrop.
(Fig. 1f) Moreover, we use the entire field of view of the camera to include 120 parallel
channels, enhancing the throughput by a further 120x relative to a single channel. In
contrast to previous approaches, which used lithographically patterned apertures to
modulate the fluorescent droplet in the time-domain129, we can achieve 100x improved
throughput and obviate the need for lithographically defined apertures, enabling
extremely low-cost implementation that requires no lithography (<10ȼ/chip)146.
Furthermore, our use of conventional cell phone cameras offers an opportunity for
droplet microfluidics to be harnessed for point of care applications due to the ubiquitous
availability of smartphones144,147,148. To demonstrate the utility of our platform, we
demonstrated extremely high throughput (1M droplets/sec, ɸ = 166 mL/hr), sensitivity
comparable to conventional laser-based techniques (1 µM resorufin dye)136, and a
dynamic range of fluorescent droplets:non fluorescent droplets (1:107 to 1:40) that
matches the typical dynamic ranges for ultrasensitive digital assays149,150. (Table 1)

2.3 Methods
Microdroplet Megascale Detector (µMD) Design
The key innovation of our µMD technology is the modulation of the excitation light
with a pseudorandom maximum length sequence (MLS). (Fig. 1f) This modulation of the
excitation light in time translates into a modulation of the image streak in space, (Fig.
1g) which allows fluorescent droplets to be detected even amongst other densely
packed fluorescent droplets. (Fig. 1i) The modulated image is analyzed by correlating
the image with the expected modulation pattern m, creating a signal Ψ(X) =
∫Sn(x)m(x+X)dx = Sn⊗m, wherein droplets can be resolved with far greater resolution
than in the unprocessed image. (Fig. 1h,j) We have chosen as our modulation pattern
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the MLS sequence because its autocorrelation function approximates a Kronecker delta,
thereby allowing the best possible resolution of droplets in the processed signal Ψ. MLS
sequences

were

originally

developed

for

applications

in

radar

and

telecommunications,151 and have previously been used in droplet based detection
schemes129.
To design the optimal MLS sequence for our detection platform, there are two
main considerations. First, it is advantageous to include as many bits in the MLS
sequence as is possible to minimize the width of its autocorrelation peak. The number of
bits is constrained by several key parameters of our smartphone based implementation.
The maximum number of bits in the MLS sequence |m|max = Lstreak/Δx = v*Texp/Δx is set
by the spatial resolution of the camera Δx, the droplet velocity v, and the exposure time
of the camera Texp. This value is further constrained by the length of our imaging field of
view LFOV = 12 mm, which sets the length of the droplet streak Lstreak that can be imaged.
We chose to set Lstreak ≈ 1/3*LFOV, such that each droplet’s modulated streak is measured
fully in at least one frame. The length of the MLS sequence that we used was |m| = 63
bits. One further consideration for our technique is droplet diameter d. If the droplets
have a diameter d larger than the resolution of our camera Δx, it sets the minimum bit
size in the MLS pattern. In this implementation, we set the droplet diameter to d = 35
µm. For the |m| = 63 bit MLS pattern that we use, where each bit is ~60 µm, the droplet
diameter must follow the condition d < 60 µm to avoid blurring the MLS pattern.
Signal Extraction
The µMD’s signal analysis workflow is as follows: i. the video stream from the cell
phone camera is partitioned into individual frames. (Fig. 2a) ii. The image is digitally
filtered, such that only the red component from the RGB image representation remains
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and spherical aberrations, which arise from our inexpensive smartphone based optics,
are digitally corrected. (Fig. S1). iii. Each of the individual 120 microfluidic channels in
the image is partitioned, (Fig. 2b) and for each channel, the fluorescence intensity is
measured along the length of the channel using a line average. Thus, each video frame
is converted into 120 one-dimensional vectors Sn=1:120 of length 1080. iv. For each of
these vectors Sn, droplets are identified by correlating the fluorescence intensity in the
channel Sn with the expected MLS signal m, Ψ = Sn⊗m. (Fig. 2c) v. Indexed by the
video frame k and the channel n, a matrix [xk,n,vk,n] is generated that reports the droplets
detected.
A major challenge of our detection technique is that it requires knowledge of
each droplet signal’s velocity v and its phase shift θ relative to the MLS pattern m used
to excite the droplets. Rather than add additional cost to our platform by phase locking
the excitation of our LED to the cell phone camera or controlling velocity using a more
expensive pump, we instead use a cloud computing implemented algorithm to optimally
detect each droplet with unknown velocity v and phase θ. To this end, we correlate each
Sn,k with the MLS pattern m(x,v,θ), a three dimensional matrix that contains all possible
phases θ and velocities v, (Fig. 2d) and search within the resultant 3D matrix Ψ(x,v,θ)
(Fig. 2f) for peaks with an amplitude greater than a defined threshold, and record the
position and velocity [xk,n,vk,n] of every droplet. This analysis allows the correct phase θc
(Fig. 2g) and velocity vc (Fig. 2h) to be determined for each individual droplet.
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Figure 2.2. Signal Analysis Workflow. a. Each video frame from the cell phone
camera is first partitioned into 120 one dimensional vectors Sn (b), corresponding to the
fluorescence intensity along the length of each microfluidic channel. c. Each vector Sn is
analyzed by correlating it with the expected signal m(x/v-θ), where v is the expected
droplet velocity and θ is the expected droplet phase. d. A flow chart of the µMD’s
algorithm to detect droplets with unknown velocity v and phase θ. e. A timing diagram of
our cell phone’s rolling shutter readout, which complicates our measurement by giving
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each vector Sn a different phase θ. f. Each Sn is correlated with m(x,v,θ), a three
dimensional matrix that contains all possible phases θ and velocities v, resulting in a 3D
matrix Ψ(x,v,θ). Within this 3D vector Ψ(x,v,θ), peaks are identified that allow droplets to
be detected at their correct phase θc (g) and velocity vc (h). i. A single microfluidic
channel is shown at various frames k, showing that individual droplets are detected in
multiple frames. j. We perform correlation analysis on Ψ between subsequent frames to
further improve accuracy. with a pseudorandom sequence, modulating the streak (g)
such that it can be resolved using correlation based detection (h), even amongst close
by neighboring droplets (i,j).

There are several considerations, based on our hardware implementation, that
inform the design of our algorithm. The computation time for our algorithm is
approximately proportional to the number of velocities v that our algorithm searches. To
determine the appropriate number of velocities, we measured the coefficient of variation
of droplet velocity CV = 4.4% at ɸ = 100 mL/hr by imaging the streak lengths of sparse
non-overlapping droplets. (Fig. S3) Based on this measurement, we calculate Ψ(x,v,θ)
over a domain that covers ±20% of the mean velocity, with 34 increments. Matching the
phase θ for each signal Sn to the phase of the MLS pattern m is complicated by our cell
phone camera's (Samsung Galaxy S7 Edge) use of rolling shutter. In a digital camera
that uses rolling shutter, which includes most currently available cell phone cameras,
each row of the imaging sensor is sequentially readout over the period defined by the
frame rate. (Fig. 2e) Thus, the exposure time for each row Texp is sampled at an offset
window in time, resulting in a phase shift between each Sn. Because of this readout
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technique, we choose to orient our microfluidic channels to align with the rows of the
CMOS sensor in the digital camera, such that within each vector Sn the phase θ is
constant.
In addition to the analysis performed on each individual frame k in the video, we
also perform correlation analysis between subsequent frames to further improve
accuracy. Detected droplets in a given frame k are cross referenced with droplets
detected in subsequent frames (Fig. 2i) by comparing the droplet's expected position
x*k+1,n = xk,n + vk,nTexp, based on its measured velocity and position [xk,n,vk,n], (Fig. 2j) with
its measured position in the subsequent frame xk+1,n. The algorithm described above is
implemented in Matlab (source code provided in SI). Due to the required
computational power, this program is not performed directly on the cell phone. Using a
Windows 7 PC with an Intel Core i7-4700 @ 3.4 GHz and 16 GB RAM, we can locally
process the data at a rate of 106 droplets/30 min. In addition, we take advantage of
ubiquitous wireless networks, and perform the computation either on a local server or
using Matlab's Cloud service, to greatly speed up processing, both of which interface
with a mobile app installed on the cell phone based device that we created. (Fig. S2)
µMD Implementation
The µMD consists of a disposable microfluidic chip, a cell phone, and a 3D
printed piece that we designed. The 3D printed piece contains an LED, a low-cost
commercial plastic lens (<$4), and a slot to automatically align and focus the microfluidic
chip. (Fig. 3a) The disposable microfluidic chip is constructed of only PDMS and glass,
and is prototyped using soft lithography at The University of Pennsylvania's Singh
Center. A hobbyist-grade, clip-on plastic macro lens (15x magnification, Carson
HookUpz, ML-515) is used to magnify the microfluidic chip to a field of view FOV = 7x12
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mm2. Mounted in-line with this lens is a longpass filter (λc = 605 nm, Edmund Optics,
#52-528) to diminish background scattered excitation light in the image. (Fig 3b) An
ultra-bright green LED (λex = 530 nm, Luminus, CBT-90-G-C11-JK201) is used with a
bandpass filter (λcuton = 535, λcutoff = 585 nm, Omega Optical, 560AF50-X), to further
diminish the excitation light that reaches the cell phone's camera. The LED is driven
using external electronics consisting of an LED driver circuit (Luminus Development Kit,
DK-114N-3) and a microcontroller (Arduino Mega2560). To illuminate the droplets in the
microfluidic channels we make use of anti-resonant side coupling152 which ensures
uniform illumination. The MLS sequence that we use is stored in our microcontroller, and
is used to modulate our LED. The non-disposable cost, excluding the cell phone, of the
µMD prototype is < $500.

39

Figure 2.3. µMD Implementation. a. A schematic cross section of the µMD. A
microcontroller controls the LED excitation pattern. Bandpass BP ex and long pass LPFem
filters reduce background signal in the cell phone image. The microfluidic chip is sidecoupled to LED such that total internal reflection ensures uniform excitation across the
chip. The cell phone video is processed using a remote server that has the processing
power to perform our computationally intensive signal processing. b. The spectrum of
the LED excitation, the cell phone camera’s red channel CMOS-R, the excitation BPex
and emission filters LPFem, and Rhodamine dye’s absorption and emission. c. A
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schematic of the µMD chip, showing the droplet generation module, the droplet
distribution module, and the detection module. Micrographs of each of these modules
are shown. Scale bars are 100 µm.

The disposable microfluidic chip consists of three modules, i. a module to rapidly
generate monodispersed droplets

130,131;

ii. a module to distribute these droplets to

parallel detection channels44, and which in future implementations can include delay
lines for chemical reactions to take place within the droplets 45; and iii. the µMD's ultrahigh throughput cell phone based fluorescence droplet detection. These modules are
integrated into a low-cost all-polymer (PDMS) and glass chip, for point of care
implementation. To rapidly generate droplets, we make use of an architecture
previously published by our group17, which enables N = 200 droplet generators to be
incorporated onto a single chip with only one input for the droplet phase, one input for
the continuous phase, and one output line.16,17 (Fig. 3c) Droplets were generated with
droplet diameter d = 35 µm, using a ladder geometry that can achieve high throughput
>106 droplets/sec with only small variation in droplet diameter (CV < 7%)17. Droplet
diameter was validated using fluorescence microcopy (Fig. 3c). Downstream of the
droplet generator, the droplets are evenly distributed over the 120 channels using an
array of pillars, which are 60 µm in diameter and are spaced by 180 µm in a hexagonal
array. (Vid. S1, CAD schematic provided in SI)153. The N = 120 flow channels where
µMD detection is carried out have a height of 40 µm and a width of 35 µm to
accommodate d = 35 µm diameter water droplets suspended in 0.65 cSt Silicone Oil
(Consolidated Chemical) with 5% v/v Span80 (Sigma). We fabricate the chip using
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traditional soft lithography154 and use oxygen plasma surface activation to permanently
bond the PDMS to a glass slide (Corning® Glass Slides, ID: 26005).
Simulations to Parameterize Device Performance
To characterize and to aid in the design of our platform, we created a numerical
model to simulate the performance of the µMD. The model was carried out using Matlab
and all source code is included in the Supplementary Information. In this model, a
simulated signal from the passing droplet was created using an MLS sequence m(x/v −
tp), scaled by a droplet velocity v and placed into a particular channel's signal Sn at time
point tp. N droplets are iteratively placed into Sn with randomly generated tp, and
Gaussian noise is added to the signal to obtain the intended signal to noise ratio (SNR).
The model was verified by comparing it directly to our experimental data. Using this
model, we were able to determine the limits of our detection strategy, and answer the
following questions: i. how does our platform's sensitivity scale with the number of bits in
the MLS sequence? and ii. what design parameters define the throughput of our
platform? For these simulations, we set velocity v = 4 mm/Texp, which corresponds to a
volumetric flow rate ɸ = 145 mL/hr, for 120 channels with dimensions that match our
prototype device and a frame rate of 60 FPS.
To quantify the scaling of our platform's performance with the number of bits in
the MLS sequence, we measured the SNR in our model system using MLS sequences
that ranged from 10 bits to 100 bits. The output signal from our platform Ψ is expected to
have a greater SNRΨ than the raw data SNRraw, as correlation of the raw image with the
expected MLS pattern acts as an ideal filter, diminishing the majority of the noise
because it does not correlate with the expected pattern. To determine the SNR Ψ of our
platform, we calculate the ratio of the energy of the signal from a passing droplet ∫Ψ 2sigdx
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to the energy of a background signal ,where there is only noise and no signal ∫Ψ2bgdx,
over the length of the signal. To test each condition, we ran the simulation for 500
independently simulated droplets. We found that as the number of bits in the MLS
sequence increased, so did the SNRΨ (Fig 4a- top inset). Moreover, as we increased
the number of bits in the MLS sequence, we could detect droplets with diminishing
values of SNRraw (Fig 4a- bottom inset). For example, for a droplet with an SNRraw= 1 (0
dB), the SNRΨ of the output of our platform, for an |m| = 63 bit MLS, increased to SNRΨ
= 100 (20dB).

Figure 2.4. Modeling and Simulating the µMD. a. To determine the number of bits in
the MLS sequence |m|, we compared the signal to noise ratio SNRΨ of the droplet in Ψ
to the droplet in the unprocessed signal SNRraw. Inset Top: At SNRraw = 0 dB, as the
number of bits |m| increased, SNR increased. Inset Bottom: As the number of bits |m|
43

increased at SNRΨ = 20 dB decreased, we could detect droplets with diminishing values
of SNRraw. b. Droplets D1 and D2, not resolvable in the raw signal Sn, could be resolved
in Ψ. c. Twenty droplets, not resolvable in the raw signal Sn, could be resolved in Ψ with
perfect fidelity. d. Receiver Operator Characteristic (ROC) curves for increasing number
of droplets per channel, demonstrate excellent performance Area Under the Curve
(AUC) ~ 1 up to N = 20 droplets in a channel. e. In comparison, using conventional
constant excitation, performance degraded with more than one droplet in the channel. f.
For the MLS patterned droplets, the AUC > 0.95 for as many as N = 20 droplets in a
channel, but the AUC degrades severely for N > 1 droplets using constant (DC)
excitation.

To determine the design parameters that control the µMD's throughput, we
performed a simulation to determine how many positive droplets could be
simultaneously detected in a single channel. For these simulations we used an MLS
sequence containing |m| = 63 bits. We created a set of simulated data consisting of
signals Sn that have N droplets pass through the µMD at random time points tp, within a
single exposure time Texp. To illustrate the µMD's performance at high droplet densities
N, we first successfully demonstrated detection of individual droplets with N = 2 droplets
(Fig. 4b) and N = 20 (Fig. 4c) droplets per channel, which could not be detected using
non-modulated detection due to droplet overlap. The signal from passing droplets in Ψ
was found to have a full width half maximum of 10 pixels, allowing droplets to be
resolved as long as the spacing between droplets was > 20 pixels (3.5*ddrop). To quantify
the tradeoff of sensitivity, specificity, and throughput, we calculated the sensitivity = TP/P
and specificity = (P- FP)/P at various numbers N of positive droplets per channel, where
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true positives (TP) are instances where the detected droplet matched the true locations
of the droplets that were randomly spaced, positives (P) were the total number of
droplets that were randomly placed, and false positives (FP) were detected droplets that
did not co-register with a true droplet. We quantified the device's performance by
sweeping the droplet detection threshold in Ψ, to create a Receiver Operator
Characteristic curve (ROC) and calculate the corresponding Area Under the Curve
(AUC). We tested the device using a density of positively fluorescent droplets with
densities ranging from N = 1 to N = 27 droplets per channel in a given frame. (Fig. 4d)
To test each condition, we ran the simulation 100 times to average over the effect of
random droplet placement tp. We demonstrated that device performance was near
perfect (AUC ~ 1) for N < 19 droplets per channel per frame, above which the AUC
began to drop off. (Fig. 4d,f) We compared this performance to non-modulated
detection, and found that without modulation, at only N = 2 droplets per channel per
frame, the performance (AUC = 0.43) was already extremely degraded. (Fig. 4e,f)
Design Validation
We performed a series of experiments to validate our prototype µMD's capability
to detect droplets across a wide range of velocities v, phase shifts θ, droplet density N,
and fluorophore concentrations C. We first demonstrated that neighboring channels in
the µMD's detection region can be partitioned automatically into channels Sn, allowing
passing droplets to be detected without cross-talk between channels. (Fig. 5a) Next, to
demonstrate that droplets can be detected that have a signal comparable to the noise
level, we measure a droplet with C = 1 µM Rhodamine. In the raw image, the signal from
this passing droplet is barely detectable (SNRraw ~ 1). However, in the correlation output
Ψ, the signal from the passing droplet is easily detected versus the background
45

(SNRΨ ~ 100). (Fig. 5b) Next, we demonstrate that nearby droplets can be detected,
which would otherwise overlap due to the exposure time of the cell phone camera. In
Fig. 5c, two droplets are shown in the raw data, which are not resolvable in Sn, but
become easily resolvable in the correlation output Ψ. We next demonstrate the µMD's
capability to detect droplets across a range of droplet velocities v. In Fig. 5d, two
droplets from separate flow rate experiments, one with a velocity of v = 2.5 mm/Texp and
another with a velocity of v = 6.25 mm/Texp, were simultaneously detected using our
velocity and phase scanning algorithm. We demonstrated the µMD’s capability to detect
droplets across a range of droplet phase shifts θ, which arise from the lack of phase
locking and the rolling shutter of modern cell phone cameras. Fig. 5e shows three
separate channels with different phase shifts θ, which were correctly detected using our
detection algorithm. For these experiments, we generated d = 35 µm diameter droplets
containing Dextran Rhodamine B 10,000 MW with 0.15 M MgSO4 (Thermo, D1824).
These droplets were dispersed in a continuous phase consisting of 0.65 cSt Silicone Oil
(Consolidated Chemical) with 5% v/v Span80. We chose Silicone oil due to its low
viscosity and cost, and found that the known PDMS swelling effects to the oil were
minimal given the short time frame droplets were driven through the device 155. These
experiments were conducted at a volumetric flow rate ɸ = 80 mL/hr and 30 FPS.
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Figure 2.5. Experimental Validation of the µMD’s Key Features. a. Droplets in
neighboring channels can be detected, and their correct channel identified. b. Droplets
with low signal to noise ratio in the raw signal SNRraw ~ 1 could be resolved with high
SNR in Ψ. c. Two droplets that overlap and cannot be resolved in the raw data are easily
resolved in Ψ. d. Two droplets traveling at different velocities v are both detected
accurately due to our velocity invariant detection method. e. Three droplets, in three
different channels n = 47, 64, and 83, with different phases θ, are detected accurately
due to our phase θ invariant detection method.
Quantification of Device Sensitivity and Dynamic Range
To quantify the limit of detection (LOD) of the µMD, we performed a serial dilution
with Rhodamine dye and demonstrated an LOD = 1 µM, sufficient for performing
biological assays such as digital PCR132, enzyme assays133, and ELISA156. In these
experiments, we diluted the dye at various concentrations and measured the SNR of
passing droplets in our µMD. The SNRΨ of a passing droplet in Ψ was calculated by
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integrating the energy of the signal ∫Ψ2sigdx over its length, 20 pixels, and compared it to
the case when there is no droplet passing. The µMD's camera frame rate, which
modifies Texp and thus the SNR, controls the tradeoff between throughput and sensitivity.
In the raw images, the SNRraw can be seen to decrease with concentration C of dye. The
droplets became difficult to observe relative to the noise at concentrations below C = 10
µM Rhodamine at 30 FPS (Fig. 6a) and 50µM Rhodamine at 60 FPS. (Fig. 6b) After
running the raw video data though our algorithm, the SNR Ψ for both the 30 FPS (Fig. 6c)
and 60 FPS (Fig. 6d) data increased by 100x compared to SNRraw. The measured limit
of detection was CLOD = 1 µM Rhodamine at 30 FPS and CLOD ≅ 5 µM Rhodamine at 60
FPS, and was ultimately not defined by SNRΨ but by the digitization error of the digital
camera. Thus, sensitivity can be further improved by using a camera with higher gain or
by increasing the intensity of the LED. For these experiments, the throughput was ɸ = 80
mL/hr for the 30 FPS measurements and ɸ = 166 mL/hr for the 60 FPS experiments.
Quantification of Dynamic Range and Throughput
To quantify the µMD’s dynamic range for counting droplets and its throughput,
we performed experiments where we spiked a known number of fluorescent droplets into
a suspension of non-fluorescent droplets and evaluated the accuracy of the device's
response. The positive fluorescent droplets contained 100 µM Rhodamine and the
negative droplets contained only water. These positive and negative droplets were
generated on two separate flow-focusing droplet generating chips and collected
separately. Droplets in the collection tubes were concentrated based on buoyancy, as
the aqueous phase (ρaq = 1.00 g/mL) had a higher density than the oil phase (ρoil = 0.75
g/mL) and sank to the bottom. Positive fluorescent droplets were then spiked into
negative droplets and thoroughly mixed by pipetting to generate a concentration of 1:40
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positive:negative droplets. This suspension was then serially diluted into lower
concentrations of positive:negative droplets, and each concentrations was independently
measured using microscopy. These suspensions were reinjected into the detection
module of our chip for evaluation. These emulsions had a volumetric fraction of 53% of d
= 35 µm droplets suspended in 0.65 cSt Silicone Oil with 5% v/v Span80.
As the concentration of positively fluorescent droplets increases, passing
droplets begin to overlap in the raw video such that they are not detectable without
processing. (Fig. 6e,f) For numbers of spiked droplets ranging from 3 to 6*105 per mL,
the droplets could be quantified on the µMD with extremely high fidelity (R 2 = 0.985).
(Fig 6g) In Fig. 6g, we demonstrate that the µMD can detect as few as 1:107 to 1:40
positive: negative droplets using the same settings. The upper limit of the dynamic range
was experimentally validated at concentrations as high as 1:40 positive:negative
droplets, beyond which overlapping signals within a single channel begin to limit device
performance. We demonstrated this effect in simulations (Fig. 4f), wherein the
performance began to drop (AUC < 0.95), as the number of overlapping droplets
increased beyond N > 19 droplets in a single channel at any given time, which
corresponds to a concentration of ~1:18 positive:negative droplets. The limit of detection
of 1:107 could be improved even further by analyzing more droplets, at the expense of
increased assay time. These experiments were carried out at ɸ = 166 ml/hr,
corresponding to an f = 1 MHz detection rate (Calculations provided in SI) for ratios of
positive:negative droplets of 10-7 to 2.5*10-2, a value consistent with typical digital
assays157.
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Figure 6. Characterization of the µMD’s Performance. a. Raw cell phone images of a
passing droplet at different concentration of Rhodamine dye, at a frame rate of (a) 30
FPS and (b) 60 FPS. The µMD could detect droplet with SNRΨ > 100 for dye
concentrations as low as C = 1 µM, where the SNRraw ~ 1 at both (c) 30 FPS and (d) 60
FPS. e. The ratio of positively fluorescent droplets to the negative number of droplets
was titrated from 1:107 to 1:40, to evaluate the devices dynamic range for detecting
positive droplets. f. As the density of positive droplets increased to 1:40, many of the
droplets were not resolvable in the raw data due to droplet overlap, but could be
resolved with high fidelity in Ψ. g. A serial dilution of fluorescent droplets: negative
droplets was performed, and a dynamic range from 3 positive droplets /mL to 6*10 5
positive droplets /mL was demonstrated (R2 = 0.985).
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2.4 Discussion
Our µMD platform, with its very large scale integrated parallelized droplet
production and detection, allows digital assays containing 10 million droplets to be
performed in as little as three minutes on a mobile cell phone based platform. By
automating, speeding up, and miniaturizing digital assays, the µMD can translate digital
diagnostics from a laboratory research tool to a point of care diagnostic. Building on this
work, temperature control and delay lines can be additionally incorporated into the
µMD158, to move this work beyond a proof of concept and to molecular sensing. In
addition to making existing digital assays more accessible, due to the µMD’s ultra-high
throughput rate, it can detect sparse molecules in large volume samples (V > 10 mL)
that are impractical to measure using conventional hardware, for applications such as
detecting mutant KRAS genes in the blood of pancreatic cancer patients5 or for
evaluating cures for HIV by detecting sparse copies of latent HIV in the blood of
patients159. While in this paper each of the device's channels were used to measure
droplets from the same suspension, individual channels, or sets of channels, can be
used to measure independent assays simultaneously, allowing for facile multiplexed
biomarker detection. Because our detection method is invariant to droplet velocity, it is
possible to use the detection scheme with low cost portable pumps for point of care
applications. While the droplet generation module demonstrated in this paper130,131 would
suffer from increased droplet polydispersity with a low cost pump, recent strategies for
droplet generation that have greater flow rate invariance could potentially solve this
issue18. Additionally, though this platform was designed for detecting droplets, due to the
high sensitivity of its correlations based detection, it can also be applied to the detection
of fluorescently labeled cells or microbeads145,147. Moreover, this high throughput droplet-
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based chip can be combined with sample processing modules to sort out rare cells,
bacteria, virus, or exosomes for integrated downstream analysis160–162.
To further expand the µMD’s functionality, there are several additional features
that can be incorporated onto the µMD’s monolithic, microchip-based format. For
example, we postulate that this technique can be extended to the detection of multiple
fluorescent colors by including multiple LEDs with different colors, each uniquely
identified by its modulation with a distinct MLS pattern. In addition to measuring the
fluorescence signal from each droplet, dielectric sensors158 could also be added to count
the non-fluorescent droplets as well. The counting of negative droplets is not necessary
for quantifying the number of molecular targets in a digital assay, in the case when the
total number of droplets is much greater than the number of molecular targets. By
adding dielectric sensing to quantify the number of negative droplets, the dynamic range
can be extended to the regime when the number of molecular targets approaches the
total number of droplets. In this paper, we demonstrated cloud computing using a local
server or Matlab’s cloud computing service. Achieving the real time data processing
required for droplet sorting will be challenging and cannot feasibly be done at this time
with cloud computing. Alternatively, local digital signal processing (DSP) based
processing techniques have the potential to solve this problem163. However, resources
such as Amazon Cloud services that allow access to larger numbers of computing cores
could be used to dramatically increase the rate at which the signal is analyzed.
Alternatively, the processing can be carried out using parallel computing on a Graphical
Processing Unit (GPU) for improved computing times.
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2.5 Supplementary Information

Supplementary Figure 2.1: Software Image Correction. a. The low cost macro lens
used in our µMD caused a pincushion distortion (left) on the acquired images that could
be corrected using Matlab’s computer vision toolbox (right). The theoretical distortion
was generated by creating a grid and running the image correction parameters in
reverse to demonstrate how distortion from the lens can be corrected using software
rather than resorting to expensive hardware solutions. b. To calculate the camera
parameters for the image distortion, we used MATLAB’s cameraParameters function to
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find how the coordinates of the checkerboard were distorted due to the lens (left). These
coordinates were used to correct the distortion (right), and these parameters were also
saved for the microfluidic device c. We then implemented this transform for our
microfluidic device, where corrections from translation vectors due to misalignment were
adapted. We show three sequential frames (F1, F2, F3) where initially the distortion does
not allow for proper segmentation as the curvature bends the channels. d. We show that
after image correction, the channels can be properly segmented and the droplet can be
followed through the frames for correlation and further analysis.
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Supplementary Figure 2.2: μMD App for Cloud computing. A custom built app allows
users to record droplet video, upload the video to the Matlab drive, and retrieve results
after running the code online a. The record button opens the Camera app on the phone.
b. The upload button connects to the Matlab drive via a browser, where the files sync to
the cloud. c. The analyze button opens the Matlab Mobile app, which connects to the
Matlab drive and allows users to run the analysis code remotely. The app is provided in
the SI as an .apk file that can be installed on Android phones.
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Supplementary Figure 2.3: Velocity Distribution. To determine the dispersion of
droplet velocity v in the µMD, we measured velocity of droplets in multiple channels at
multiple flow rates ɸ. a. At a given flow rate ɸ, the channels were binned to determine if
the droplet velocity varied as a function of the row position in the device. There was no
significant change in velocity moving across the chip. The error bars represent the
standard deviation. b. Droplet velocity scales linearly with the flow rate (R2 = 0.9978).
Error bars show the standard deviation at each of the given data points.
Supplementary Video 1: Animation of device setup and workflow, along with how the
app interfaces with the cell phone to record and analyze the data.
Cell Phone Parameters:
Unlike a traditional scientific CMOS camera where the user is in control of most image
acquisition parameters35, a cell phone camera has only a handful of features that can to
be optimized prior to recording. Using the S7 Edge’s Camera “Pro” Mode, the following
settings were used to record: i. the focus was manually fixed so the chip could slide in to
an acrylic casing without having to align the chip; ii. the ISO was set to 3200 and
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Exposure to +2 maximize light input unless specified otherwise; iii. aperture was set to
1/30; iv. metering mode was set to Matrix; and (v) the color correction was set to Auto.
All videos were recorded 1920x1080p size at 60 fps or 30 fps using the OpenCamera
App, since this setting captured all 120 channels properly without extremely large file
sizes, and with a field of view of ~12mm by 7mm. While higher resolution videos could
be captured, this would create file sizes that would take much longer to analyze without
significantly increasing the field of view.
Calculation of Droplet Throughput:
To calculate the droplet throughput, we first measured the droplet diameter to be d = 35
µm and the volume fraction of dispersed phase to continuous phase to be 𝝌 = 53%. For
the volumetric throughput ɸ = 166 ml/hr, the droplet throughput f = ɸ / (Vd * 𝝌) = 1.1 MHz
was calculated. To create a suspension with a filling factor of 𝝌 = 53%, we generated the
droplets using a separate chip and concentrated the droplets based on buoyancy before
re-injecting them into the detection region of our chip.

2.6 Supplementary Code:
The supplementary zip file contains: (i) Matlab code for simulations, (ii) Matlab code for
video analysis, (iii) Arduino code to modulate the LED, (iv) CAD schematic of detection
chip, and (v) an apk to install the app on an Android phone. Each folder contains a
readme on how to run the code and parameters to change.
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20161111_Clean_matlab_code_COMPLETE

~~~~~~~~ Simulation_Spacing_Distance_two_beads_ONLY
Simulation_Spacing_Distance_two_beads_ONLY.m
clear all
close all
num_bits = 63; %number of bits in the MLS to use
logbase2pow = ceil(log2(num_bits));%get base power of 2 for number of
bits desired
MLS_seq = mseq(2,logbase2pow,0,0); %generates an MLS
MLS_seq = MLS_seq(1:num_bits); %truncates only the first bits of the
MLS desired
%Stretch the MLS such that each bit = 10 points, or that each bit = 10
%pixels in in the CMOS frame
x = 1:length(MLS_seq);
v = MLS_seq;
xq = 1:.1:length(MLS_seq);
vq2 = 10*(interp1(x,v,xq,'nearest')+1);

%Store a signal matrix
Signal_Mat = zeros(27,1920);
%Create several signals that are spaced apart
Signal_Mat(1,1:length(vq2)) = vq2;
for i = 2:27
Signal_Mat(i,1+floor((i-1)*length(vq2)/13):length(vq2)+floor((i1)*length(vq2)/13)) = vq2;
end
%Add white noise to the signal
snr = -10;
for i = 1:27
Signal_Mat(i,:) = awgn(Signal_Mat(i,:),snr);
end
%Plot the first, middle, and last pattern in the matrix
figure
stairs(Signal_Mat(1,:),'Color',[1 0 0])
hold on
stairs(Signal_Mat(13,:),'Color',[0 1 0])
hold on
stairs(Signal_Mat(27,:),'Color',[0 0 1])
Signal = zeros(1,length(Signal_Mat(1,:)));
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%Add two signals that are next to eaceh other
for i = 13:14
Signal = Signal + Signal_Mat(i,:);
end
%Find correlatoin between the expected and summed signals
corr_vector = xcorr(vq2,Signal);
figure
subplot(2,1,1)
plot(Signal)
title('Summed Signal of 2 64-bit patterns spaced 23 px apart')
subplot(2,1,2)
plot(corr_vector)
title('Correlation of expected signal with Summed Signal')

figure
stairs(Signal,'LineWidth',1)
title('Summed signal')
axis([0 1920 0 300])
%Filter out DC and low frequencies from the correlation
figure
Fs = 1920;
half_freq = Fs/2;
notch_freq_filter =1;
low_freq_filt = 2;
smoothing_factor = 2;
w0=notch_freq_filter/half_freq;
[num,den]=iirnotch(w0,w0/35,-45);
[a,b]=butter(2,low_freq_filt/half_freq,'high');
y=filter(num,den,corr_vector);
yfil=filtfilt(a,b,y);
ysm=smooth(yfil,smoothing_factor);
figure
plot(abs(ysm))
figure
%Due to the shift in the correlation, only a segment of it is relevant
to
%when the expected and signal of interest overlap
actual_vector_that_matters = abs(ysm(640:1920+640));
actual_vector_that_matters=actual_vector_that_matters/max(actual_vector
_that_matters);
plot(actual_vector_that_matters,'LineWidth',2)
%select a threshold
threshold2 = max(actual_vector_that_matters)*.4;
%Find peaks based on a minimal peak distance
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[pks,locs] =
findpeaks(actual_vector_that_matters,'MinPeakDistance',20,'MinPeakHeigh
t',threshold2);
%Plot the information
threshold_line_x = 1:20:length(actual_vector_that_matters);
threshold_line_y = zeros(1,length(threshold_line_x))+threshold2;
hold on
plot(locs,pks,'ro','MarkerSize',6,'LineWidth',2)
hold on
plot(threshold_line_x,threshold_line_y,':','Color',[1 0
0],'LineWidth',4)
axis([0 1920 0 1.2])
xlabel('Frame Pixel')
ylabel('Signal Correlation')
title('Max beads that can be packed into a frame')

%Plot all the relevant information onto one figure
figure
subplot(4,1,1)
stairs(Signal_Mat(13,:),'LineWidth',1)
axis([400 1400 0 50])
title('Signal 1')
grid off
box off
subplot(4,1,2)
title('Signal 2')
stairs(Signal_Mat(14,:),'LineWidth',1)
axis([400 1400 0 50])
grid off
box off
subplot(4,1,3)
stairs(Signal_Mat(14,:)+Signal_Mat(13,:),'LineWidth',1)
title('Signals Overlap')
axis([400 1400 0 50])
grid off
box off
subplot(4,1,4)
plot(actual_vector_that_matters,'LineWidth',2)
hold on
plot(locs,pks,'ro','MarkerSize',6,'LineWidth',2)
title('Correlation peaks')
plot(threshold_line_x,threshold_line_y,':','Color',[1 0
0],'LineWidth',4)
axis([400 1400 0 1.2])
grid off
box off
%
set(gca,'visible','off');

~~~~~~~~ Simulation_packing_dense_droplets_COMPLETE
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SpacingProximity_vs_ROC
Function_to_call_noplotsV3.m
%pick number of bits for MLS and generate signal
num_bits = 63;
logbase2pow = ceil(log2(num_bits));%get base power of 2 for number of
bits desired
MLS_seq = mseq(2,logbase2pow,0,0);
MLS_seq = MLS_seq(1:num_bits);
x = 1:length(MLS_seq);
v = MLS_seq;
close all
xq = 1:.1:length(MLS_seq);
vq2 = 10*(interp1(x,v,xq,'nearest')+1);
%preallocate a signal matrix
Signal_Mat = zeros(27,1920);
%add droplets randomly into segments that are atleast two droplet
diameters
%apart; some code was borrowed from the following:
Signal_Mat(1,401:400+length(vq2)) = vq2;
Signal_Mat(2,401+distnace:400+distnace+length(vq2)) = vq2;
real_locations_droplets = [401 401+distnace];
%place the droplets at different starting points
% for i = 1:num_droplets
%
number_toshift = Pshuffled(i);
%
Signal_Mat(i,1+number_toshift:number_toshift+length(vq2)) = vq2;
%
real_locations_droplets(i) =1+number_toshift;
% end
%add noise to the signal
snr = -10;
for i = 1:2
Signal_Mat(i,:) = awgn(Signal_Mat(i,:),snr);
end
%start adding the droplets such that they overlap
Signal = zeros(1,length(Signal_Mat(1,:)));
for i = 1:2
Signal = Signal + Signal_Mat(i,:);
end
%take a correlation from the expected to the signal that contains all
the
%droplet summations
corr_vector = xcorr(vq2,Signal);
%filter out DC components
Fs = 1920;
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half_freq = Fs/2;
notch_freq_filter =1;
low_freq_filt = 2;
smoothing_factor = 2;
w0=notch_freq_filter/half_freq;
[num,den]=iirnotch(w0,w0/35,-45);
[a,b]=butter(2,low_freq_filt/half_freq,'high');
y=filter(num,den,corr_vector);
yfil=filtfilt(a,b,y);
ysm=smooth(yfil,smoothing_factor);
%plot a portion where the vectors overlap completely
actual_vector_that_matters = abs(ysm(640:1920+640));
actual_vector_that_matters = flipud((ysm(1:1920)));
%normalize the vector
actual_vector_that_matters=actual_vector_that_matters/max(actual_vector
_that_matters);
%the threshold is set from earlier. the threshold value can be changed
to
%get differnet amounts of counted droplets
[pks,locs] =
findpeaks(actual_vector_that_matters,'MinPeakDistance',6,'MinPeakHeight
',threshold2);
threshold_line_x = 1:20:length(actual_vector_that_matters);
threshold_line_y = zeros(1,length(threshold_line_x))+threshold2;

%true positives are where locs match the locs of where droplets are
placed
%false positives are when locs show up that are no in the original list
%false negatives are when a peak is supposed to be there but nothing
shows
%up
%we already know where the droplets were initially placed; so find
those
%locations first and sort
locs2 = locs;
real_locations_droplets2
=sort(real_locations_droplets(real_locations_droplets~=0))';
%this is the known number of droplets we placed randomly
positives = 2;
%preallocate
true_pos = 0;
locs =locs(locs~=0);
real_locations_droplets
=real_locations_droplets(real_locations_droplets~=0);
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%another way to measure this is to look at the differences between
where
%droplets were placed and the distances between peaks incase the
%correlation is off from the exact location; both can be used to affirm
%positive droplets
diff_locs = diff(locs2);
diff_reals = diff(real_locations_droplets2);
diff_locs2 = diff_locs;
diff_reals2 = diff_reals;
%for each of the locations found in corrrelation, compare it to the
list of
%locations where droplets were randomly placed in simulation. If a
droplet
%location matches that of where it was placed, add a true positive.
for i = 1:length(locs)
for j = 1:length(real_locations_droplets)
if locs(i) == real_locations_droplets(j)
true_pos = true_pos +1;
real_locations_droplets(j) = 5000;
locs(i) = 0;
end
end
end
for i = 1:length(real_locations_droplets)
if real_locations_droplets(i) == 5000;
real_locations_droplets(i) = 0;
end
end
true_pos2 = 0;
for i = 1:length(diff_locs)
for j = 1:length(diff_reals)
if diff_locs(i) == diff_reals(j)
true_pos2 = true_pos2 +1;
diff_reals(j) = 5000;
diff_locs(i) = 0;
end
end
end

for i = 1:length(diff_reals)
if diff_reals(i) == 5000;
diff_reals(i) = 0;
end
end
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%false positives are locations that were found in correlation but were
not
%locations were droplets were placed
true_pos ;
false_neg = nnz(real_locations_droplets);
false_pos = nnz(locs);
true_pos2 ;
false_neg2 = nnz(diff_reals);
false_pos2 = nnz(diff_locs);

Packing_MLS_droplets_simulation_MAIN.m
% clear all
% close all
%pick the number of droplets you want to pack
dropletspacing = [6:40];
distances_analyzed = length(dropletspacing);
%set a threshold that you can change to manually sweep different levels
of
%the ROC curve to find the tradeoff between sensitivity and
specificity.
%after inputting a threshold value, the resulting values from the
matrices
%need to be transferred to generate the roc plots
% threshold2 = .5;
%the first matrix set keeps track of the number of droplets
%the second
total_stat_matrix = zeros(distances_analyzed,2);
total_stat_matrix2 = zeros(distances_analyzed,6);
total_stat_matrix3 = zeros(distances_analyzed,6);

%for each number of droplets to look at...
for distance_iteration= 1:distances_analyzed
distnace = dropletspacing(distance_iteration);

%loop through and simulate the total number of false and true
positives
%that occur
%
for repeatingtrialnumber = 1:1
repeatingtrialnumber=1;
Function_to_call_noplotsV3
true_pos_total(distnace) = true_pos;
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%

false_neg_total(repeatingtrialnumber) = false_neg;
false_pos_total(distnace) =false_pos;
%
true_pos_total2(repeatingtrialnumber) = true_pos2;
%
false_neg_total2(repeatingtrialnumber) = false_neg2;
%
false_pos_total2(repeatingtrialnumber) =false_pos2;
%
locs2_length(repeatingtrialnumber) = length(locs2);
% %
end
%
total_stat_matrix(distnace,1:3) = [distnace mean(locs2_length)
std(locs2_length)] ;
%
total_stat_matrix2(distnace,1:6) = [mean(true_pos_total)
std(true_pos_total) mean(false_neg_total) std(false_neg_total)
mean(false_pos_total) std(false_pos_total) ];
%
total_stat_matrix3(distnace,1:6) = [mean(true_pos_total2)
std(true_pos_total2) mean(false_neg_total2) std(false_neg_total2)
mean(false_pos_total2) std(false_pos_total2) ];
%
clearvars -except threshold2 numberofdropletstocall
rangeofdroplets total_stat_matrix total_stat_matrix2 total_stat_matrix3
rangeofdroplets
end

% total_stat_matrix;
% total_stat_matrix2;
% total_stat_matrix3;
%
%
%
sens = true_pos_total/2;
one_minspec = false_pos_total/2;

Packing_thresholdvalue_change.m
% Change threshold value and change
close all
clear all
%several threshold values to sweep for the ROC
threshold_vec = [0:.05:1];
Senstivity_vector = zeros(40,length(threshold_vec));
Specificity_vector = zeros(40,length(threshold_vec));
%Select a threshold and start running the relevant code
for threshold_iterator = 1:length(threshold_vec)
threshold2 = threshold_vec(threshold_iterator);
Packing_MLS_droplets_simulation_MAIN
fprintf('%i',threshold_iterator)
%The matrices here are the sensitivity and 1-specificity of the
%resulting analysis
Senstivity_vector(:,threshold_iterator) = sens;
Specificity_vector(:,threshold_iterator) = one_minspec;
end
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plot_ROC_curves.m
%create ROCs curves
% close all
% clear all
%From the stat matrices found in the first simulation, we can extract
%relevant sensitivities and spec; by manually altering the threshold
for a
%range of values and collecting the data at different increments of
%thresholds
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one_min_spec = [49.5
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% one_min_spec=one_min_spec';
% sens=sens';
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figure
[ m n ] = size(sens);
%since we cannot interpolate with the same set of values, we add a tiny
%amount just to separate overlapping datapoints so that the
interpolation
%algorithm can work.
for i =1:m
for j = 1:n
one_min_spec(i,j) = one_min_spec(i,j) + .0001*j;
end
end

figure
plot(one_min_spec(1,:),sens(1,:),'LineWidth',2)
hold on
plot(one_min_spec(3,:),sens(3,:),'LineWidth',2)
plot(one_min_spec(5,:),sens(5,:),'LineWidth',2)
plot(one_min_spec(10,:),smooth(sens(10,:),3),'LineWidth',2)
plot(one_min_spec(15,:),smooth(sens(15,:),3),'LineWidth',2)
plot(one_min_spec(20,:),smooth(sens(20,:),3),'LineWidth',2)
legend('
1',' 3',' 5','
10','
15','
20')
axis([-.05 1.05 -.05 1.05])
xq = 0:.01:1;
for i = 1:m
x = one_min_spec(i,:);
v = sens(i,:);
vq1 = interp1(x,v,xq,'pchip');
interp_plots(i,1:length(vq1)) = vq1;
end
[o p ] = size(interp_plots);
figure
for i = 1:m
AUC(i) = sum(interp_plots(i,2:end))/(p-1);
end
AUC = smooth(AUC,4);
plot(AUC,'LineWidth',2)
title('AUC v droplets in DC')
xlabel('Droplets overlapping')
axis([0 30 0 1])
figure
plot(xq,interp_plots(1,:),'LineWidth',2)
hold on
plot(xq,interp_plots(3,:),'LineWidth',2)
plot(xq,interp_plots(5,:),'LineWidth',2)
plot(xq,interp_plots(10,:),'LineWidth',2)
plot(xq,interp_plots(15,:),'LineWidth',2)
plot(xq,interp_plots(20,:),'LineWidth',2)
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legend('
1',' 3',' 5','
axis([-.05 1.05 -.05 1.05])

10','

15','

20')

interp_plots = interp_plots';
xq = xq';

%the following loads the data from an example set and plots the
resulting
% AUCS
% figure
% load('AUC_AC.mat')
% load('AUC_DC.mat')
% figure
% plot(AUC_DC, 'LineWidth', 2)
% hold on
% plot(AUC_AC, 'LineWidth', 2)

~~~~~~~~ uMD_Video_Analysis-code
The following files carry out the functions described:
The files follow the workflow described in Figure 2:
uMD_Initialize_Code.m
%initializes all variables such as expected signals, camera parameters,
etc.
%sets the frames to view within the video to start analysis
%calls Frame_Undistrotion to start a chain to .m files that creates a
matrix where correlations are stored
%once the vector is saved into a .mat file that can also be accessed
later as done typically...
%calls Corr_Hough_matrix_script to begin a chain for peak finding
analysis
Frame_Undistrotion.m
%uses camera parameters to undistort spherical aberrations and rotates
any offsets
%calls Frame_segmentation
Frame_segmentation.mat
%segments the frame into N channels and stores the vector into a 1d
line vector
%sends 1d line vector to Segmented_1D_CrossCorr_PhaseVel
Segmented_1D_CrossCorr_PhaseVel.m
%loops through phase and for each phase, begins proper correlation
initiation
%after calling Cross_Corr_no_graphs.m, it finds the optimal phase and
velocity
Cross_Corr_no_graphs.m
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%begins a 2d correlation for the input signal and the selected expected
signal based on the phase
%finds the best matching velocity for the given phase after searching
through the 2d map
Corr_Hough_matrix_script.m
%loads the correlation matrix and begins to search for each segmented
channel, how droplets travel through sequentially
%calls detect_real_droplets
detect_real_droplets.m
%searches through the passed 2d matrix for a given segmented channel if
droplets appear more than 2+ frame in series
%based on expected velocity to designate as a true positive
uMD_Initialize_Code.m
%initializes all variables such as expected signals, camera parameters,
etc.
%sets the frames to view within the video to start analysis
%calls Frame_Undistrotion to start a chain to .m files that creates a
matrix where correlations are stored
%once the vector is saved into a .mat file that can also be accessed
later as done typically...
%calls Corr_Hough_matrix_script to begin a chain for peak finding
analysis

close all force
clear all
% parpool
%uncommeting the above can start the parallel computing toolbox if
%available in matlab. Doing so increases computational speed
significantly
%initialize variables
x1 = 0 ;
x2 = 0;
y1 = 0;
y2 = 0;
inc = 0;
%load the MLS that was used in the Arduino Code
MLS_seq = [-1, 1, -1, 1, -1, 1, 1, -1, -1, 1, 1, -1, 1, 1, 1, -1,
1, 1, -1, 1, -1, -1, 1, -1, -1 , 1 ,1 ,1, -1, -1, -1, 1, -1, 1,
1, 1, 1, -1, -1, 1, -1, 1, -1, -1, -1, 1 ,1, -1, -1, -1, -1,
1, -1, -1 , -1, -1, -1, 1, 1, 1, 1, 1, 1];
%load camera params once to fix image distortion
%The main variables that affect spherical distortion is
'RadialDistortion'
load('cameraParams1.mat')
cameraParams2 = cameraParameters('IntrinsicMatrix',
[716,0,0;0,716,0;1920/2,1080/2,1],...
'RadialDistortion',[.06,0.0,.00],...
'TangentialDistortion',[0,0],...
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'RotationVectors',[0 0 0],...
'TranslationVectors',[0 0 0],...
'ReprojectionErrors',[0 0],...
'WorldPoints',cameraParams1.WorldPoints,...
'WorldUnits',cameraParams1.WorldUnits,...
'EstimateSkew',cameraParams1.EstimateSkew,...
'NumRadialDistortionCoefficients',cameraParams1.NumRadialDistortionCoef
ficients,...
'EstimateTangentialDistortion',cameraParams1.EstimateTangentialDistorti
on);

%select amount of channels and segment based on the pixels per channel
segmented_ch_num = 120;
pixels_per_ch = floor(1080/segmented_ch_num);
%load the interpolated masks. these represent the expected signal
%NOTE: the interpolated masks can change to fit the velocity range
required
%and can be increased or shortened to improve computation. In this
%particular case, the range was chosen to match the data, and
obviously,
%larger ranges with finer resolution will always work but the tradeoff
is
%computation time.
load('All_Interpolated_Masks.mat')
%the table below has several values, but the main ones that are
relevant
%are the first entry which is the filename of a video to be analyzed,
and
%the last term (flip) which represents the direction the droplets are
going
%in.
%Droplets can either go left to right or right to left based on how the
%chpi is attached; the flip vector properly selects the option
%The remaining variables can be ignored for this code.
data_table = {'20160927_165111.mp4' 27 7
624 800 1142
392 1142
377 624 1142
1};
load('cmap2.mat')

800 0

filename = data_table{1}; frame = data_table{2};
flip = data_table{15}; inc = data_table{8};
x1 = data_table{4}; y1 =data_table{5}-inc; x2 = data_table{6}; y2 =
data_table{7} -inc;
%bead two start and end
x3 = data_table{9}; y3 = data_table{10}; x4 = data_table{11}; y4 =
data_table{12};
dropletstart = data_table{13}; dropletend = data_table{14};
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startframe = 450; endframe = 650; %select frames in video to analyze
%a portion of the video is analyzed since there may be a lag time for
%droplets to reach the proper velocity initially, saving computation
time.
%select the background frame to subtract out background signal in the
%algorithm
background_frame = 1;
v_file = VideoReader(filename);
video_frame = read(v_file,background_frame);
R_channel = video_frame(:,:,1);
R_background = R_channel;
%begin loop through each frame
for framestoprocess = 1:endframe-startframe+1
framenum=framestoprocess ;
frame = startframe+framestoprocess-1;
fprintf(num2str(framestoprocess))
%%%%%%%%%%%%%%%%%%%%%% Workflow Chain Begins
%%%%%%%%%%%%%%%%%%%%%%%%%%
Frame_Undistrotion
end
%save the correlation results in a matrix for analysis later if
necessary
save('Frames450to650.mat','-v7.3','corr_matrix_final')
%begin analysis on the correlation matrix
Corr_Hough_matrix_script
Frame_Undistrotion.m
%uses camera parameters to undistort spherical aberrations and rotates
any offsets
%calls Frame_segmentation

close all
%load frame and subtract background
video_frame = read(v_file,frame);
img = video_frame;
red = img(:,:,1)-R_background; % Red channel
%undistort with camera parameters chosen
[J1] = undistortImage(red, cameraParams2);
%define angle to rotate image
x_ang_1 = 607; y_ang_1 = 669;
x_ang_2 = 1435; y_ang_2 = 655 ;
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J1 = imrotate(J1,rad2deg(atan((y_ang_2-y_ang_1)/(x_ang_2-x_ang_1))));
%resize properly. during this portion, we lose several channels that
can be
%imaged but are too distorted at the edges on the top and bottom.
J1 = J1(57:1026,119:1835,:);
red = imresize(J1,[1080 1920]);
%begin segmenting each channel to create 1D line vectors
Frame_segmentation

Segmented_1D_CrossCorr_PhaseVel.m
%loops through phase and for each phase, begins proper correlation
initiation
%after calling Cross_Corr_no_graphs.m, it finds the optimal phase and
velocity
%store the 1d vector ina variable
Patterned_droplet = droplet_line;
whatbead = 1;
sig = Patterned_droplet;
%if droplets flow in reverse direction, we can flip the 1d line vector
for
%correlation here
if flip ==1
sig = fliplr(sig);
end
%begin looping through phase. phase is defined as when the MLS starts,
so
%since the MLS is cyclical, we simply begin at the next cycle of the
MLS to
%loop through the phase
for phase = 1:4:length(MLS_seq)
%for each phase, store the output into a 2d matrix
Cross_Corr_no_graphs
Final_vec_before_phase(phase,1:mat_b) = FINAL_CORR_VECTOR;
end
%find the optimal fit for all the phases
[I,J] = find(Final_vec_before_phase==max(max(Final_vec_before_phase)));
max_corr_Vec_phase = fliplr(Final_vec_before_phase(I(1),:));
Cross_Corr_no_graphs.m
%begins a 2d correlation for the input signal and the selected expected
signal based on the phase
%finds the best matching velocity for the given phase after searching
through the 2d map
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%To vary the range of velocities to scan, this variable can be altered.
%Preallocating the expected signal improves computational time.
Signal_Mat(:,:) = All_Interpolated_Masks(phase,:,:);
ma = Signal_Mat;
out8=xcorr2(sig,ma);
[mat_a mat_b] = size(out8);
%store the length of each MLS for different velocities to normalize
later
flipped_vec = fliplr(lengths_vector);
out8_new = zeros(mat_a,mat_b);
%take correlatoins and normalize by length of the mask
for i = 1:mat_a
out8_new(i,1:mat_b) = out8(i,:)/flipped_vec(i);
end
%select the velocity that generates the largest peak.
[M,N] = find(out8_new==max(max(out8_new)));
Max_out = out8_new(M(1),:);
%Filter to get rid of DC effects
Fs = 1920;
half_freq = Fs/2;
notch_freq_filter =1;
low_freq_filt = 1;
smoothing_factor = 1;
w0=notch_freq_filter/half_freq;
[num,den]=iirnotch(w0,w0/35,-45);
[a,b]=butter(2,low_freq_filt/half_freq,'high'); %remove low frequency
components
y=filter(num,den,Max_out);
yfil=filtfilt(a,b,y);
ysm=smooth(yfil,smoothing_factor);
FINAL_CORR_VECTOR = (ysm);
Corr_Hough_matrix_script.m
%loads the correlation matrix and begins to search for each segmented
channel, how droplets travel through sequentially
%calls detect_real_droplets
clear all
load('Frames450to650.mat')
clear loc_info_all
load('cmap2.mat')
%it may be useful to segment the vector into smaller pieces to analyze
% corr_matrix_final = corr_matrix_final(1+50*3:51+50*3,:,:);
[frames_total, numberofchannels ,framelengtha] =
size(corr_matrix_final);
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%if the droplet was going in the reverse direction, the direction the
%droplet peaks move can be reversed if the proper flip variable was not
%set; rearranging the correlations can correct this
% for i = 1:numberofchannels-1
%
corr_matrix_final(:,i,:) = flipud(corr_matrix_final(:,i,:));
% end
%plot everything frame by frame
warning('off','all')
%convert the 3d matrix into a 1d for each channel
%count all the peaks in a certain channel
max_entire_vector = max(max(max(corr_matrix_final)));
numberofdroplets = zeros(numberofchannels);
allchannelsvectors =
zeros(numberofchannels,frames_total*framelengtha);
threshold2 = max_entire_vector*.4; %set threshold
%for each channel, loop through all the frames and begin counting
for chan_loop_2 = 1:numberofchannels
for chan_loop_2_2 = 1:frames_total
corr_matrix_per_channel(chan_loop_2_2,1:framelengtha) =
corr_matrix_final(chan_loop_2_2,chan_loop_2,:);
end
%for a particular channel, send the data to analyze to:
detect_real_droplets
%store detected droplets into a matrix for each channel
n_matrix(chan_loop_2) = num_totalpeaks_final;
nonzero_perchannel_matrix(chan_loop_2,:) = nonzeros_per_channel;
end
%calculates the total number of droplets in the matrix
sum(n_matrix)

detect_real_droplets.m
%detect peaks in array
%searches through the passed 2d matrix for a given segmented channel if
droplets appear more than 2+ frame in series
%based on expected velocity to designate as a true positive
%initialize variables and input data
hough_array = corr_matrix_per_channel';
[hough_array_a, hough_array_b] = size(hough_array);
loc_info_all = zeros(hough_array_b+3,20);
full_matrix_pks_locs = zeros(hough_array_b,100,100);

for i = 1:hough_array_b
%find peaks in the data based on the threshold set and the expected
%minimum distance between droplets
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[pks,locs] =
findpeaks(hough_array(:,i),'MinPeakDistance',20,'MinPeakHeight',thresho
ld2);
%store the pk values and the locations in a matrix
full_matrix_pks_locs(i,1:length(locs),1:2) = [pks locs];
loc_info_all(i,1:length(locs)) = locs;
end
%find the total number of peaks that were found in the matrix by
%counting all entires that are nonzero as peaks that passed the
%thresholding step
num_totalpeaks_initial = nnz(loc_info_all);
%we now loop through and find repeating peaks.
%if peaks are within the expected velocity range, and occur at least
twice
%we count them as real droplets. If a peak only occurs once with no
%followup, this can be attributed to noise.
expected_velocity = 540;
range = 50;
for i = 1:hough_array_b
set_of_locs = loc_info_all(i,:);
for j = 1:length(set_of_locs)
if set_of_locs(j) ~=0
repeatcount = 0; %this variable checks if a droplet was
able to be seen two or three times successfuly.
locationvalue = set_of_locs(j);
nextlocationvalue = locationvalue+expected_velocity; %this
finds the next location value based on the ranges selected
set_of_locs2 = loc_info_all(i+1,:);
for k=1:length(set_of_locs2)
if set_of_locs2(k)>nextlocationvalue-range &&
set_of_locs2(k)<nextlocationvalue+range
repeatcount = 1; %if a droplet is within the range,
this means a peak was successfully found in the given range of
prediction
if repeatcount==1
nextlocationvalue2 = nextlocationvalue
+expected_velocity; %look for a third peak
set_of_locs3 = loc_info_all(i+2,:);
for l=1:length(set_of_locs2)
if
set_of_locs3(l)>nextlocationvalue2-range &&
set_of_locs3(l)<nextlocationvalue2+range
repeatcount = 2;
if repeatcount==2
loc_info_all(i+2,l) = 0;
break %set repeat peaks to 0 so droples are not overcounted (three
peaks case)
end
end
end
loc_info_all(i+1,k) = 0; %set repeat peaks to 0 so
droples are not overcounted (two peaks case)
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break
%in cases of repeat peaks, the original location
still
%remains, so this is the peak that gets counted as
a
%true positive
end
end
end
if repeatcount==0
loc_info_all(i,j) = 0; %if a droplet was only detected
one time, then discard it. This peak corresponds to a false positive
end
end
end
end
%find all the remaining peaks that correspond to true droplets rather
than
%repeat peaks or single peaks from noise.
num_totalpeaks_final = nnz(loc_info_all);
nonzeros_per_channel= sum(loc_info_all~=0,2);

~~~~~~~~ 2016111_uMD_App_Final_Package_COMPLETE
MainActivity.java
package vraviy.exosomedetection;
import
import
import
import
import
import
import
import
import
import
import
import
import
import
import
import
import
import
import
import
import
import
import
import
import

android.app.Notification;
android.app.NotificationManager;
android.app.PendingIntent;
android.content.ComponentName;
android.content.Context;
android.content.pm.PackageManager;
android.graphics.Bitmap;
android.media.MediaMetadataRetriever;
android.support.v4.app.NotificationCompat;
android.support.v7.app.AppCompatActivity;
android.os.Bundle;
android.view.Menu;
android.view.MenuItem;
java.io.File;
java.io.FilenameFilter;
java.util.Arrays;
android.app.Activity;
android.app.AlertDialog;
android.app.AlertDialog.Builder;
android.app.Dialog;
android.content.DialogInterface;
android.content.Intent;
android.content.SharedPreferences;
android.database.Cursor;
android.graphics.Color;
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import
import
import
import
import
import
import
import
import
import
import
import
import
import
import
import
import
import
import
import

android.net.Uri;
android.os.Bundle;
android.os.Environment;
android.preference.PreferenceManager;
android.provider.MediaStore;
android.provider.MediaStore.MediaColumns;
android.util.Log;
android.view.Menu;
android.view.MenuInflater;
android.view.MenuItem;
android.view.MotionEvent;
android.view.View;
android.view.View.OnTouchListener;
android.widget.Button;
android.widget.ImageView;
android.widget.TextView;
android.widget.Toast;
android.widget.VideoView;
java.util.HashMap;
java.lang.Object;

public class MainActivity extends AppCompatActivity implements
OnTouchListener{
private static final int SELECT_VIDEO = 1;
private static final int RECORD_VIDEO = 2;
// private static final int SELECT_GIF = 3;
private static final String TAG = "MainActivity";
private NotificationManager notificationManager;
MediaMetadataRetriever retriever = new MediaMetadataRetriever();
//FFmpegMediaMetadataRetriever retriever = new
FFmpegMediaMetadataRetriever();
private VideoView selected_video;
//Getting video dimensions for pixels
private int vid_width = 0;
private int vid_height = 0;

//Frames from video
ImageView img, img2, img3, img4, img5, img6, img7, img8, img9,
img10;
ImageView imageView;
TextView textview_ratio, t0,t1,time0_text,time5_text,time10_text;
TextView rotatedYLabel;
@Override
protected void onCreate(Bundle savedInstanceState) {
super.onCreate(savedInstanceState);
if(savedInstanceState != null){
Log.d("STATE",savedInstanceState.toString());
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}
setContentView(R.layout.activity_main);
setupButtonClickListeners();
notificationManager = (NotificationManager)
getSystemService(Context.NOTIFICATION_SERVICE);
CharSequence tickerText = "Hello";
long when = System.currentTimeMillis();
NotificationCompat.Builder mBuilder = new
NotificationCompat.Builder(this)
.setSmallIcon(R.mipmap.ic_launcher)
.setContentTitle("Microdroplet Detector");
Intent resultIntent = new Intent(this, MainActivity.class);
PendingIntent resultPendingIntent = PendingIntent.getActivity(
this,
0,
resultIntent,
PendingIntent.FLAG_UPDATE_CURRENT);
mBuilder.setContentIntent(resultPendingIntent);
Notification notification = mBuilder.build();
notification.flags |= Notification.FLAG_NO_CLEAR |
Notification.FLAG_ONGOING_EVENT;
NotificationManager mNotifyMgr = (NotificationManager)
getSystemService(NOTIFICATION_SERVICE);
mNotifyMgr.notify(1, notification);
}
private void setupButtonClickListeners()
{
//Button exitButton = (Button)findViewById(R.id.exit);
//exitButton.setOnClickListener(this);
((Button)findViewById(R.id.GalleryButton)).setOnTouchListener(this);
((Button)findViewById(R.id.RecordButton)).setOnTouchListener(this);
((Button)findViewById(R.id.Matlabbutton)).setOnTouchListener(this);
}
@Override
public void onActivityResult(int requestCode, int resultCode,
Intent data)
{
Log.d("CREATION", "Clicked button");
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//
Intent browserIntent = new Intent(Intent.ACTION_VIEW,
Uri.parse("https://drive.matlab.com"));
//
startActivity(browserIntent);

}
private void VideoAnalysis(String path) {
retriever.setDataSource(path);
imageView.setImageBitmap(retriever.getFrameAtTime(1000000,
MediaMetadataRetriever.OPTION_CLOSEST));
}
private String getPath(Uri uri)
{
//file:///mnt/sdcard/DCIM/Camera/VID_20111217_233451.mp4
if(uri.toString().contains("content"))
{
try
{
String[] projection = {MediaColumns.DATA};
Cursor cursor =
managedQuery(uri,projection,null,null,null);
int column_index =
cursor.getColumnIndex(MediaColumns.DATA);
cursor.moveToFirst();
return cursor.getString(column_index);
}
catch(Exception ex)
{
return null;
}
}
else
{
return uri.toString();
}
}
private void handleClickEvent(View v)
{
switch(v.getId())
{
case R.id.GalleryButton:
Intent browserIntent = new Intent(Intent.ACTION_VIEW,
Uri.parse("https://drive.matlab.com"));
startActivity(browserIntent);
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//
Intent intent = new Intent();
//
intent.setType("video/*");
//
intent.setAction(Intent.ACTION_GET_CONTENT);
//
startActivityForResult(Intent.createChooser(intent,"Select
Video"),SELECT_VIDEO);
//image/*
break;
case R.id.RecordButton:
Intent recordIntent = new Intent();
recordIntent.setAction(MediaStore.ACTION_VIDEO_CAPTURE);
recordIntent.putExtra(MediaStore.EXTRA_VIDEO_QUALITY,
1);
//recordIntent.putExtra(MediaStore.EXTRA_OUTPUT,
Uri.fromFile(file));
startActivityForResult(recordIntent,RECORD_VIDEO);
break;
case R.id.Matlabbutton:
//
Intent intent = new Intent(Intent.ACTION_MAIN);
//
intent.setComponent(ComponentName.unflattenFromString("com.mathworks.ma
tlabmobile"));
//
intent.addCategory(Intent.CATEGORY_LAUNCHER);
//
startActivity(intent);
PackageManager pm = this.getPackageManager();
Intent appStartIntent =
pm.getLaunchIntentForPackage("com.mathworks.matlabmobile");
if (null != appStartIntent)
{
this.startActivity(appStartIntent);
}
break;
}
}
//#FFA500
@Override
public boolean onTouch(View v, MotionEvent event) {
switch(event.getAction())
{
case MotionEvent.ACTION_DOWN:
switch(v.getId())
{
case R.id.GalleryButton:
//((Button)findViewById(R.id.GalleryButton)).setBackgroundColor(0xFFFFA
500);
break;
case R.id.RecordButton:
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//
((Button)findViewById(R.id.RecordButton)).setBackgroundColor(0xFFFFA500
);
break;
}
return true;
case MotionEvent.ACTION_UP:
switch(v.getId())
{
case R.id.GalleryButton:
//
((Button)findViewById(R.id.GalleryButton)).setBackgroundColor(Color.BLA
CK);
handleClickEvent(v);
break;
case R.id.RecordButton:
//
((Button)findViewById(R.id.RecordButton)).setBackgroundColor(Color.BLAC
K);
handleClickEvent(v);
break;
case R.id.Matlabbutton:
//
((Button)findViewById(R.id.RecordButton)).setBackgroundColor(Color.BLAC
K);
handleClickEvent(v);
break;
}
default:
return true;
}
}
//In an
private
private
private
private
private

Activity
String[] mFileList;
File mPath;
String mChosenFile;
static final String FTYPE = ".gif";
static final int DIALOG_LOAD_FILE = 1000;

private void loadFileList(){
try
{
mPath = new
File(getApplicationContext().getExternalFilesDir(null).getAbsolutePath(
) + "/");
Log.i(TAG,"loadFileList() path: " + mPath.getAbsolutePath()
+ "/");
}
catch(Exception ex)
{
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mPath = null;
return;
}
try{
mPath.mkdirs();
}
catch(SecurityException e){
Log.e(TAG, "unable to write on the sd card " +
e.toString());
}
if(mPath.exists()){
FilenameFilter filter = new FilenameFilter(){
@Override
public boolean accept(File dir, String filename){
File sel = new File(dir, filename);
return filename.contains(FTYPE) ||
sel.isDirectory();
}
};
mFileList = mPath.list(filter);
}
else{
mFileList= new String[0];
}
}
@Override
public boolean onCreateOptionsMenu(Menu menu) {
// Inflate the menu; this adds items to the action bar if it is
present.
getMenuInflater().inflate(R.menu.menu_main, menu);
return true;
}
@Override
public boolean onOptionsItemSelected(MenuItem item) {
// Handle action bar item clicks here. The action bar will
// automatically handle clicks on the Home/Up button, so long
// as you specify a parent activity in AndroidManifest.xml.
int id = item.getItemId();
//noinspection SimplifiableIfStatement
if (id == R.id.action_settings) {
return true;
}
return super.onOptionsItemSelected(item);
}
}
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CHAPTER 3: MOBILE PLATFORM FOR RAPID SUB PG/ML, MULTIPLEXED,
DIGITAL DROPLET DETECTION OF PROTEINS
This chapter is a slightly modified version of a manuscript published in PNAS:
V Yelleswarapu, J Buser, M Haber, J Baron, E Inapuri, D Issadore. Mobile platform for rapid
sub-picogram-per-milliliter, multiplexed, digital droplet detection of proteins. PNAS, 116,
4489–4495 (2019).

V.Y., J.R.B., and D.I. designed research; V.Y., M.H., J.B., and E.I. performed research;
V.Y. contributed new reagents/analytic tools; V.Y. analyzed data; and V.Y. and D.I. wrote
the paper.

3.1 Significance statement
Digital assays have enormous untapped potential for diagnostics, environmental
surveillance, and biosafety monitoring, but are currently confined to laboratory settings
due to the instrumentation necessary to generate, control, and measure millions of
droplets. We instead use a mobile phone-based imaging technique that is >100x faster
than conventional microfluidic droplet detection, does not require expensive optics, is
invariant to flow-rate, and can simultaneously measure multiple fluorescent dyes in
droplets. By using this time-domain modulation with cloud computing, we overcome the
low frame rate of digital imaging, and achieve throughputs as high as one million
droplets per second. We integrate on-chip delay lines and a microbead processing unit,
resulting in a robust device, suitable for a low-cost implementation, with ultra-sensitive
measurement capabilities.

3.2 Abstract
Digital droplet assays - in which biological samples are compartmentalized into millions
of femtoliter-volume droplets and interrogated individually - have generated enormous
enthusiasm for their ability to detect biomarkers with single-molecule sensitivity. These
assays have untapped potential for point-of-care diagnostics but are currently mainly
confined to laboratory settings due to the instrumentation necessary to serially generate,
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control, and measure tens of millions of droplets / compartments. To address this
challenge, we developed an optofluidic platform that miniaturizes digital assays into a
mobile format by parallelizing their operation. This technology is based on three key
innovations: 1. the integration and parallel operation of a hundred droplet generators
onto a single chip that operates >100x faster than a single droplet generator. 2. the
fluorescence detection of droplets at >100x faster than conventional in-flow detection
using time-domain encoded mobile phone imaging, and 3. the integration of on-chip
delay lines and sample processing to allow serum-to-answer device operation. To
demonstrate the power of this approach, we performed a duplex digital ELISA. We
characterized the performance of this assay by first using spiked recombinant proteins
into a complex media (fetal bovine serum) and measured a limit of detection 0.004
pg/mL (300 aM), a 1,000x improvement over standard ELISA and matching that of the
existing laboratory-based gold standard digital ELISA system. We additionally measured
endogenous GM-CSF and IL6 in human serum from N = 14 human subjects using our
mobile duplex assay, and showed excellent agreement with the gold standard system
(R2 = 0.96).

3.3 Introduction
Digital

droplet-based

assays

achieve

1000x

improved

sensitivity

over

conventional assays by performing millions of assays in parallel within femtoliter volume
droplets. This parallelization converts the traditionally analog problem of quantifying
biomarkers into a digital one, where each droplet contains either one copy or zero copies
of the target molecule. Digital assays have demonstrated enormous utility as a platform
for the ultrasensitive detection of nucleic acids
the analysis of single cells

173–176

164–167

and proteins,

and single exosomes.
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177

84,85,168–172

as well as

Digital enzyme-linked

immunosorbent assays (dELISA)
(dPCR)

180

86,170,178,179

and digital polymerase chain reaction

have found broad utility and have been successful achieving (attogram per

mL) sensitivity and high levels of multiplexing for a broad range of targets.

180

In a

particularly exciting demonstration, digital assays were recently used to measure both
protein and mRNA simultaneously from single cells.

181

The improvement in sensitivity of

digital assays over conventional assays has allowed measurement of previously
undetectable concentrations of clinical biomarkers, opening new opportunities for
improved diagnostics and prognostics for applications such as traumatic brain injury,
HIV, and early cancer detection. 119,178,182–185
Due to digital assays' high sensitivity, their capability for absolute quantification
without calibration, and the robustness of digital detections to reaction conditions, they
are particularly well-suited for point-of-care diagnostics. However, the instrumentation
currently required to generate, process, and detect the many independent reaction
vessels for ultrasensitive digital assays has proven cumbersome to implement. The gold
standard commercial implementation of dELISA is Quanterix’s Simoa

49,86,

which uses a

microfabricated array of 200,000 wells that are each 40 fL. The Simoa HD-1 Analyzer
provides a fully automated sample-to-answer readout, capable of being loaded with up
to four 96-well ELISA plates. The machine has automated the entire digital ELISA assay,
minimizing the time required to process multiple samples through their workflow,
resulting in a throughput of 66 samples per hour.86 Furthermore, the Simoa HD-1 can
perform a multiplexed 10-plex assay on each sample. While the Simoa system has
demonstrated the value of ultrasensitive protein detection in a laboratory setting, it
requires bulky optics and bulky fluid handling, resulting in a technology not suitable for
portable use and that has an instrumentation cost of more than a hundred thousand
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dollars. Point-of-care systems have been developed that typically use smaller numbers
(< 10,000) of nanoliter wells, much larger than the femtoliter wells used in the
ultrasensitive systems,

186

and as a result do not achieve the same sensitivity, dynamic

range, or capability for multiplexing. 132,187,188
Compared to static arrays, continuous flow microfluidic droplet systems allow
much greater numbers of partitions to be analyzed (> 1 million), allowing increased
multiplexing, sensitivity, and the capability for downstream sorting of the droplets.
55,84,171,175,176

However, droplet microfluidic systems are currently hindered by both 1. the

throughput (<104 droplets per sec) at which droplets can be serially generated in
microfluidic systems and be monodisperse

131,189

and 2. the throughput (<104 droplets

per sec) at which the fluorescence of droplets can be detected by flowing them one-byone through a micrometer-scale laser spot. (Fig. 1a) (SI Appendix, Table S1)

55,175,176

An emerging approach to overcome these limitations has been to incorporate many
replica generators or detectors that can operate on the same chip in parallel to increase
throughput.

129,131,139,141,190,191

However, it has not yet been possible to fully implement

ultrasensitive digital assays into a mobile format due to the required instrumentation to
generate the highly controlled flows required for conventional droplet microfluidics,192 the
difficulty of parallelizing the optics necessary for multi-color fluorescence detection, and
the challenge of integrating sample preparation.
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Figure 1. Miniaturization and parallelization of droplet dELISA. a. A schematic of the
conventional workflow for dELISA, which requires multiple hands-on steps and is ratelimited by the serial partitioning of the sample into droplets and the serial detection of the
fluorescence of each individual droplet. b. µMD parallelizes droplet generation,
incubation, and detection to miniaturize dELISA fully onto a mobile platform and increase
its throughput by 100x. c. Antibody-functionalized, color-coded beads are used in a
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duplex dELISA assay, wherein individual beads are encapsulated into droplets and read
out if they have captured a single target protein.
To address this challenge, we have developed an optofluidic platform, the
microdroplet Megascale Detector (µMD), that miniaturizes digital droplet assays into a
mobile device, while matching the limit of detection of the current laboratory-scale goldstandard technology. To achieve this limit of detection in a robust, mobile device, the
µMD is built on three key innovations.( Fig. 1b) 1. Rather than generate droplets one at
a time, we instead incorporate a parallelized microfluidic droplet generator that operates
>100x faster than a single droplet generator. Moreover, by making use of the recently
published Millipede geometry,131 the monodispersity of the generated droplets are
invariant to flow rate, which allows use of inexpensive peristaltic pumps that can be
incorporated into a mobile device. 2. To rapidly read-out the fluorescence of the droplets
(>105 drops/sec), we use a mobile-phone based imaging technique that is >100x faster
than conventional detection, wherein droplets are detected one-by-one.

55,176

Our

approach does not require expensive optics and is invariant to flow-rate, making it well
suited for a mobile implementation

190.

The key innovation of this approach is that it

overcomes the low frame rate of digital imaging, and can achieve multicolor
fluorescence detection, by modulating multiple, differently colored LED/laser diode
excitation sources with unique non-periodic signals. The video feed can be decoded to
accurately measure each droplet's fluorescent signals at throughputs far exceeding that
of the frame rate of the camera, as high as 1 million droplets per second. This work
builds on a previously published proof-of-concept device that demonstrated the
measurement of only a fluorescent dye in passing droplets,

190

and is here extended to

measure three fluorescent channels in each droplet to implement dELISA. 3. We
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integrate a microbead processing unit, droplet generators, on-chip delay lines for droplet
incubation, and droplet fluorescence detection, resulting in a robust device, suitable for a
low-cost implementation, that allows raw serum to be input and for molecular data to be
output.
To demonstrate the power of this approach, we implement multiplexed dELISA
using microbeads color-coded with different fluorescent dyes, where the color code
corresponds to the protein targeted by its antibody.( Fig. 1c) We performed a duplex
cytokine assay (GM-CSF, IL6) in serum using UV and green fluorescent beads, where
droplets containing a bead with a complete immunocomplex fluoresce red. We
accurately measured IL6 and GM-CSF simultaneously in complex media (bovine serum)
over four orders of magnitude with a limit of detection as low as 0.004 pg/mL (~300aM) –
a thousand-fold improvement over standard ELISA and matching that of the current gold
standard digital platform.

168,169

Our chip is designed for minimal user interaction (SI

Appendix, Vid S1), has a total droplet processing time of 10 minutes for 10 million
droplets, where the workflow encompasses droplet generation, droplet incubation, and
fluorescence droplet detection for each sample, and has a prototype instrumentation
cost of $500 and a disposable cost $5.

3.4 Results and Discussion
µMD Design
The complete workflow of dELISA is incorporated onto our chip,(Fig. 2a) and
consists of: 1. A microbead processor where microbeads capture their target proteins
from serum, are tagged with enzyme labeled immunocomplexes for downstream
amplification within droplets, and are iteratively washed between each labeling step, 2. a
droplet generator, where the microbeads are mixed with the enzyme's substrate and
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encapsulated into water-in-oil droplets. 3. A three-dimensional microfluidic channel that
takes 3.2 minutes for the droplets to pass, allowing time for the enzymatic amplification
of the fluorescence signal. 4. A mobile phone based detector, where the droplets'
fluorescence are rapidly detected using time-domain encoded optofluidics.
The microbead processor unit consists of a semi-permeable membrane to
immobilize the beads. Multiple reagents and washing buffers are sequentially delivered
to the immobilized beads, after which the beads are released for downstream
analysis.({Fig. 2b) One of the populations of color-coded microbeads (Spherotech, d =
5.4 µm, λex/λem = 470/490 nm) is functionalized with antibody for GM-CSF (R&D
MAB2172). The other population of beads (Spherotech, d = 4.5 µm, λ ex/λem =
370/410nm) is functionalized with antibody for IL6(MAB206). The beads are first
incubated with the sample for 60 minutes, and then immobilized on the membrane.
Subsequently, the beads are washed with 1 mL of T20 Buffer at 10 mL/hr, incubated
with 0.1 mL of 0.7 nM detection antibody (R&D BAF206, BAM215) in T20 buffer for 30
minutes, washed in 1 mL of T20 Buffer at 10 mL/hr, and subsequently released from the
membrane by reversing the flow at 6 mL/hr. The semi-permeable membrane is an A =
300 mm2 track etched polycarbonate membrane with d = 3 µm pores.(Fig. 2a) The
membrane is incorporated into the microfluidic chip using laser cut mylar membrane
microfluidics.

193,194

(SI Appendix, Fig. S1, S2) For testing, a syringe pump (Harvard

Apparatus) or a low cost peristaltic (Intllab, <$10) were used.
Downstream of the microbead processor, the released microbeads are mixed
with the ELISA substrate (QuantaRed™ Enhanced Chemifluorescent HRP Substrate,
Thermo)(Fig. 2c,d) and encapsulated into d = 40 µm droplets suspended in QX200™
Droplet Generation Oil (Biorad, 1864006).(Fig. 2d) A channel length of 14 mm with a
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staggered herringbone design is used to ensure proper mixing of the beads and the
substrate, while minimizing background signal that comes from enzymes generating
fluorescence signal before they are encapsulated into droplets

195,196.(SI

Appendix, Fig.

S3). To generate monodisperse droplets that are robust to flow rate, we used the
Millipede geometry described by Amstad et al (Amstad2016). In brief, the millipede uses
step emulsification, where the droplet diameter depends only on the channel geometry
and not the flow rates of the dispersed or continuous phase over a large range of flow
rates. Our device consists of 100 droplet generators to achieve a throughput of 100k
droplets/sec. The droplet generator layer has a height h = 10 µm and the continuous
phase layer has a height h = 120 µm.(SI Appendix, Fig. S2) Each droplet encapsulates
one or zero beads (Fig. 2d) by setting the concentration of beads such that there are
10x more droplets than beads, resulting in a 0.5% probability of a droplet containing two
beads based on Poisson statistics.
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Figure 2. Integrated µMD workflow. a. A schematic of the µMD chip, showing both a
top view and a bottom view. Each inset shows a schematic cartoon of the modules that
are incorporated onto the µMD. b. A photograph of the disposable µMD chip, with the
channels filled with dye to make them visible. c. A micrograph showing the droplet
generator encapsulate microbeads into d = 40 µm droplets. The arrows highlight the
microbeads. (Scale bar = 50 µm) d. A fluorescence micrograph of the droplets after the
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delay line. (Scale bar = 50 µm) e. A schematic of the µMD platform, consisting of a
mobile phone, three light sources, and the disposable µMD chip.
Downstream of the droplet generator, the droplets pass through a delay line,
(Fig. 2a) which we have designed to hold droplets for a precise minutes-scale duration
in continuous flow, without the need for active valves. To achieve a precise minute-scale
delay, a channel is required that has both a large cross-sectional area, to reduce
velocity, and a long length. To achieve a large cross-sectional area, we mold the PDMS
microfluidics using a laser-cut acrylic mold rather than conventional SU-8 to achieve
channels with width w = 1.8 mm and height h = 1.5 mm. To achieve a large channel
length, without leading to an overly large device footprint, we stack N = 4 spiral channels
vertically by plasma bonding multiple PDMS pieces with punched hole vias.(SI
Appendix, Fig. S1) Using a flow rate of Φd = 67 mL/hr, it takes droplets 3.2 minutes to
traverse the entire channel, allowing the enzymes time to generate a measurable
fluorescence signal.( Fig. 2d)
Time-domain encoded optofluidic fluorescence detection
To achieve high throughput, multicolor, fluorescence droplet detection on a
mobile platform, we modulate the excitation light in time with a pseudorandom sequence
that allows individual droplets to be resolved that would otherwise overlap due to the
limited frame rate of digital cameras. Using conventional excitation that is constant in
time, a droplet moving across a camera's field of view is imaged as a streak (L streak =
v*Texp, where v is the droplet velocity and Texp the exposure time of the camera). This
streak length L sets the minimum distance between droplets, and thus severely limits
throughput. We overcome this limitation by modulating the excitation light source with a
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pseudorandom sequence at a rate >10× faster than the exposure time of the camera,
modulating the streak so that it can resolved amongst neighboring droplets as close as
three droplet diameters via correlation detection, and do so in 120 parallel channels in
the camera's field of view. In our previous work in this area,

129,190

we only interrogated a

single fluorescent dye in each droplet, which is not sufficient to readout the multiplexed
dELISA assays carried out in this paper. We had previously presented a proof-ofconcept demonstrating that two distinct dyes could be detected.

36

Here, we expand this

approach by using three light sources, each of which emits a wavelength tuned to excite
a different dye and that is modulated in time with a unique maximum length sequence
(MLS) that can be decoded independently to readout each fluorescence channel. A
band-pass filter is placed on the camera to diminish the effects of scattered excitation
light.(Edmund Optics, #87-241) We implemented a three-color system using two LEDs
(blue, green) and one diode laser (UV). This µMD platform is invariant to flow rate, has a
maximum throughput of 160 mL/hr (106 droplets/sec), and a dynamic range of 1: 107 to
1: 40 fluorescent: non-fluorescent droplets.
To decode the videos taken by our cell phone camera we perform a correlation
detection for the three expected modulation patterns m, corresponding to each of the
three light sources. By doing so, we generate the correlation vectors Ψk,nr,g,b =
Sk,nR,G,B(x)mr,g,b(x+X)dx = Sk,nR,G,B ⊗ mr,g,b), where the indices k are the video frames, n
are the n = 1:120 channels in the device, (R,G,B) correspond to the color channels of
the digital camera, and (r,g,b) correspond to each of the three unique excitation
sources.(Fig. 3a) We chose to pattern the droplets using MLS with |m| = 63 bits, where
each bit corresponds to 10 pixels in the digital image. Thus, 63 bits would correspond to
630px, or 1/3 of a 1920px wide video frame. To create a set of MLS with minimal auto97

correlation and cross correlation from each other, we followed the process in
MacWilliams and Sloane

151

to create a pseudorandom vector with (212-1=4095)

elements, that we folded into a 63*65 matrix, and chose the first three rows to select the
three MLS patterns.

Figure 3. Software workflow for multi-color phase and velocity invariant
optofluidic fluorescence droplet detection. a. The algorithm for detecting droplets. b.
Truth table for interpreting the readout of the µMD's three-color (r: red ELISA signal, g:
green beads, b: blue beads) fluorescence measurement. c. Schematic showing the µMD
platform collecting data, which is sent to the cloud to be processed, and then returned to
the mobile phone to report the results of the assay to the user. d. A sample workflow for
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a droplet that contains a green bead and that is positive for its target. The video's image
frames are segmented into 1d vectors. e. A 3D correlation results in a data matrix where
the phase is first identified (f). From this 2D "slice" of the data matrix, the velocity of the
droplet is found and the position is recorded for each peak in the correlation space (g).
The goal of the fluorescence detector is to inspect each droplet and determine 1.
if the droplet contains a microbead, and if so determine its color (UV or green) which
indicates the protein target the droplet is measuring (GM-CSF, IL6 respectively). (Fig.
3b), 2. if the droplet fluoresces red, which indicates whether the droplet has detected
one molecule of its target. The workflow to extract this information from each droplet is
as follows: (i) The kth frame of the video is separated into its red, green, and blue
components IkR,G,B based on the camera’s red, green, and blue sensors.(Fig. 3d) (ii) A
line-average is taken along the direction of each of the n = 120 microchannels Sk,nR,G,B(x)
. (iii) To simplify the hardware of the system, rather than control the droplet velocity v or
phase θ, relative to the MLS excitation, of the passing droplets we instead use cloud
computing to computationally detect droplets with unknown phase and velocity.(Fig. 3c)
We generate a 3d matrix by correlating each of the modulated signals with expected
emission patterns that scans the range of velocities and phase at which the LED strobes
mr,g,b(x/v-θ)

⊗

SnR,G,B,

corresponding

to

the

three

excitation

sources

(r,g,b)

respectively.(Fig.3e) (iv) By selecting the optimal phase (θc) and velocity (vc) of every
droplet, we can identify peaks in the correlation space Ψ k,nr,g,b(x, vc, θc).(Fig.3f,g) These
detected signals are tabulated [Nb&r, Ng&r], where Nb&r corresponds to droplets that
contain a UV bead and fluoresce red and thus contain a molecule of GM-CSF and Nb&r
corresponds to droplets that contain a green bead and fluoresce red and thus contain a
molecule of IL6. The data is collected using our custom Android app, sent into the cloud,
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processed using MATLAB in a remote server, and then sent back to the smartphone and
reported to the user in an easy-to-interpret format. For each target molecule, the active
enzymes per bead

168

(AEB) is calculated by quantifying the number droplets that

contained a bead and that fluoresced red, normalized to the total number of beads. The
values that we report are calculated by subtracting the AEB measured when we ran a
blank sample, which does not contain the target protein, and corrected for the precalculated loss factor, obtained in the measurements of spiked proteins into PBS,
multiplied by the molecular weight of the target protein.

Figure 4. Flow rate invariant droplet generation using step emulsification generate
droplets of the same diameter. a. By using the Millipede geometry, droplet size is
invariant to dispersed phase flow rate. b. For a range of continuous flow rates (45-65
mL/hr) and dispersed flow rates (2-14 mL /hr), the generated droplets remained
monodispersed with syringe pumps (CV = 5.3%) and with inexpensive peristaltic pumps
(CV = 6.0%).

c. To evaluate the enzymatic amplification of captured protein in the
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droplets, we inspected the droplets after the delay line with fluorescence microscopy. d.
After a 3.2 minute delay, the distribution of droplets positive and negative for enzyme
were measured. (Scale Bar = 50 µm)
Droplet generation and integrated incubation line
Droplet uniformity is critical for digital assays, because variance in droplet
diameter leads to variance in fluorescence after the delay line, confounding the ability to
discriminate positive and negative droplets. To evaluate the droplet generator's
capability to generate monodispersed droplets in a mobile setting, we scanned the
continuous phase over flow rates Φc = 45-65 mL/hr and we scanned the dispersed
phase over flow rates Φo = 2-14 mL/hr.(Fig. 4a) We generated droplets with a diameter
d = 40 µm and a coefficient of variation CV < 6% with both syringe pumps and
inexpensive peristaltic pumps.(Fig. 4b) The greater the ratio of the aqueous flow rate to
the continuous flow rate, the larger the volume fraction of droplets was, allowing
increased throughput.
To evaluate and optimize the delay line and the enzymatic amplification of
captured protein in the droplets, we inspected the droplets after the delay line with
fluorescence microscopy (Leica DM4200). (Fig. 4c) We calculated the distribution of
fluorescence intensities of droplets with and without an enzyme to identify the delay time
that minimized their overlap. For a 3.2 minute delay, the ratio of the average droplet with
an enzyme had a > 30x greater mean fluorescence intensity (MFI) than a droplet without
an enzyme. (Fig. 4d)
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Figure 5. Benchmarking and characterization of ultrasensitive, duplex protein
detection in complex media. a. Single-plex detection of GM-CSF spiked into PBS. The
limit of detection LOD = 0.0045 pg/mL (320 aM). b. Single-plex detection of IL6 spiked
into PBS. LOD = 0.0070 pg/mL. c. The same samples of fetal bovine serum (FBS)
spiked with varying concentrations of GM-CSF were measured using the µMD and
Quanterix's Simoa. Good agreement was found between the two measurements (R 2)=
0.95. d. The limit of detection (LOD), limit of quantification (LOQ), dynamic range, and
coefficient of variation (CV) are reported for the µMD's and Simoa's measurement of
GM-CSF in FBS. e. The duplex assay is tested by measuring various concentrations of
GM-CSF and IL6 spiked into FBS. f. Varying concentrations of GM-CSF into FBS
resulted in insignificant cross-talk with the measurement of IL6 and did not significantly
change the LOD for GM-CSF. g. Conversely, varying concentrations of IL6 into FBS
resulted in insignificant cross-talk with the measurement of GM-CSF and did not
significantly change the LOD for IL6. h. 22 various concentrations of GM-CSF and IL6
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were spiked into FBS and measured. Good agreement was found between the spiked
and measured results, for both GM-CSF (R2 = 0.99) and IL6 (R2 = 0.99).
Ultrasensitive, duplex protein detection in complex media
To evaluate our integrated µMD's capability for sensitively detecting proteins, we
first measured IL6 and GM-CSF in PBS, complex media (FBS), and human serum, and
compared the results with those from a commercial dELISA device (Quanterix Simoa).
Non-human serums provides a good model to simulate human serum

168,197,198,

because

it has the convenient property that it does not include any human IL6 or GM-CSF
allowing titration experiments to be performed down to our device’s LOD. In these initial
experiments, we performed bead processing off-chip, such that the droplet generator,
incubator, and detector could be evaluated. In PBS, we first performed separate singleplex measurements on GM-CSF (Fig. 5a) and IL6 (Fig. 5b) by measuring serial dilutions
from 10-4 - 102 pg/ml. We achieved a limit of detection LOD = 0.0045 pg/mL (320 aM)
and LOD = 0.0070 pg/mL (350 aM) for GM-CSF and IL6, respectively. We next
performed the same titration measurement for GM-CSF in 1:4 FBS solution. In this
experiment we split the sample between our µMD platform and Simoa (GM-CSF 2.0 kit)
to perform a head-to-head comparison. We found excellent agreement between the
output of our chip and that of Simoa (R2 = 0.95). (Fig. 5c) The LOD, limit of
quantification (LOQ), dynamic range, and average CV were tabulated for the µMD and
Simoa, (Fig. 5d) and showed similar performance.
Next, we evaluated the µMD chip's capability to simultaneously measure two
protein levels in a duplex measurement of GM-CSF and IL6 in complex media. To this
end, we first spiked various quantities of GM-CSF into FBS, keeping IL6 concentrations
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at 0 pg/ml. In these samples, we measure both GM-CSF and IL6 using our duplex
microbead assay and evaluate cross-talk and compare to our single-plex results. (Fig.
5f,g) We also performed the same experiment, but instead spiked various levels of IL6
and kept GM-CSF concentrations at 0 pg/ml. In both cases the LOD, for GM-CSF or IL6,
did not change significantly from the singleplex measurement (p > 0.88 for GM-CSF, p >
0.90 for IL6) To further verify our capability to simultaneously measure both GM-CSF
and IL6, we evaluated our chip's accuracy in measuring N = 22 separate titrations of
various quantities of GM-CSF and IL6 spiked into FBS. (Fig. 5h) We found excellent
agreement

between

the

expected

spiked

concentrations

and

the

measured

concentrations (R2> 0.99) for GM-CSF and (R2> 0.99) for IL6.
We next validated that the µMD can measure endogenous protein in human
serum. We collected serum from N = 14 healthy subjects, and for each subject
measured an aliquot using our mobile µMD platform’s IL6 and GM-CSF duplex assay
and we measured an aliquot using Quanterix’s commercial assay (Fig. 6a), allowing us
to compare our results to the commercial gold standard. We saw excellent agreement
between measurements on our mobile platform and that performed on Quanterix’s
Simoa (R2 = 0.96) (Fig. 6b), demonstrating that our microfluidic device can perform on
human serum.

3.5 Conclusion
Our µMD platform, with its integrated and miniaturized implementation, its high
sensitivity, and its high droplet throughput, allows digital assays containing millions of
droplets to be performed rapidly on a mobile platform. By integrating and miniaturizing
digital assays, the µMD can translate the benefits of dELISA assays to a mobile
diagnostic platform. While in this paper we performed a duplex assay, we can further
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leverage improvement in droplet throughput} and multicolor detection to increase
multiplexing to 100s of markers. Multiplexing can be increased by both 1. running M
assays in parallel by leveraging our chip's high droplet throughput and dividing the
sample to be mixed with different reagents in either individual channels or sets of
channels of the N = 120 detection channels. This approach comes at the expense of
device throughput and a reduction in sensitivity that comes from splitting the sample
volume for each additional assay. 2. Microbeads with varying concentrations of multiple
dyes can be used to barcode the microbeads for M assays in a single pot, as has been
done by groups such as Luminex.

199

Moreover, these two approaches can be combined

on the same chip to achieve M >100 multiplexed assays. Similarly, multiple samples can
be processed by either running them serially through the µMD or in parallel by dividing
up the N = 120 detection channels. In either approach, the samples would be incubated
with beads, labeled, and washed in separate wells to avoid cross-contamination. In
serial operation, the incubation time would remain the same (currently three hours), and
the total processing time would increase linearly with the number of samples (5
additional minutes per sample, given a droplet throughput of 100k droplets/sec and a
four minute droplet incubation time). The additional processing time per sample could be
reduced by parallelizing the droplet incubation stage. Our miniaturized technology
matches the limit of detection to existing dELISA, however, it is important to highlight
that the µMD does not currently have the ability to sequentially load samples in an
automated fashion that the Simoa HD-1 has demonstrated for up to 384 samples

86

making use of recent developments of applying dELISA to miRNA detection,

By
179

multiplexed detection of miRNA and protein can be measured on the same chip for
multi-modal characterization of complex disease states.

200,201

By automating and

incorporating dELISA onto a mobile platform, the µMD allows ultrasensitive, multiplexed
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biomarker detection to be brought directly to the point-of-use, where digital assays can
have the greatest impact.

3.6 Methods and Materials
Device Fabrication
The µMD is composed primarily of four components, all integrated into a
monolithic chip (Fig. 2a): 1. a bead processor where beads are incubated and washed in
successive steps, 2. droplet generators, 3. a delay line for the enzymatic amplification
reaction, and 4. the fluorescence detection region. The bead filtration unit consists of a 3
µm polycarbonate filter (Sterlitech) sandwiched between laser-cut layers of adhesive
coated mylar (7602A54, McMaster Carr). The top PDMS piece contains the droplet
generators, and is fabricated using multi-layer soft lithography, consisting of a layer that
contains the nozzles and the spine (h = 10 µm), a second layer that contains only the
spine delivery channels (h = 120 µm), and a third layer that contains herringbone
structures for enhanced mixing (h = 30 µm). The bottom PDMS piece was also
fabricated using soft lithography, and consist of the spiral delay line (h = 1.5mm) and the
detector channels (h = 40 µm). The three pieces are assembled by bonding the droplet
generators PDMS piece to the top of a glass slide and the delay line PDMS piece to the
bottom, using plasma bonding. The glass slide (Corning® Glass Slides, ID: 26005) is
etched with a through-hole d = 200 µm using a CO2 laser, to serve as a via between the
top and bottom pieces of PDMS microfluidics.(Fig. 2a) The bead processing unit is
adhered to the top PDMS piece using adhesive coated mylar (7602A54, McMaster
Carr). The PDMS portion of the chip was made hydrophobic by running 1% silane
(Trichloro(1H,1H,2H,2H-perfluorooctyl)silane,

Sigma)

in

Novec

7500

(Oakwood

Chemical) and flushed with Novec7500 alone. The filter portion of the µMD was soaked
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in 1% F127 in PBS, flushed with PBS, and then soaked in T20 buffer to reduce adhesion
with antibodies and labeling enzyme.
Measurement of Endogenous Protein in Human Serum
We collected blood from N = 14 healthy subjects (age = 20-43, 71% male, 29%
female), in which all experiments involving human subjects were approved by University
of Pennsylvania Institutional Review Board protocols (Protocol 828435).

Informed

consent was obtained from the eligible subject directly. A written document was provided
to the subject detailing the procedure involved and the rational for the study. The risks
and benefits of study participation were explained. After a consent document was
signed, an 8 mL blood draw was acquired along with information regarding gender and
age. Blood was collected in yellow cap tubes which contain Acid Citrate Dextrose
Solution (ACD) and serum separating gels (BD Vacutainer™ Venous Blood Collection
Tubes: SST™ Serum Separation Tubes: Hemogard, BD 368013). Blood was allowed to
sit for 15 minutes after collection, and then centrifuged at 1500 rcf for 15 minutes to
isolate the serum. After centrifugation, serum was frozen at -80℃. Samples were thawed
immediately before use, ensuring that all samples experienced the same freeze-thaw
cycling. For Simoa measurements, we followed Quanterix’s protocol for the singleplex
GM-CSF 2.0 and IL-6 2.0 kits, using the standard protocol. (SimoaIL6, SimoaGMCSF)
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Figure 6. The measurement of endogenous protein in human serum. a. Human
serum was collected from N = 14 healthy controls, and an aliquot was measured using
our µMD’s duplex IL6, GM-CSF assay and measured on Quanterix’s commercial assay.
b. Good agreement between Simoa and the µMD was found for measurements of both
IL6 and GM-CSF (R2 = 0.96).
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3.7 Supplementary Material
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Supplementary Figure 1. 3D design of chip. a-c. Isometric and side views of the µMD
display the how the modular components are stacked in a 3d case. d. Draftsight
drawings of each layer of µMD, followed by component layers for the bead processor
(e,i) and the droplet generator (e,ii).
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Supplementary Figure 2. Design of µMD casing. a,b. The µMD consists of a
disposable microfluidic chip, a cell phone, and an acrylic casing that we designed. The
acrylic casing comes in two parts: one that is attached to the cell phone to fix the
distance between the imaging plane and the macro lens, and the second which houses
the LEDs and locks the cell phone into position when the disposable chip is inserted.
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Supplementary Figure 3. Mixing of aqueous phases. A channel length of 14 mm is
used to ensure proper mixing of the beads and the substrate, while minimizing
background signal that comes from enzymes generating fluorescence signal before they
are encapsulated into droplets.

The video demonstrates the workflow of the droplet digital assay, as well as features of
the robust droplet generation and detection.
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dELISA Assay
On our chip, the bead processing, droplet generation, droplet incubation, and
detection are integrated. By avoiding manual processing steps, loss, contamination, and
unreliable reinjection of droplets after incubation, as has been observed in similar
systems

202,

can be avoided. To functionalize the microbeads used in our assay, we first

washed both the 5.4 µm Carboxyl Green Particles (Spherotech, CFH-5052-2) and 4.5
µm Carboxyl UV beads (CFP-4041-2) 6 times each, using centrifugation at 15k rcf for 5
min to remove the sodium azide, which inhibits HRP, from the supernatant.
Subsequently, we used the PolyLink Protein Coupling Kit (PolySciences, 24350-1) to
attach anti-human GM-CSF (R&D, MAB2172) and anti-human IL-6 (MAB206) antibodies
onto the beads, respectively. To evaluate our device, we created serial dilutions of the
protein targets (R&D #215-GM-010, R&D #206-IL-010) in low protein binding tubes to
reduce protein binding to the surface.
The on-chip bead processing steps were carried out as follows. The input to the
device is 1:4 diluted serum, diluted in T20 buffer. Incubation with the beads is performed
in a total volume of 100 µL T20 buffer and protein sample. Reagents are stored off-chip
in this study, but can be preloaded on-chip in future device generations. The reagents for
the HRP substrate are prepared immediately before the assay to reduce the background
of the fluorescence substrate. The reagents can be loaded into a pre-loaded tubing and
dispensed using a peristaltic pump. On the on-chip membrane, which captures the
beads for processing, the following steps are carried out. Following the initial incubation,
the beads are washed and then incubated with 0.7 nM concentration of detection
antibody in T20 buffer. After an hour of incubation, the sample is washed and replaced
with 12.5 pM concentration of HsHRP in T20 Buffer (Life Technologies), and washed
113

again. Subsequently, the flow is reversed so that beads are released and the output is
encapsulated into droplets for analysis. For droplet generation, the continuous phase is
Biorad Oil. Droplets of diameter d = 40 µm (CV = 5.3%) are generated with the total
dispersed phase fixed at Φd = 12 ml/hr with a fixed continuous phase of Φc = 55 ml/hr.
QuantaRed™ Enhanced Chemifluorescent HRP Substrate Kit was mixed with the
microbeads in the on-chip vortex mixer (Fig. 2a, SI Appendix, Fig. S3) immediately
upstream of the droplet generator. The substrate is introduced at a flow rate of 6 ml/hr.
We selected QX200 Droplet Generation Oil for EvaGreen (Biorad) to encapsulate the
beads in stable droplets with minimal dye leakage. The µMD uses high fluorescence
intensity dye beads, and HRP substrate compared to the low intensity dyes and the βgal enzyme and RGP substrate found in Simoa’s technology. 49,168
When performing the bead-processing off-chip, we used the following protocol.
Capture beads are added into sample in low protein binding tubes, and incubated for an
hour. The sample is diluted into 1mL with T20 Buffer and centrifuged at 12k rcf to
remove background cell debris and nontarget molecules in the supernatant. The beads
are resuspended into 0.7 nM concentration of detection antibody in T20 buffer and
incubated for an hour. This solution is diluted into 1mL T20 Buffer and centrifuged at 12k
rcf to remove unbound detection antibody, and 12.5 pM concentration of HsHRP in T20
Buffer. This sample is washed 4 times using a centrifuge and resuspended in T20
Buffer, to remove any HsHRP that could result in a false positive. The resulting sample
is then introduced as the aqueous inlet for the droplet generating device.
To calculate the limit of detection (LOD) and limit of quantification (LOQ), we
measured the number of false positives in replicate (N = 3) "blank" samples that included
FBS but contained no spiked protein. The LOD and LOQ was converted to units pg/mL
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using the know molecular weights of the target molecules. The LOD was defined as LOD
= <FP> + 2.5 σ(FP), where <FP> was the mean number of false positives and σ(FP)
was the standard deviation of the false positives. The LOQ was defined as LOQ = <FP>
+10σ(FP). We defined these values so that they agree with what is used to describe the
gold standard technology, Quanterix’s Simoa. (SimoaIL6, SimoaGMCSF)
Design of the Non-Disposable Components of the µMD and its Software
The µMD consists of a disposable microfluidic chip, a cell phone, and an acrylic
casing that we designed. (SI Appendix, Fig. S1,S2) The acrylic casing comes in two
parts. The first part is attached to the cell phone and fixes the distance between the
imaging plane and the macro lens. The second part houses the LEDs and the cell
phone, and sets the position of the disposable chip relative to the excitation sources and
the camera (SI Appendix, Vid S1). This casing contains a low cost commercial plastic
lens (<$4), a bandpass filter (λcw = 512 ± 11.5 nm, 630 ± 45.5 nm, Edmund Optics, #87241), and a slot to automatically align the microfluidic chip. The disposable microfluidic
chip is constructed of only PDMS, glass and mylar, and is prototyped using soft
lithography at The University of Pennsylvania's Singh Center for Nanotechnology. The
low cost plastic macro lens (15x magnification, Carson HookUpz, ML-515) is used image
the device Field of View FOV = 7x12 (mm2). (Fig. 3b) There are three excitation
sources, each mounted in the acrylic casing: an ultra-bright UV LED (λex = 400 nm,
Luminus, CBT-90-UV-C31-M400-22), a fat beam (laser diameter > 10mm) blue laser
diode (450nm, 400mW Laser Diode Module, APT Lighting), and a fat beam green laser
(532nm, 300mW Laser Diode Module, APT Lighting). The light sources are driven using
external electronics consisting of an LED driver circuit (Luminus Development Kit, DK114N-3) for the LEDs, TTL modules for the laser diodes, and a microcontroller (Arduino
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Mega2560) programmed with unique MLS patterns for each light source. To illuminate
the droplets in the microfluidic channels we make use of antiresonant side coupling to
achieve uniform illumination

152.

The non-disposable cost, excluding the cell phone, of

the µMD prototype is < $1000.
The software used in this study implements the data analysis shown in Fig. 3.
This software detects multiple fluorescent colors in each individual droplet, rather than
just one, as was done in previous work.
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A custom App is written that is installed on a

Galaxy S8 phone. This App controls, and coordinates, the multiple components in this
experiment, including the cloud computing, and the cell phone camera. A commercially
available App Open Camera is used to interface with the cell phone’s camera, and
allows manual control of the camera’s settings. Video collected on the phone is
uploaded to a Maltab cloud server (MathWorks Cloud). Optical aberrations in the video
are fixed by the software based on a calibration used to calculate the distortion from the
macro lens. Small errors in the position and angle of the chip relative to the camera are
also corrected. The software then parses the frames into 120 individual channels, and
carries out the algorithm described in Fig. 3. The data analysis currently takes 10
minutes to analyze 10 million droplets. Data analysis can further be sped up using a
GPU or cloud server, but we currently run the process locally on a Using an Ubuntu OS
with an Intel Core i7-7700HQ @ 2.80 GHz x 8 and 16 GB RAM. All source code for the
software used in this study is included in the SI Appendix, SI Text.

3.8 Supplementary Code
Source code can be found in the following
\href{https://sites.google.com/site/issadorelab/Issadore-Lab/protocols-and-software}{link}
to the lab website contains all of the software with a readme file to explain how to use
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each of the components. All code is commented thoroughly for ease of use. Source
code is shared for: (i) Matlab software for image analysis, (ii) Arduino code that
modulates the LED excitation, and (iii) an Android App that connects the software to
cloud.
~~~~~~~~
MATLAB_uMD_Video_Analysis-code
uMD_Initialize_Code.m
%initializes all variables such as expected signals, camera parameters,
etc.
%sets the frames to view within the video to start analysis
%calls Frame_Undistrotion to start a chain to .m files that creates a
matrix where correlations are stored
%once the vector is saved into a .mat file that can also be accessed
later as done typically...
%calls Corr_Hough_matrix_script to begin a chain for peak finding
analysis

close all force
clear all
% parpool
%uncommeting the above can start the parallel computing toolbox if
%available in matlab. Doing so increases computational speed
significantly
%initialize variables
x1 = 0 ;
x2 = 0;
y1 = 0;
y2 = 0;
inc = 0;
%load the MLS that was used in the Arduino Code
MLS_seq = [-1, 1, -1, 1, -1, 1, 1, -1, -1, 1, 1, -1, 1, 1, 1, -1,
1, 1, -1, 1, -1, -1, 1, -1, -1 , 1 ,1 ,1, -1, -1, -1, 1, -1, 1,
1, 1, 1, -1, -1, 1, -1, 1, -1, -1, -1, 1 ,1, -1, -1, -1, -1,
1, -1, -1 , -1, -1, -1, 1, 1, 1, 1, 1, 1];
MLS_seqR = [-1, 1, -1, 1, -1, 1, 1, -1, -1, 1, 1, -1, 1, 1, 1, -1,
1, 1, -1, 1, -1, -1, 1, -1, -1 , 1 ,1 ,1, -1, -1, -1, 1, -1, 1,
1, 1, 1, -1, -1, 1, -1, 1, -1, -1, -1, 1 ,1, -1, -1, -1, -1,
1, -1, -1 , -1, -1, -1, 1, 1, 1, 1, 1, 1];
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MLS_seqG = [-1, 1, -1 , 1 ,1 ,1 ,1, -1, -1, 1, -1 ,-1 , 1 ,-1 , 1
,1, 1, -1 , -1 , 1 ,1 ,1 ,-1, -1 , -1 , -1 , -1 , -1, 1, 1 ,1, -1 , 1
,1, 1 ,-1 , 1 ,-1 , -1 ,1, 1 ,1 ,1 ,-1 , 1, -1 , 1, -1 , -1, 1 ,-1
,1 ,-1 ,-1 ,-1 ,-1 ,-1 ,-1 ,1 ,-1 ,1 ,-1 , 1];
MLS_seqB = [-1, -1, 1, 1, 1, 1, 1, 1, -1, -1, 1, -1, 1, -1, 1, 1, 1, -1, -1, 1, 1, -1, -1, 1, 1, -1, -1, 1, -1, 1, -1, -1,
1, 1, 1, 1, 1, -1, 1, -1, -1, 1, 1, 1, -1, -1, -1, -1, 1, -1, 1, -1, 1, 1, -1, 1, 1, -1, -1, 1, -1, -1, -1];
%load camera params once to fix image distortion
%The main variables that affect spherical distortion is
'RadialDistortion'
load('cameraParams1.mat')
cameraParams2 = cameraParameters('IntrinsicMatrix',
[716,0,0;0,716,0;1920/2,1080/2,1],...
'RadialDistortion',[.06,0.0,.00],...
'TangentialDistortion',[0,0],...
'RotationVectors',[0 0 0],...
'TranslationVectors',[0 0 0],...
'ReprojectionErrors',[0 0],...
'WorldPoints',cameraParams1.WorldPoints,...
'WorldUnits',cameraParams1.WorldUnits,...
'EstimateSkew',cameraParams1.EstimateSkew,...
'NumRadialDistortionCoefficients',cameraParams1.NumRadialDistortionCoef
ficients,...
'EstimateTangentialDistortion',cameraParams1.EstimateTangentialDistorti
on);

%select amount of channels and segment based on the pixels per channel
segmented_ch_num = 120;
pixels_per_ch = floor(1080/segmented_ch_num);
%load the interpolated masks. these represent the expected signal
%NOTE: the interpolated masks can change to fit the velocity range
required
%and can be increased or shortened to improve computation. In this
%particular case, the range was chosen to match the data, and
obviously,
%larger ranges with finer resolution will always work but the tradeoff
is
%computation time.
load('All_Interpolated_Masks.mat')
load('All_Interpolated_MasksB.mat')
load('All_Interpolated_MasksG.mat')
%the table below has several values, but the main ones that are
relevant
%are the first entry which is the filename of a video to be analyzed,
and
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%the last term (flip) which represents the direction the droplets are
going
%in.
%Droplets can either go left to right or right to left based on how the
%chpi is attached; the flip vector properly selects the option
%The remaining variables can be ignored for this code.
data_table = {'20160927_165111.mp4' 27 7
624 800 1142
392 1142
377 624 1142
1};
load('cmap2.mat')

800 0

624

filename = data_table{1}; frame = data_table{2};
flip = data_table{15}; inc = data_table{8};
x1 = data_table{4}; y1 =data_table{5}-inc; x2 = data_table{6}; y2 =
data_table{7} -inc;
%bead two start and end
x3 = data_table{9}; y3 = data_table{10}; x4 = data_table{11}; y4 =
data_table{12};
dropletstart = data_table{13}; dropletend = data_table{14};

startframe = 450; endframe = 455; %select frames in video to analyze
%a portion of the video is analyzed since there may be a lag time for
%droplets to reach the proper velocity initially, saving computation
time.
%select the background frame to subtract out background signal in the
%algorithm
background_frame = 1;
v_file = VideoReader(filename);
video_frame = read(v_file,background_frame);
R_channel = video_frame(:,:,1);
R_background = R_channel;
G_channel = video_frame(:,:,2);
G_background = G_channel;
B_channel = video_frame(:,:,3);
B_background = B_channel;

%begin loop through each frame
for framestoprocess = 1:endframe-startframe+1
framenum=framestoprocess ;
frame = startframe+framestoprocess-1;
fprintf(num2str(framestoprocess))
%%%%%%%%%%%%%%%%%%%%%% Workflow Chain Begins
%%%%%%%%%%%%%%%%%%%%%%%%%%
Frame_Undistrotion
end
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%save the correlation results in a matrix for analysis later if
necessary
save('FramesAnalyzed.mat','v7.3','corr_matrix_final','corr_matrix_final_G','corr_matrix_final_B')
%begin analysis on the correlation matrix
Corr_Hough_matrix_script

Frame_Undistrotion.m
%uses camera parameters to undistort spherical aberrations and rotates
any offsets
%calls Frame_segmentation

close all
%load frame and subtract background
video_frame = read(v_file,frame);
img = video_frame;
red = img(:,:,1)-R_background; % Red channel
blue = img(:,:,2)-R_background; % Red channel
green = img(:,:,3)-R_background; % Red channel

%undistort with camera parameters chosen
[J1] = undistortImage(red, cameraParams2);
[J2] = undistortImage(blue, cameraParams2);
[J3] = undistortImage(green, cameraParams2);

%define angle to rotate image
x_ang_1 = 607; y_ang_1 = 669;
x_ang_2 = 1435; y_ang_2 = 655 ;
J1 = imrotate(J1,rad2deg(atan((y_ang_2-y_ang_1)/(x_ang_2-x_ang_1))));
J2 = imrotate(J2,rad2deg(atan((y_ang_2-y_ang_1)/(x_ang_2-x_ang_1))));
J3 = imrotate(J3,rad2deg(atan((y_ang_2-y_ang_1)/(x_ang_2-x_ang_1))));
%resize properly. during this portion, we lose several channels that
can be
%imaged but are too distorted at the edges on the top and bottom.
J1 = J1(57:1026,119:1835,:);
J2 = J2(57:1026,119:1835,:);
J3 = J3(57:1026,119:1835,:);
red = imresize(J1,[1080 1920]);
green = imresize(J1,[1080 1920]);
blue = imresize(J1,[1080 1920]);

%begin segmenting each channel to create 1D line vectors
Frame_segmentation
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Frame_segmentation.m
%segments the frame into N channels and stores the vector into a 1d
line vector
%sends 1d line vector to Segmented_1D_CrossCorr_PhaseVel

x = [1:1920];
for segmented_channel= 1:segmented_ch_num
%take line average for channel
%If fluorescent signal is leeching onto the edge of the channels,
the
%segmented channels, Sn, can be made narrower to prevent the
leakage.
droplet_line = mean(red(1+(0+pixels_per_ch)*(segmented_channel1):(0+pixels_per_ch)*(segmented_channel),:));
droplet_line_g = mean(green(1+(0+pixels_per_ch)*(segmented_channel1):(0+pixels_per_ch)*(segmented_channel),:));
droplet_line_b = mean(blue(1+(0+pixels_per_ch)*(segmented_channel1):(0+pixels_per_ch)*(segmented_channel),:));
%send each segmented vector for correlation analysis
Segmented_1D_CrossCorr_PhaseVel
%store the results in a matrix based on frame, channel, and
position
%where peak occurs (mapped to CMOS pixel location)
corr_matrix_final(framenum, segmented_channel,:) =
max_corr_Vec_phase(1:1920);
corr_matrix_final_G(framenum, segmented_channel,:) =
max_corr_Vec_phase_G(1:1920);
corr_matrix_final_B(framenum, segmented_channel,:) =
max_corr_Vec_phase_B(1:1920);
end

Segmented_1D_CrossCorr_PhaseVel.m

%loops through phase and for each phase, begins proper correlation
initiation
%after calling Cross_Corr_no_graphs.m, it finds the optimal phase and
velocity
%store the 1d vector ina variable
Patterned_droplet = droplet_line;
whatbead = 1;
sig = Patterned_droplet;
%if droplets flow in reverse direction, we can flip the 1d line vector
for
%correlation here
if flip ==1
sig = fliplr(sig);
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end
%begin looping through phase. phase is defined as when the MLS starts,
so
%since the MLS is cyclical, we simply begin at the next cycle of the
MLS to
%loop through the phase
for phase = 1:4:length(MLS_seq)
%for each phase, store the output into a 2d matrix
Cross_Corr_no_graphs
Final_vec_before_phase(phase,1:mat_b) = FINAL_CORR_VECTOR;
Final_vec_before_phase_G(phase,1:mat_b) = FINAL_CORR_VECTOR_G;
Final_vec_before_phase_B(phase,1:mat_b) = FINAL_CORR_VECTOR_B;
end
%find the optimal fit for all the phases;
[I,J] = find(Final_vec_before_phase==max(max(Final_vec_before_phase)));
max_corr_Vec_phase = fliplr(Final_vec_before_phase(I(1),:));
[I,J] =
find(Final_vec_before_phase_G==max(max(Final_vec_before_phase_G)));
max_corr_Vec_phase_G = fliplr(Final_vec_before_phase_G(I(1),:));
[I,J] =
find(Final_vec_before_phase_B==max(max(Final_vec_before_phase_B)));
max_corr_Vec_phase_B = fliplr(Final_vec_before_phase_B(I(1),:));

Cross_Corr_no_graphs.m
%begins a 2d correlation for the input signal and the selected expected
signal based on the phase
%finds the best matching velocity for the given phase after searching
through the 2d map

%To vary the range of velocities to scan, this variable can be altered.
%Preallocating the expecte;d signal improves computational time.
Signal_Mat(:,:) = All_Interpolated_Masks(phase,:,:);
ma = Signal_Mat;
out8=xcorr2(sig,ma);
[mat_a mat_b] = size(out8);
%store the length of each MLS for different velocities to normalize
later
flipped_vec = fliplr(lengths_vector);
out8_new = zeros(mat_a,mat_b);
%take correlatoins and normalize by length of the mask
for i = 1:mat_a
out8_new(i,1:mat_b) = out8(i,:)/flipped_vec(i);
end
%select the velocity that generates the largest peak.
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[M,N] = find(out8_new==max(max(out8_new)));
Max_out = out8_new(M(1),:);
%Filter to get rid of DC effects
Fs = 1920;
half_freq = Fs/2;
notch_freq_filter =1;
low_freq_filt = 1;
smoothing_factor = 1;
w0=notch_freq_filter/half_freq;
[num,den]=iirnotch(w0,w0/35,-45);
[a,b]=butter(2,low_freq_filt/half_freq,'high'); %remove low frequency
components
y=filter(num,den,Max_out);
yfil=filtfilt(a,b,y);
ysm=smooth(yfil,smoothing_factor);
FINAL_CORR_VECTOR = (ysm);
%%%%%%%%%%%%%% Repeat for G channel %%%%%%%%%%%%%%
%To vary the range of velocities to scan, this variable can be altered.
%Preallocating the expecte;d signal improves computational time.
Signal_Mat(:,:) = All_Interpolated_MasksG(phase,:,:);
ma = Signal_Mat;
out8=xcorr2(sig,ma);
[mat_a mat_b] = size(out8);
%store the length of each MLS for different velocities to normalize
later
flipped_vec = fliplr(lengths_vector);
out8_new = zeros(mat_a,mat_b);
%take correlatoins and normalize by length of the mask
for i = 1:mat_a
out8_new(i,1:mat_b) = out8(i,:)/flipped_vec(i);
end
%select the velocity that generates the largest peak.
[M,N] = find(out8_new==max(max(out8_new)));
Max_out = out8_new(M(1),:);
%Filter to get rid of DC effects
Fs = 1920;
half_freq = Fs/2;
notch_freq_filter =1;
low_freq_filt = 1;
smoothing_factor = 1;
w0=notch_freq_filter/half_freq;
[num,den]=iirnotch(w0,w0/35,-45);
[a,b]=butter(2,low_freq_filt/half_freq,'high'); %remove low frequency
components
y=filter(num,den,Max_out);
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yfil=filtfilt(a,b,y);
ysm=smooth(yfil,smoothing_factor);
FINAL_CORR_VECTOR_G = (ysm);
%%%%%%%%%%%%%% Repeat for B channel %%%%%%%%%%%%%%
%To vary the range of velocities to scan, this variable can be altered.
%Preallocating the expecte;d signal improves computational time.
Signal_Mat(:,:) = All_Interpolated_MasksB(phase,:,:);
ma = Signal_Mat;
out8=xcorr2(sig,ma);
[mat_a mat_b] = size(out8);
%store the length of each MLS for different velocities to normalize
later
flipped_vec = fliplr(lengths_vector);
out8_new = zeros(mat_a,mat_b);
%take correlatoins and normalize by length of the mask
for i = 1:mat_a
out8_new(i,1:mat_b) = out8(i,:)/flipped_vec(i);
end
%select the velocity that generates the largest peak.
[M,N] = find(out8_new==max(max(out8_new)));
Max_out = out8_new(M(1),:);
%Filter to get rid of DC effects
Fs = 1920;
half_freq = Fs/2;
notch_freq_filter =1;
low_freq_filt = 1;
smoothing_factor = 1;
w0=notch_freq_filter/half_freq;
[num,den]=iirnotch(w0,w0/35,-45);
[a,b]=butter(2,low_freq_filt/half_freq,'high'); %remove low frequency
components
y=filter(num,den,Max_out);
yfil=filtfilt(a,b,y);
ysm=smooth(yfil,smoothing_factor);
FINAL_CORR_VECTOR_B = (ysm);

Corr_Hough_matrix_script.m
%loads the correlation matrix and begins to search for each segmented
channel, how droplets travel through sequentially
%calls detect_real_droplets
clear all
load('FramesAnalyzed.mat')
clear loc_info_all
load('cmap2.mat')
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%it may be useful to segment the vector into smaller pieces to analyze
%we now allocate the number of frames, the 1D line segments, and the
pixel
%length of each of the correlations we took earlier
[frames_total, numberofchannels ,framelengtha] =
size(corr_matrix_final);
% (100,19200)
% frames_total*numberofchannels, framelengtha
%We look through and find the local peaks for each of them based on a
%threshold found experimentally
%if the droplet was going in the reverse direction, the direction the
%droplet peaks move can be reversed if the proper flip variable was not
%set; rearranging the correlations can correct this
% for i = 1:numberofchannels-1
%
corr_matrix_final(:,i,:) = flipud(corr_matrix_final(:,i,:));
% end
%plot everything frame by frame
warning('off','all')
%convert the 3d matrix into a 1d for each channel
%count all the peaks in a certain channel
%one way to set the threshold is to find the max correlation value in
all
%the correlations found; and set the threshold to be 40% of that;
%assuming there was at least one positive in the entire analysis done
%Another method is to take an average of the entire correlation
vector
%matrix and use this as the background noise if the events are
sparse,
%and add 3*standadd deviation of the noise to the mean to separate
the
%peaks from the background
%A final way to set threshold is to manually verify in several peaks
that
%can be visually inspected and verified, and then setting the
threshold
%based on what was epxerimeentally observed in cases of misalignment
of
%the chip and excitation sources.
max_entire_vector = max(max(max(corr_matrix_final)));
max_entire_vector_G = max(max(max(corr_matrix_final_G)));
max_entire_vector_B = max(max(max(corr_matrix_final_B)));
numberofdroplets = zeros(numberofchannels);
allchannelsvectors =
zeros(numberofchannels,frames_total*framelengtha);
threshold2 = max_entire_vector*.4; %set threshold; threshold was
determined experimentally for each particle and varies for dye, and
bead color based on the intensity of background and particle intensity
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threshold2_G = max_entire_vector_G*.4;
threshold2_B = max_entire_vector_B*.4;
%for each channel, loop through all the frames and begin counting
for chan_loop_2 = 1:numberofchannels
for chan_loop_2_2 = 1:frames_total
corr_mat_R(chan_loop_2,(chan_loop_2_21)*framelengtha+1:chan_loop_2_2*framelengtha) =
corr_matrix_final(chan_loop_2_2,chan_loop_2,:);
corr_mat_G(chan_loop_2,(chan_loop_2_21)*framelengtha+1:chan_loop_2_2*framelengtha) =
corr_matrix_final_G(chan_loop_2_2,chan_loop_2,:);
corr_mat_B(chan_loop_2,(chan_loop_2_21)*framelengtha+1:chan_loop_2_2*framelengtha) =
corr_matrix_final_B(chan_loop_2_2,chan_loop_2,:);
end
end
counter_R_G
counter_R_B
counter_G =
counter_B =

= 0;
= 0;
0;
0;

[indexR_a, indexR_b] = size(corr_mat_R);
[indexG_a, indexG_b] = size(corr_mat_G);
[indexB_a, indexB_b] = size(corr_mat_B);

for chan_loop_2 = 1:numberofchannels
[pks,locs] =
findpeaks(corr_mat_R(chan_loop_2,:),'MinPeakDistance',30,'MinPeakHeight
',threshold2);
[pks,locs_G] =
findpeaks(corr_mat_G(chan_loop_2,:),'MinPeakDistance',30,'MinPeakHeight
',threshold2);
[pks,locs_B] =
findpeaks(corr_mat_B(chan_loop_2,:),'MinPeakDistance',30,'MinPeakHeight
',threshold2);
peaks_R(chan_loop_2,1:length(locs)) = locs;
peaks_G(chan_loop_2,1:length(locs_G)) = locs_G;
peaks_B(chan_loop_2,1:length(locs_B)) = locs_B;
end

%find where both colors peak together to count true positives
for chan_loop_2 = 1:numberofchannels
%go through each 1d line vector segment
for index_track = 1:nnz(peaks_R(chan_loop_2,:))
%for each nonzero number for the 1d vector; check if there is a
value
%that is close to the peak location in G or B
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for index_track_G = 1:nnz(peaks_G(chan_loop_2,:))
if (peaks_R(chan_loop_2,index_track)-10) <
peaks_G(chan_loop_2,index_track_G) &&
(peaks_R(chan_loop_2,index_track)+10) >
peaks_G(chan_loop_2,index_track_G)
counter_R_G =counter_R_G+1;
end
end
for index_track_B = 1:nnz(peaks_B(chan_loop_2,:))
if (peaks_R(chan_loop_2,index_track)-10) <
peaks_B(chan_loop_2,index_track_B) &&
(peaks_R(chan_loop_2,index_track)+10) >
peaks_B(chan_loop_2,index_track_B)
counter_R_B =counter_R_B+1;
end
end

end
end
%count the number of beads based on the total nonzero elements in the
%matrix containing peaks for g and b correlation peaks
counter_G = nnz(peaks_G);
counter_B = nnz(peaks_B);
%Active enzyme for beads is defined as fraction of total beads that
%caputred a protein
AEB_G = counter_R_G/counter_G;
AEB_B = counter_R_B/counter_B;

~~~~~~~~
uMD_ThreeColor_Arduino_Code
ThreeColorArduino
int fps = 25;
int bits = 63;
//int delay_time = 0;
long delay_time = 1000000L/(fps*bits); //delaytime is in us based on
fps
//int MLS_Seq[63];
int MLS_Seq[] = {-1, 1, -1, 1, -1, 1, 1, -1, -1, 1, 1, -1, 1, 1,
1, -1, 1, 1, -1, 1, -1, -1, 1, -1, -1 , 1 ,1 ,1, -1, -1, -1, 1,
-1, 1, 1, 1, 1, -1, -1, 1, -1, 1, -1, -1, -1, 1 ,1, -1, -1, 1, -1, 1, -1, -1 , -1, -1, -1, 1, 1, 1, 1, 1, 1};
int MLS_SeqTwo[] = {-1, 1, -1 , 1 ,1 ,1 ,1, -1, -1, 1, -1 ,-1 , 1
,-1 , 1 ,1, 1, -1 , -1 , 1 ,1 ,1 ,-1, -1 , -1 , -1 , -1 , -1, 1, 1
,1, -1 , 1 ,1, 1 ,-1 , 1 ,-1 , -1 ,1, 1 ,1 ,1 ,-1 , 1, -1 , 1, -1 , 1, 1 ,-1 ,1 ,-1 ,-1 ,-1 ,-1 ,-1 ,-1 ,1 ,-1 ,1 ,-1 , 1};
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int MLS_Seq3[] = {-1, -1, 1, 1, 1, 1, 1, 1, -1, -1, 1, -1, 1, -1,
1, -1, 1, -1, -1, 1, 1, -1, -1, 1, 1, -1, -1, 1, -1, 1, -1, 1, 1, 1, 1, 1, 1, -1, 1, -1, -1, 1, 1, 1, -1, -1, -1, -1, 1, 1, -1, -1, 1, 1, -1, 1, 1, -1, -1, 1, -1, -1, -1};
// the setup function runs once when you press reset or power the board
void setup() {
// initialize digital pin 13 as an output.
pinMode(24, OUTPUT);pinMode(25, OUTPUT);pinMode(26, OUTPUT);
Serial.begin(9600);
}
// the loop function runs over and over again forever
void loop() {
//Serial.print(delay_time);
Serial.print('\n');
//Largest number for delayMicroseconds function is 16383
for (int i=0; i<bits; i=i+1){
if (MLS_Seq[i]>0){
digitalWrite(24, LOW); //LOW leads ot LED being on from the Driver
}
else {
digitalWrite(24, HIGH);
}
if (MLS_SeqTwo[i]>0){
digitalWrite(25, LOW); //LOW leads ot LED being on from the Driver
}
else {
digitalWrite(25, HIGH);
}
if (MLS_Seq3[i]>0){
digitalWrite(26, LOW); //LOW leads ot LED being on from the Driver
}
else {
digitalWrite(26, HIGH);
}
delayMicroseconds(delay_time);
}
//Serial.print(micros()) ;
}

~~~~~~~~
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ddELISA_App_Final_Package_COMPLETE
MainActivity.java
package vraviy.exosomedetection;
import
import
import
import
import
import
import
import
import
import
import
import
import
import
import
import
import
import
import
import
import
import
import
import
import
import
import
import
import
import
import
import
import
import
import
import
import
import
import
import
import
import
import
import
import

android.app.Notification;
android.app.NotificationManager;
android.app.PendingIntent;
android.content.ComponentName;
android.content.Context;
android.content.pm.PackageManager;
android.graphics.Bitmap;
android.media.MediaMetadataRetriever;
android.support.v4.app.NotificationCompat;
android.support.v7.app.AppCompatActivity;
android.os.Bundle;
android.view.Menu;
android.view.MenuItem;
java.io.File;
java.io.FilenameFilter;
java.util.Arrays;
android.app.Activity;
android.app.AlertDialog;
android.app.AlertDialog.Builder;
android.app.Dialog;
android.content.DialogInterface;
android.content.Intent;
android.content.SharedPreferences;
android.database.Cursor;
android.graphics.Color;
android.net.Uri;
android.os.Bundle;
android.os.Environment;
android.preference.PreferenceManager;
android.provider.MediaStore;
android.provider.MediaStore.MediaColumns;
android.util.Log;
android.view.Menu;
android.view.MenuInflater;
android.view.MenuItem;
android.view.MotionEvent;
android.view.View;
android.view.View.OnTouchListener;
android.widget.Button;
android.widget.ImageView;
android.widget.TextView;
android.widget.Toast;
android.widget.VideoView;
java.util.HashMap;
java.lang.Object;
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public class MainActivity extends AppCompatActivity implements
OnTouchListener{
private static final int SELECT_VIDEO = 1;
private static final int RECORD_VIDEO = 2;
// private static final int SELECT_GIF = 3;
private static final String TAG = "MainActivity";
private NotificationManager notificationManager;
MediaMetadataRetriever retriever = new MediaMetadataRetriever();
//FFmpegMediaMetadataRetriever retriever = new
FFmpegMediaMetadataRetriever();
private VideoView selected_video;
//Getting video dimensions for pixels
private int vid_width = 0;
private int vid_height = 0;

//Frames from video
ImageView img, img2, img3, img4, img5, img6, img7, img8, img9,
img10;
ImageView imageView;
TextView textview_ratio, t0,t1,time0_text,time5_text,time10_text;
TextView rotatedYLabel;
@Override
protected void onCreate(Bundle savedInstanceState) {

super.onCreate(savedInstanceState);
if(savedInstanceState != null){
Log.d("STATE",savedInstanceState.toString());
}

setContentView(R.layout.activity_main);
setupButtonClickListeners();
notificationManager = (NotificationManager)
getSystemService(Context.NOTIFICATION_SERVICE);

CharSequence tickerText = "Hello";
long when = System.currentTimeMillis();
NotificationCompat.Builder mBuilder = new
NotificationCompat.Builder(this)
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.setSmallIcon(R.mipmap.ic_launcher)
.setContentTitle("Microdroplet Detector");
Intent resultIntent = new Intent(this, MainActivity.class);
PendingIntent resultPendingIntent = PendingIntent.getActivity(
this,
0,
resultIntent,
PendingIntent.FLAG_UPDATE_CURRENT);
mBuilder.setContentIntent(resultPendingIntent);
Notification notification = mBuilder.build();
notification.flags |= Notification.FLAG_NO_CLEAR |
Notification.FLAG_ONGOING_EVENT;
NotificationManager mNotifyMgr = (NotificationManager)
getSystemService(NOTIFICATION_SERVICE);
mNotifyMgr.notify(1, notification);
}

private void setupButtonClickListeners()
{
//Button exitButton = (Button)findViewById(R.id.exit);
//exitButton.setOnClickListener(this);
((Button)findViewById(R.id.GalleryButton)).setOnTouchListener(this);
((Button)findViewById(R.id.RecordButton)).setOnTouchListener(this);
((Button)findViewById(R.id.Matlabbutton)).setOnTouchListener(this);
}

@Override
public void onActivityResult(int requestCode, int resultCode,
Intent data)
{
Log.d("CREATION", "Clicked button");
//
Intent browserIntent = new Intent(Intent.ACTION_VIEW,
Uri.parse("https://drive.matlab.com"));
//
startActivity(browserIntent);

}
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private void VideoAnalysis(String path) {
retriever.setDataSource(path);
imageView.setImageBitmap(retriever.getFrameAtTime(1000000,
MediaMetadataRetriever.OPTION_CLOSEST));

}
private String getPath(Uri uri)
{
//file:///mnt/sdcard/DCIM/Camera/VID_20111217_233451.mp4
if(uri.toString().contains("content"))
{
try
{
String[] projection = {MediaColumns.DATA};
Cursor cursor =
managedQuery(uri,projection,null,null,null);
int column_index =
cursor.getColumnIndex(MediaColumns.DATA);
cursor.moveToFirst();
return cursor.getString(column_index);
}
catch(Exception ex)
{
return null;
}
}
else
{
return uri.toString();
}
}
private void handleClickEvent(View v)
{
switch(v.getId())
{
case R.id.GalleryButton:
Intent browserIntent = new Intent(Intent.ACTION_VIEW,
Uri.parse("https://drive.matlab.com"));
startActivity(browserIntent);
//
Intent intent = new Intent();
//
intent.setType("video/*");
//
intent.setAction(Intent.ACTION_GET_CONTENT);
//
startActivityForResult(Intent.createChooser(intent,"Select
Video"),SELECT_VIDEO);
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//image/*
break;
case R.id.RecordButton:
Intent recordIntent = new Intent();
recordIntent.setAction(MediaStore.ACTION_VIDEO_CAPTURE);
recordIntent.putExtra(MediaStore.EXTRA_VIDEO_QUALITY,
1);
//recordIntent.putExtra(MediaStore.EXTRA_OUTPUT,
Uri.fromFile(file));
startActivityForResult(recordIntent,RECORD_VIDEO);
break;
case R.id.Matlabbutton:
//
Intent intent = new Intent(Intent.ACTION_MAIN);
//
intent.setComponent(ComponentName.unflattenFromString("com.mathworks.ma
tlabmobile"));
//
intent.addCategory(Intent.CATEGORY_LAUNCHER);
//
startActivity(intent);
PackageManager pm = this.getPackageManager();
Intent appStartIntent =
pm.getLaunchIntentForPackage("com.mathworks.matlabmobile");
if (null != appStartIntent)
{
this.startActivity(appStartIntent);
}
break;
}
}

//#FFA500
@Override
public boolean onTouch(View v, MotionEvent event) {
switch(event.getAction())
{
case MotionEvent.ACTION_DOWN:
switch(v.getId())
{
case R.id.GalleryButton:
//((Button)findViewById(R.id.GalleryButton)).setBackgroundColor(0xFFFFA
500);
break;
case R.id.RecordButton:
//
((Button)findViewById(R.id.RecordButton)).setBackgroundColor(0xFFFFA500
);
break;
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}
return true;
case MotionEvent.ACTION_UP:
switch(v.getId())
{
case R.id.GalleryButton:
//
((Button)findViewById(R.id.GalleryButton)).setBackgroundColor(Color.BLA
CK);
handleClickEvent(v);
break;
case R.id.RecordButton:
//
((Button)findViewById(R.id.RecordButton)).setBackgroundColor(Color.BLAC
K);
handleClickEvent(v);
break;
case R.id.Matlabbutton:
//
((Button)findViewById(R.id.RecordButton)).setBackgroundColor(Color.BLAC
K);
handleClickEvent(v);
break;
}
default:
return true;
}
}
//In an
private
private
private
private
private

Activity
String[] mFileList;
File mPath;
String mChosenFile;
static final String FTYPE = ".gif";
static final int DIALOG_LOAD_FILE = 1000;

private void loadFileList(){
try
{
mPath = new
File(getApplicationContext().getExternalFilesDir(null).getAbsolutePath(
) + "/");
Log.i(TAG,"loadFileList() path: " + mPath.getAbsolutePath()
+ "/");
}
catch(Exception ex)
{
mPath = null;
return;
}
try{
mPath.mkdirs();
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}
catch(SecurityException e){
Log.e(TAG, "unable to write on the sd card " +
e.toString());
}
if(mPath.exists()){
FilenameFilter filter = new FilenameFilter(){
@Override
public boolean accept(File dir, String filename){
File sel = new File(dir, filename);
return filename.contains(FTYPE) ||
sel.isDirectory();
}
};
mFileList = mPath.list(filter);
}
else{
mFileList= new String[0];
}
}

@Override
public boolean onCreateOptionsMenu(Menu menu) {
// Inflate the menu; this adds items to the action bar if it is
present.
getMenuInflater().inflate(R.menu.menu_main, menu);
return true;
}
@Override
public boolean onOptionsItemSelected(MenuItem item) {
// Handle action bar item clicks here. The action bar will
// automatically handle clicks on the Home/Up button, so long
// as you specify a parent activity in AndroidManifest.xml.
int id = item.getItemId();
//noinspection SimplifiableIfStatement
if (id == R.id.action_settings) {
return true;
}
return super.onOptionsItemSelected(item);
}
}
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CHAPTER 4: MAGNETIC NICKEL IRON ELECTROFORMED TRAP (MAGNET): A
MASTER / REPLICA FABRICATION STRATEGY FOR ULTRA-HIGH THROUGHPUT
(> 100 ML/HR) IMMUNOMAGNETIC SORTING
This chapter is a slightly modified version of a manuscript published in Lab on a Chip:
J Ko*, VR Yelleswarapu*, A Singh, N Shah, D Issadore. Magnetic Nickel iron
Electroformed Trap (MagNET): A master / replica fabrication strategy for ultra-high
throughput (> 100 mL/hr) immunomagnetic sorting, Lab on a Chip, 2016. (*Equal
Contribution)
V. Y. conceived and performed experiments in this study, coded the Comsol and Matlab
software, as well as prepared the manuscript and figures.

4.1 Abstract
Microfluidic devices can sort immunomagnetically labeled cells with sensitivity and
specificity much greater than that of conventional methods, primarily because the size of
microfluidic channels and micro-scale magnets can be matched to that of individual
cells. However, these small feature-sizes come at the expense of limited throughput ɸ <
5 mL/hr and susceptibility to clogging, which have hindered current microfluidic
technology from processing relevant volumes of clinical samples, e.g. V > 10 mL whole
blood. Here, we report a new approach to micromagnetic sorting that can achieve highly
specific cell separation in unprocessed complex samples at a throughput (ɸ > 100 mL/hr)
100x greater than that of conventional microfluidics. To achieve this goal, we have
devised a new approach to micromagnetic sorting, the Magnetic Nickel iron
Electroformed Trap (MagNET), which enables high flow rates by having millions of
micromagnetic traps operate in parallel. Our design rotates the conventional microfluidic
approach by 90° to form magnetic traps at the edges of pores instead of in channels,
enabling millions of the magnetic traps to be incorporated into a centimeter sized device.
Unlike previous work, where magnetic structures were defined using conventional
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microfabrication, we take inspiration from soft lithography and create a master from
which many replica electroformed magnetic micropore devices can be economically
manufactured. These free-standing 12 µm thick permalloy (Ni80Fe20) films contain
micropores of arbitrary shape and position, allowing the device to be tailored for maximal
capture efficiency and throughput. We demonstrate MagNET’s capabilities by fabricating
devices with both circular and rectangular pores and use these devices to rapidly (ɸ =
180 mL/hr) and specifically sort rare tumor cells from white blood cells.

4.2 Introduction
The isolation of specific populations of cells, such as stem cells, pathogens, or
circulating tumor cells (CTCs), from complex biological fluids is an emerging
methodology that holds enormous potential for detecting, monitoring, and studying a
wide variety of diseases.203–206 The use of magnetic fields to separate cells labeled with
magnetic nanoparticles (MNPs) has shown particular promise because it can achieve
highly selective sorting even in complex biological media, due to the inherently negligible
magnetism of biological samples compared to MNP labeled cells.207–211 Moreover,
platforms that use micro-scale structures, where the dimensions of the microfluidic
channels and the micrometer-scale magnets can be designed to match those of the
targeted cells, have been harnessed for highly selective sorting of rare cells. However,
conventional microfluidic geometries where immunomagnetically labelled cells travel
through microfluidic channels and are captured with patterned microstructures have
limited throughput (ɸ < 5 mL/hr) and are susceptible to clogging, due to their microscale
channels. The limited throughput (ɸ < 5 mL/hr) and susceptibility to clogging of
microscale devices have kept these approaches from being translated from the
laboratory to many medical applications, where large volume samples, e.g. V > 10 mL of
whole blood, must be processed rapidly (< 15 minutes) to provide relevant point-of-care
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information. In particular, applications where extremely rare cells (e.g. CTCs, pathogens,
stem cells) must be sorted from complex biological fluids (e.g. blood, sputum,
environmental samples) require large volumes of unprocessed clinical samples to be
sorted with the precision of microfluidics within timescales relevant to providing real-time
information (T < 30 minutes). For example, using CTCs for the diagnosis of cancer
requires the detection of extremely sparse cells (< 1 CTC / mL) in volumes of blood > 10
mL.212

Figure 4.1. High throughput immunomagnetic sorting with the Magnetic Nickel
iron Electroformed Trap (MagNET). a. MagNET uses magnetophoretic traps to isolate
cells specifically targeted with functionalized magnetic nanoparticles. This design
enables high flow rates by having millions of micromagnetic traps operate in parallel. b.
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MagNET rotates the conventional microfluidic geometry by 90° to form magnetic traps at
the edges of pores instead of in microfluidic channels (c). d. Micrographs of Track
Etched Magnetic microPOre (TEMPO) devices. In this approach as the density of
micropores is increased so did the number of overlapped pores, which limited
performance. Scale bar 30 µm. e. Micrographs of MagNET devices. In this approach
density and the shape of the micropores could be tailored to maximize performance.
Scale bar 30 µm. f. A graph summarizing the trade-off relationship between % open area
and % overlap for both TEMPO and MagNET.
To address these challenges, we have developed a new approach to the micromagnetic
separation of cells, the Magnetic Nickel iron Electroformed Trap (MagNET).(Fig. 1a) In
contrast to lateral flow devices208–210,212213, our vertical flow design enables high flow
rates (ɸ > 100 mL/hr) by having millions of micromagnetic traps operate in parallel. This
improved throughput allows typical clinical samples (V > 10 mL of blood) to be
processed in less than fifteen minutes, allowing precise microfluidic cell sorting to be
used for rapid point-of-care diagnostics. Our design achieves this performance by
rotating the conventional microfluidic geometry (Fig. 1b) by 90° to form magnetic traps at
the edges of pores instead of in microfluidic channels. (Fig. 1c) An external static field,
provided by an inexpensive NdFeB magnet, magnetizes both the MNP labeled cells and
the MagNET filter. This geometry allows millions of magnetic traps to be incorporated
into a single centimeter sized device. Furthermore, the large density of micropores (ρ =
5*104 pores/cm2) reduces clogging from clinical samples, as the blockage of a few pores
does not significantly change the device’s behavior.214 The trapping of a cell in MagNET
is based on a competition between the individual cell’s drag force and its magnetic force
as it passes through a magnetic micropore. Thus, the contrast in the magnetic trapping
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of targeted cells versus non-targeted cells is not affected by the concentration of cells.
Unlike previous work, where magnetic micropores were defined using conventional
microfabrication,215,216 we instead take inspiration from soft lithography217 and create a
master that can be used repeatedly to economically produce replica permalloy
membranes with lithographically defined micropores. The micropores on these 12 µm
thick electroformed membranes can have arbitrary shape and position, allowing the
device to be tailored for maximal capture efficiency and throughput. We demonstrate
MagNET’s capabilities by fabricating devices with both circular and rectangular pores
and use these devices to rapidly (ɸ = 180 mL/hr) and specifically sort rare tumor cells
(LOD = 3 cells/mL) from white blood cells.
Our MagNET approach builds upon previous work from our lab, where track etching was
used to fabricate magnetic micropores.214216 The MagNET approach offers several
important advantages over our previous approach, which we called Track Etched
Magnetic microPOre (TEMPO). The TEMPO consists of an ion track-etched
polycarbonate membrane coated with soft magnetic film, permalloy (Ni80Fe20). The main
advantage of track etching is the ability to fabricate microscale pores over large areas (A
> 1 cm2) at a cost < 5¢ /cm2, much less than conventional microfabrication.214 MagNET
conserves the advantages of TEMPO, and also addresses its two key weaknesses:
1. TEMPO’s low cost fabrication comes at the expense of its inability to control the
position or shape of the pores.(Fig. 1d) The MagNET strategy solves this challenge,
allowing pores to be created with arbitrary shape and position.(Fig. 1e) The inability
of TEMPO to control the position of the pores creates a tradeoff relationship between
the density of the micropores and the fraction of pores that overlap with one another
(Fig. 1f), which results in a tradeoff between the device’s throughput ɸ and the
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capture efficiency of magnetically labeled cells ζ. The reason for this tradeoff is that
as the fraction of open area is increased by increasing the density of micropores, the
flow velocity through each pore decreases. As the flow rate decreases, the capture
efficiency of each magnetic micropore increases, increasing the overall capture rate
ζ. However, for TEMPO, as the density of track etched micropores increases, so
does the fraction of pores that overlap.(Fig. 1d) For pores that overlap, the effective
pore diameter is increased and so fewer cells come in close proximity to the pore’s
edge to be trapped, and thus the overall capture efficiency ζ is reduced. MagNET’s
ability to control the position and shape of the pores allows this tradeoff relationship
to be broken (Fig. 1f) and extremely high flow rates to be achieved ɸ > 100 mL/hr
without having to sacrifice capture rate ζ > 104.
2. While track etching allows the polycarbonate membranes in TEMPO to be
fabricated at low-cost, the deposition of the magnetic film is expensive, slow, and
requires specialized facilities.12 The MagNET strategy solves this challenge. Once
the master is made, which requires a cleanroom and lithography equipment,
subsequent replicas only require electroplating, which can be performed at high
throughput and without specialized laboratory facilities.218 Moreover, the MagNET
method allows thick permalloy films (12 µm) compared to thermal evaporation, which
is practically limited to < 1 µm, while also achieving consistent reproducibility of film
thickness (± 0.5 µm). The increased thickness of MagNET leads to an increased
capture rate, due to both increased magnetic field gradients (Fig. 3b) and the
formation of two traps in series for each pore: one on the top surface of the filter and
one on the bottom (Fig. S2).
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4.3 Methods
Fabrication of the MagNET master. We take inspiration from soft lithography217 and
create a master from which many replica MagNET devices can be produced using
electroformation. Electroformation is a well-known process to form metal parts by
electroplating onto a master (i.e. a mandrel), and subsequently removing the
electroplated piece from the master to form a free-standing metal piece. Much work has
been done to use this technique to form free-standing metal pieces with microscale
features,219–221 but to our knowledge this work represents the first such work that creates
a reusable microscale master to generate many replica devices. The creation of a
reusable micro-scale master for electroformation comes with the following challenges: 1.
A thin metal piece (i.e. 12 µm) must be removed from the master without tearing. 2. The
master must be mechanically robust, such that the removal of the electroformed metal
piece from the master does not cause the microscale features of the master to be
destroyed.
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Figure 4.2. Master / replica fabrication of MagNET. a. Step by step fabrication of the
master and subsequent replicas of MagNET. b. A micrograph of the lithographically
defined aluminum mask. Scale bar 30 µm. c. Photograph of a replica MagNET being
mechanically removed from its Master. d. Three dimensional optical micrograph of
MagNET. In the region to the left, a MagNET has been electroformed. In the region to
the right, the MagNET has been removed and the polyimide and copper master can be
seen. e. Micrographs of the master and replica MagNETs after k replications. Scale bar:
30 µm. f. The fraction of damaged pillars was quantified after each replication, and there
was no statistically significant change observed. (P >> 0.05). Error bars indicate
standard error from the ratio of intact pores to total number of pores of different regions
from the same device.
To address these challenges, we made the following design choices. To remove the
electroformed permalloy piece without tearing, we needed to find a metal substrate that
has minimum adhesion to the electroformed material. We chose copper as a substrate
because it is known to have low adhesion to permalloy.222 To allow the electroformed
permalloy to be removed without destroying the master, we patterned the microscale
features of the master in polyimide, which was adhered to a roll annealed copper
substrate. The roll annealed copper on polyimide is more strongly adhered than is
possible with spun-on photo-activated polymers (e.g. SU8),219–221 and so does not
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delaminate when the electroformed permalloy is removed. We used conventional
microfabrication techniques to etch the polyimide to create the micropore pattern through
which MagNET was electroformed.
To fabricate the master for MagNET, we perform the following procedure.(Fig. 2a) We
begin with Pyralux AC181200R (Dupont), a substrate typically used for flexible
electronics, where an 18 μm copper layer is roll annealed onto a 12 μm polyimide film.
We adhere the Pyralux to a glass slide to prevent the film from wrinkling during
processing. Next, a hard mask of aluminum (Al) is thermally evaporated (PVD75 Ebeam/Thermal evaporator) and patterned using conventional planar UV photolithography
(Singh Center for Nanotechnology).(Fig. 2b) We use the same Tetramethylammonium
hydroxide (TMAH) solution (MF319, Microposit) to both develop the S1805 (Microchem)
photoresist and chemically etch the Al mask. Finally, the unexposed photoresist is
stripped in acetone. After patterning the Al hard mask, the polyimide is etched using
Inductively Coupled Plasma (ICP) etching.223–225 Whereas a pure plasma etch would
result in isotropic etching, a combination of a plasma etch with ion bombardment
provided an etch with a sufficiently anisotropic etch profile. Exposed regions of the
copper without the polyimide pillars are used as zones for electroplating permalloy. Once
the permalloy filter is > 10 μm, the filter can be peeled off mechanically due to poor
adhesion between the copper and electroplated permalloy222(Fig. 2c). The Pyralux
substrate facilitates the easy removal of the permalloy film. By gently flexing the
substrate, the permalloy delaminates from the copper.
We optimized RIE conditions for the MagNET master using The Trion Phantom at
University of Pennsylvania’s Singh Center for Nanotechnology. After exploring a variety
of combinations of pressures, RIE powers, RF powers, and gas flow rates, we found that
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O2/CF4 resulted in large undercuts in the polyimide and made etching 12μm polyimide
impractical since the undercut resulted in the erosion of the hardmask. O2/SF6 etching
resulted in less undercut, as well as slower etch rates. The optimal recipe for the etching
of the polyimide was with 40 sccm O2/ 10 sccm SF6/ 40mT Pressure/ 300W ICP/ 50W
RIE for 50 minutes. The etch profile was characterized using profilometry and 3D
imaging (Zeiss Smartzoom5 2D/3D).
Electroformation of MagNET. Permalloy was electroplated onto the MagNET master
using nickel foil (1 mm thick, 99.5%, Alfa Aesar) as the anode in an electroplating
solution containing 200 g/l NiSO4-6H2O, 8 g/l FeSO4-7H2O, 5 g/l NiCl2-6H2O, 25 g/l
H3BO3, and 3 g/l saccharin (pH=2.5-3).218 12 µm thick permalloy layer was deposited on
the 3.8 cm [W] × 4.3 cm [L] master at 0.2A for 45 min. The master was firmly attached to
a flexible mylar support for plating. To peel off the filter, the mylar/Pyralux combination
was flexed until the permalloy started to lift off at the corner. The permalloy was
separated mechanically as shown in Fig. 2c. Once removed from the master, the free
standing electroformed MagNET was then plated (Bright Electroless Gold, Transene)
with approximately 100 nm of gold to passivate the surface.
Electroformation allows precise and repeatable control over film thickness. In prior work,
permalloy has been electroplated with film thickness ranging from 500 nm to 5 µm in
uniform, smooth layers (surface roughness < 100 nm)226,227. To control the thickness of
our electroformed film, we fixed the device area exposed to the electroplating solution,
and then calibrated the deposition current and the deposition time to produce specific
film thicknesses. We measured film thickness using a profilometer (KLA Tencor P7 2D
profilometer). The variation of film thickness across individual devices was determined
by measuring film thickness at N = 10 locations across the 3.8 × 4.3 cm2 film, resulting in
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a coefficient of variation of CV = 3.6 %. The variation of film thickness across various
devices was determined by measuring the average film thickness of N = 8 independently
fabricated devices, resulting in a coefficient of variation between devices of CV = 3.3 %.
These measurements indicate that MagNETs can be fabricated with accurate and
reproducible film thickness.
Device fabrication. The MagNET filter was incorporated into the device using a
moisture-resistant polyester film (McMaster-Carr, 0.004” thick) and a solvent-resistant
tape (McMaster-Carr, adhesive on both sides). Multiple layers of the polyester film and
the solvent-resistant tape were cut by a laser cutter (Universal Laser VLS 3.50) and
assembled. For the device with multiple filters stacked in series, the filters were
separated by the height of the polyester film (0.004’’) and the tape (0.004’’). An optically
clear cast acrylic sheet (McMaster-Carr) was used as a reservoir, and the output was
made using a blunt syringe tip (McMaster-Carr) epoxy-bonded to the device to pull the
fluid from the reservoir. The design of each of the device layers, as well as a three
dimensional rendering of the device, are shown in detail in Fig. S3.

4.4 Results
Robustness of MagNET fabrication over multiple replications. One design challenge
that we overcame in developing MagNET was to find a material that we could use to
pattern the microscale features of our master that is not damaged during the removal of
each electroformed MagNET replica. We found that spin-on polymers such as
photoresists (SU8, S1818, SPR220) delaminated during mechanical peel off even after
surface treatment to improve adhesion. Dupont’s Pyralux – a material used for flexible
circuit PCBs – consisting of 18 μm copper film roll annealed onto a 12 μm polyimide film
proved to be perfect due to the polyimide layer’s strong adherence to copper. To
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demonstrate the robustness of the MagNET master for reusability, we performed
multiple cycles of plating and peeling, and for each cycle checked for any damaged
pillars (Fig. 2e). Profilometer (KLA Tencor P7 2D profilometer) and 3d images (Zeiss
Smartzoom5 2D/3D Optical Microscope) of the master confirmed that there was no
structural damage during mechanical peel off, and that the electroformed filters were
identical after multiple rounds of fabrication. The percent of damaged pores after rounds
one, two, and three were 0.5%, and did not show a statistically significant increase after
repeated use.(P >> 0.05) To visually demonstrate the functionality of our fabrication
process, we mechanically removed a MagNET such that a portion of the electroformed
permalloy remained on the polyimide pillars, and subsequently imaged it (Fig. 2d, Fig.
S1)(Zeiss Smartzoom5 2D/3D Optical Microscope). In this image, the electroformed
permalloy has been plated to the height of the pillars. Adjacent to this film, there is a
region where the film has been peeled away and the copper and polyimide pillars are
visible. The image demonstrates that the pillars are still intact, and at the same height as
the permalloy, and thus the master is robust for multiple rounds of reuse.
Magnetic Field Finite Element Simulation. To aid in the design and characterization of
the MagNET filter, we performed finite element simulations. We modeled MagNET as a
circular d = 30 µm pore in a 12 µm thick permalloy film using a finite element simulation
package (Comsol). We created a 2D axisymmetric model, containing one circular pore at
the center of the permalloy film. The film is magnetized by a B = 0.4 T field in the
cylindrical direction provided by centimeter-sized NdFeB magnet placed below MagNET.
In addition to MagNET, we also modeled a TEMPO filter for comparison. The TEMPO
model was identical to MagNET's except the thickness of the permalloy film was 200 nm.
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In these simulations, we used as our boundary conditions that at distances far from
MagNET or TEMPO, the magnetic field dropped to zero.
To calculate the magnetophoretic force Fm = (m ·∇ ) B on a cell as it passes through
MagNET, we combined the finite element field simulations described above with a
simplified model for a cell. The total magnetic moment of the cell was calculated to be
proportional to the number of magnetic nanoparticles n, each with a magnetic moment
mp = 106 Bohr magnetons, with the assumption that the external magnetic field was
sufficient to fully magnetize the beads.225 Due to the low Reynold’s number regime of
flow through the micropore, the mass of the cell does not play a role in determining the
cell’s behavior. The total number of particles per cell was assumed to be 104 particles.
There are a total of >105 CD45 receptors on a leukocyte208. The assumed number of
particles (104) corresponds to 6.2% coverage of the surface of the cell, and thus would
not result in significant steric hinderance. We assumed the cell to have a diameter d = 10
µm and the particles to have a diameter d = 50 nm. We calculated the magnetic force
experienced by the cell, Fm = ([mp*n] ·∇ ) B, as the sum of the magnetic force
experienced by all of the beads bound to the cell.
We calculated and plotted the radial force Fr experienced by the cell at one cell radius r
= 5 μm above the filter. Additionally, the force in the cylindrical direction Fz on the cell
was calculated and plotted along a line one cell radius r = 5μm away the filter edge. The
magnetophoretic force is opposed by a drag force, which can be calculated using Stokes
equation Fd = 6πηrv, where ηwater = 0.8 mPa/s, r = 5 μm for a cell. The average flow
velocity in the pore vavg = ɸ / (nporeApore), where npore is the total number of pores and Apore
is the cross sectional area of the pore. We calculated the maximum flow rate ɸ at which
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the magnetic trapping force Fm would still be greater than the drag force Fd, and the cell
would remain trapped on the edge.

Figure 4.3. Finite element simulations of MagNET. a. The field strength |B| is plotted
on the cross-section of an individual 30 μm pore. The magnetophoretic force Fm
competes with drag force Fd to trap cells at the edge of the pore. b. The magnetophoretic
force in the radial direction FM,r is plotted along r, one cell radius d = 5 µm above the
MagNET’s surface. c. The magnetophoretic force in the cylindrical direction FM,z is
plotted along z, one cell radius d = 5 µm away the MagNET’s edge.
The results of the finite element simulations were used to choose design parameters,
such as the pore diameter, and to guide us in approaches to further improve the
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throughput and enrichment of our device. Fig. 3a shows the simulated magnetic flux
density around the edge of the pore. The magnetic flux density drops rapidly away from
the edge of the pore, leading to strong gradients and magnetic forces at this region.
Based on this simulated field, we calculated the radial and vertical forces experienced by
a cell as it moves through the pore. The radial force, which pulls cells to the edge of the
pore, was plotted 5 µm above the MagNET’s surface.(Fig. 3b) The force has a
maximum magnitude of Fr = 266 pN at the edge of the pore and drops rapidly in distance
r from the pore’s edge. Thus, we can improve the device’s performance by making the
pore as small as possible, as that will force cells to come into close proximity of the
regions where the magnetic force is the strongest. However, the pores must be large
enough that we do not capture off-target cells based on their size. The max Fr and Fz are
~10x and ~50x, respectively, larger for MagNET than TEMPO, demonstrating that the
thicker metal film allows stronger trapping forces. Once a cell is translated to the pore’s
edge, the magnetic force Fz opposes the drag force Fd, and determines whether the cell
will stay in the trap or not. The magnetophoretic force (Fig. 3c), at one cell radius r = 5
µm away from the filter, is Fz = 707 pN. For the device described above ( A = 6.2 cm2),
the magnetic force will exceed the drag force up to extremely large flow rates ɸ > 1000
mL/hr. Thus, the performance of the device will be limited solely on what fraction of cells
make it to the pore’s edge. And, based on this fact, we predict that device performance
can be improved, even at flow rates ɸ >> 100 mL/hr, by stacking multiple filters in series
to give cells multiple chances to be trapped.

Characterization of MagNET’s using a suspension of microbeads as a
model sample. Before testing the MagNET’s capability to sort cells, we first
tested it with magnetic and non-magnetic polystyrene beads that have well
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characterized, homogenous properties. We used 1 µm pink fluorescent magnetic
beads (FCM-1058-2, Spherotech) and 1 µm yellow fluorescent polystyrene
beads (F13081, Invitrogen). We first compared the performance of MagNET to
TEMPO, where both filters had an area of A = 6.2 cm2. The input to each device
contained a 100:1 ratio of magnetic to non-magnetic beads. To characterize the
capability of these devices to selectively sort magnetic beads, we calculated an
enrichment factor ζ = (C1p/C1m)/(C0p/C0m), at different flow rates Φ, where C0p and
C1p are the numbers of non-targeted beads before and after sorting respectively,
and C0m and C1m are the numbers of targeted beads before and after sorting
respectively. We found that as flow rate increased, the enrichment dropped as a
power law.(Fig. 4a) At all flow rates the enrichment of MagNET was > 30x the
enrichment of TEMPO. One of the reasons for MagNET’s enhanced performance
is that, in contrast to TEMPO where beads are captured on only one side of the
filter (NiFe deposited), on MagNET the beads were captured both on the front
and back side of the 12 µm thick MagNET layer. By forming two traps, on the top
and bottom surface of MagNET, the capture efficiency is increased by providing
a second chance for cells missed by the trap on the top surface of MagNET to be
captured.(Fig. S2) Moreover, we demonstrated that enrichment could be further
improved by stacking multiple MagNET filters in series.(Fig. 4b) By increasing
from N = 1 to N = 5 at Φ = 150 ml/hr, enrichment was improved ~1,000x,
allowing high enrichment (ζ > 5,000) to be achieved even at exceedingly high
flow rates Φ = 150 mL/hr. As the filters are vertically stacked, the subset of the
cells missed by the previous filter can be captured on the next filter, which leads
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to an exponential increase in the enrichment ζ ∝ ζ0N, where ζ0 is the enrichment
of one filter. (Fig. 4b - inset)

Figure 4.4. Characterization of the MagNET using microbeads. a. 1 µm
diameter magnetic polystyrene microbeads were sorted from non-magnetic 1 µm
polystyrene microbeads using MagNET. The enrichment of the non-magnetic
beads ζ is plotted vs. flow rate. Inset: Enrichment vs. flow rate on a log-log plot
for both MagNET and TEMPO. At all flow rates the enrichment of MagNET was ζ
>30x the enrichment of TEMPO. The error bars indicate standard error from
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replicates from flow cytometry measurement. b. As N filters are vertically stacked
the enrichment at Φ = 150 ml/hr was improved ~1,000x. Inset: Enrichment ζ vs.
Φ on a log-linear plot, shows that enrichment ζ scales exponentially with the
number of filters N. The error bars indicate standard error from replicates from
flow cytometry measurement.
Reusability of the electroformed device. In addition to the reusability of the
master, MagNET can also be reused since it consists of only metal (NiFe
passivated with gold) and can be cleaned with aggressive mechanical agitation.
Unlike conventional micro-magnetic sorting devices, where a magnetic film is
adhered to a substrate, in MagNET there is no risk of delamination of the metal
layer from the substrate during cleaning. Additionally, aggressive solvents can be
used that would not be compatible with a polymer-based device (e.g. acetone
with PDMS). To test the reusability of MagNET, we compared the performance of
a previously used MagNET to a newly fabricated device. At 6 different flow rates,
the enrichment of the used MagNET was not statistically significantly different
from the newly fabricated device. (P >> 0.05)
Characterizing MagNET’s ability to sort tumor cells from leukocytes. To
demonstrate the utility of our chip to perform highly specific cell sorting, we used
MagNET to isolate spiked tumor cells from a large background of leukocytes.
The detection of rare circulating tumor cells (CTCs)(< 100 cells/mL) has
demonstrated great potential to diagnose and monitor cancer and has gained
enormous attention in the field of microfluidics.209,210,212,213,228
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MagNET’s highly specific capture of cells at ultra-high flow rates offers an
important new tool for the study of CTC biomarkers as well as their translation to
the clinics. While many ingenious microfluidic devices have been used with great
success to sort CTCs,204,209,211 there is currently a mismatch between the
throughput of microfluidic devices (ɸ ≅ 1 mL/hr) and the large sample volume of
blood (V ~ 20 mL) necessary for ultra-rare cell detection. This mismatch leads to
run times unsuitable for practical use (T > 10 hrs). MagNET, with its ɸ = 100
mL/hr flow rates, can process 20 mL of whole blood in only twelve minutes. In
this demonstration, rather than using MagNET to trap tumor cells based on one
of their heterogenous properties, we instead use negative selection, wherein the
cells that are easily identified as not being tumor cells are removed from
suspension (i.e. white blood cells) to create a concentrated population enriched
for potential CTCs.209,229 Because CTCs are present in clinical samples at a ratio
of approximately 1 tumor cell for every 1 million leukocytes, the high enrichment
of MagNET (ζ ~104) is necessary to create enriched populations (1 tumor cell for
every 100 leukocytes) that can be practically analyzed. And, MagNET is capable
of even greater enrichment ζ for applications that require high purity, e.g.
molecular analyses, by either decreasing the flow rate ɸ or increasing the
number of filters N.
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Figure 4.5. Characterizing MagNET’s ability to sort tumor cells from leukocytes. a.
Cytometry quantified cell populations before and after filtration. b. Very high enrichment
ζ was achieved at flow rates Φ > 80 mL h−1 using N = 4 filters. Inset: Enrichment vs. flow
rate on a log-log scale for the sorting of leukocytes from tumor cells using both MagNET
and TEMPO.The error bars indicate standard error from replicates from flow cytometry
measurement. c. A fluorescence micrograph showing leukocytes, stained red, trapped
on the MagNET filter. Scale bar: 30 µm. d. Titration of cultured cells into whole blood
measured using MagNET, for negative selection of leukocytes, combined with a sizedbased filter that concentrated the tumor cells into a small field of view (3x3 mm2) were
enumerated using microscopy. A limit of detection LOD < 3 cells in a 1 mL suspension
was achieved at a flow rate of Φ = 80 mL/hr.
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To test our chip’s ability to sort rare CTCs from leukocytes, a known number of
cells from pancreatic cancer cell line (PD7591) were spiked into a background of
leukocytes (Jurkat), and the enrichment of CTCs relative to leukocytes was
quantified. Cancer cells and leukocytes were stained with different fluorescent
dyes, green (CellTracker Green, Invitrogen) and red (CellTracker Red,
Invitrogen) respectively, and a suspension of 100:1 of leukocytes to cancer cells
was fed into the device. The leukocytes were labeled with CD45 functionalized
MNPs (Miltenyi) to be captured on MagNET. Both the input and output were
measured using flow cytometry, and the enrichment ζ quantified.(Fig. 5a) The
magnetically labeled leukocytes were captured on MagNET and only a very small
fraction (< 0.04%) were missed, even at extremely high flow rates ɸ = 100 mL/hr
using N = 4 MagNET filters in series.(Fig. 5b) MagNET’s performance sorting
tumor cells from leukocytes was directly compared to TEMPO's (Fig. 5b - inset),
which showed that MagNET matched TEMPO's enrichment at 5x the flow rate of
TEMPO. A fluorescence micrograph of MagNET after sorting shows leukocytes,
stained in red, captured at the edge of the pores of where the magnetic field
gradients are the largest, confirming that the cells were captured due to magnetic
forces (Fig. 5c).
To test the sensitivity of our chip to rare cells, we challenged our device with an
in-vitro model for CTCs, wherein we spiked a known number of cultured
pancreatic cancer cells (PD7591) into a background of leukocytes (Jurkat) and
enumerated the number of recovered tumor cells. To quantify the number of
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CTCs, a size-based filter that consisted of a nucleopore track-etched
polycarbonate membrane was incorporated into our device downstream of
MagNET. The size-based filter had a size of only 3x3 mm2, allowing rapid
enumeration with microscopy. On this filter, captured potential CTCs could be
imaged using an inverted fluorescence microscope (Leica DM750M). This device
used N = 4 MagNET filters in series, with an area of 6.2 cm2. A titration of varying
numbers of tumor cells spiked into a background of Jurkat cells was prepared
using serial dilution and then ran through our device (Fig. 5d). The enumeration
of these spiked cells agreed with expected cell numbers (R2 = 0.99) over a
dynamic range of 3 to >100 cells. A limit of detection (LOD) of <3 cells in a 1 mL
suspension was achieved at a flow rate of 80 mL/hr.

4.5 Discussion
MagNET offers a new approach to immunomagnetic separation that can be
performed at extremely high flow rates (ɸ > 100 ml/hr) without sacrificing the high
sorting efficiency (ζ > 104) typical of microfluidics. Additionally, we have
developed a fabrication strategy for MagNET that can produce these high
performance, microfabricated devices without specialized facilities, enabling
MagNET to be manufacturable for applications such as low-cost medical
diagnostics.230 In this paper we demonstrated the utility of MagNET to sort rare
tumor cells from blood cells for CTC detection. However, the approach is broadly
applicable to any application that requires highly specific sorting of rare cells from
large volume unprocessed samples, such as the diagnosis of infectious disease,
environmental sensing, cancer biology, and stem cell research.211,231
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Our MagNET approach to rapidly sort immunomagnetically labeled cells from
unprocessed samples is well suited for incorporation into integrated microfluidic
systems. For example, MagNET can be used to perform negative selection
upstream of ultrasensitive, low throughput single cell measurements.230,231 By
removing the vast majority of background cells, it can improve the effective
throughput of these single cell detection modalities by orders of magnitude.
Additionally, due to the high enrichment ζ of MagNET, it can isolate rare cells
with the purity necessary for downstream molecular analysis, such as
quantitative polymerase chain reaction (qPCR), sequencing, or nanodevice (e.g.
nanowire, graphene, etc…) sensing.194,212,232 In addition to negative selection,
MagNET can also be used for positive selection. The MagNET filter has the
advantage that when the external NdFeB magnet is removed, the magnetic force
disappears, and the trapped cells can be released for downstream analysis. The
viability of trapped cells in the MagNET has not yet been evaluated, but traps
with similar forces have been demonstrated to keep trapped cells viable.233,234
The master / replica electoformation fabrication strategy developed in this paper
has uses beyond the cell sorting highlighted in this manuscript. It also has broad
applications for the manufacturing of electroformed microscale devices. There
have been many previous approaches to electroform metal pieces with
microscale features for a variety of applications,

219–221,235,236

but our MagNET

technology represents the first such work that creates a reusable microscale
master to generate many replica devices. There have been several recent,
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particularly exciting, applications that use electroformed micromagnets. One
publication combined electroformation with a novel process to transfer NiFe
micro-scale structures to flexible PDMS membranes to confer magnetic
properties to substrates such as coverslips and eppendorf tubes.235 In another
example, electroformed NiFe microstructures were created to generate large
magnetic ratcheting forces to trap and translate cells in a microfluidic channel
labeled with magnetic nanomaterials.236 Our reusable master / mold technique
can reduce the cost of fabrication of such technologies by eliminating the need to
do costly lithography to create each device, and thus aid in the translation of
these emerging technologies to commercial use. Our MagNET fabrication
strategy offers a general approach to produce low-cost devices at high
production rates for a wide range of microchemical systems (MEMS), including
microsensors, microactuators, and microswitchers219.
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4.6 Supplementary Information

Figure 4.S1. Characterization of polyimide pillars on the master and during
electroformation. a. Profilometer measurement along two rectangle pillars in the master
shows the RIE process etched 12 µm deep. The profilometer tip was not able to fit in
between the gaps of the two pillars so we used the Zeiss Smartzoom5 2D/3D Optical
Microscope to verify the pillar profiles. b. 3D optical profile of the pillars shows the
copper surface at the bottom, and a boundary between where permalloy was plated and
peeled. The depth profile is plotted here to show that the permalloy can be plated to the
height of the pillars and successfully peeled at a thickness of 10 µm.
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Figure 4.S2. Bead distribution capture rate on the top and bottom surface of each
filter in stacked devices. Since MagNET is formed completely of permalloy, this leads
to the formation of two traps at the top and bottom surface of each filter (a = top, b =
bottom). To demonstrate that each surface does capture beads, the capture rate of each
surface for N=5 filters stacked in series was calculated. The capture rate was defined as
the area of the microscope image (shown below for each surface) that was covered with
beads since individual 1µm beads could not be counted individually. We also
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demonstrate that by stacking filters in series with two surfaces, we give magnetically
labelled particles multiple chances to become trapped on MagNET to exponentially
increase capture rate.

Figure 4.S3. Device Fabrication. a. A three dimensional rendering of the device.
The sample is loaded into the acrylic reservoir that sits on top of MagNET. A
negative pressure is applied at the blunt tip, which draws sample through the
MagNET to isolate immunomagnetically labeled cells. b. The design of each of the
162

device layers. The boxed in area to the left are the layers associated with each
layer of MagNET. The layers shown on the right are the microfluidics that are used
to withdraw sample from the reservoir. In this particular device, a size based filter is
attached near the output for viewing target cells in a fluorescence microscope after
the negative enrichment of the background cells.
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CHAPTER 5: MULTICOLOR DETECTION OF FLUORESCENT DROPLETS ON A
CELL PHONE USING TIME DOMAIN ENCODED OPTOFLUIDICS
This chapter is a slightly modified version of a manuscript published in IEEE:
VR. Yelleswarapu, D. Issadore. Multicolor detection of fluorescent droplets on a cell
phone using time domain encoded optofluidics. Healthcare Innovations and Point of
Care Technologies (HI-POCT), 2017 IEEE, 245-248.
V. Y. conceived and performed all experiments in this study, coded the Matlab software,
created the Android app, as well as prepared the manuscript and figures.
5.1 Abstract
Digital droplet assays – in which biological samples are compartmentalized into millions
of femtoliter volume droplets and interrogated individually – have generated enormous
enthusiasm for their ability to robustly detect nucleic acids and proteins with single
molecule sensitivity. A key challenge in the field however has been the cumbersome
instrumentation necessary to generate, process, and detect millions of individual
droplets. We have demonstrated the miniaturization of droplet diagnostics into a portable
platform that can process millions of droplets per second by combining the parallelization
of thousands of microfluidic droplet generators onto a single chip and a strategy to
rapidly detect droplets using time-domain encoded cell phone imaging. Building on our
work in this area, we show that multiple fluorescent dyes can be detected in each
individual droplet by encoding the excitation light from multiple LEDs with unique
maximum length sequences that are decoded using cloud-based computation. By
developing a strategy to carry out multiplexed digital droplet assays in a portable
platform at a rate (106 droplets / sec), 1000x faster than conventional approaches on a
cell phone based device, we have demonstrated a key step towards translating the
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sensitivity of digital assays from research laboratories to portable molecular diagnostics.

Digital

droplet-based

assays

5.2 Introduction
use femtoliter volume

emulsions

as isolated

compartments to run massively parallel biochemical reactions. These digital assays have
demonstrated enormous utility as a platform for the ultrasensitive, single molecule
detection of nucleic acids and proteins. However, although these assays are robust to
reaction conditions and thus have enormous potential for point of care diagnostics,
translating these assays into portable devices has proven challenging due to the
expensive, semi-automated machinery necessary to generate, process, and readout
each of the millions of droplets in every assay. We developed a new approach to
miniaturize droplet based assays that achieves a throughput (10 6 droplets/sec) 1000×
faster than conventional methods, using a smartphone camera and disposable plastic
microfluidic chips237 . The key innovation of this approach is the modulation of the
excitation light in time with a pseudorandom sequence that enables individual droplets to
be resolved that would otherwise overlap due to the limited frame rate of digital cameras.
This approach combines ultra-bright LEDs, the sensitivity and computing power of
smartphone based imaging, and the ubiquity and computational power of cloud-based
computing to implement our platform as a self-contained mobile device. A limitation of
our previous work in this area has been that it can only interrogate a single fluorescent
dye in each droplet, severely limiting the use of the chip for the multiplexed molecular
detection necessary for most clinical applications

238,239.

Building on prior work, we show

that multiple fluorescent dyes can be detected in each individual droplet by using
multiple LEDs, each encoded with a unique maximum length sequence (MLS) that can
be specifically readout using a correlation based detection, borrowing techniques from
the telecommunications industry. (Fig. 1a) In this paper, we experimentally demonstrate
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a two-color system wherein we can detect up to three separate molecular targets in each
droplet. (Fig. 1b,c) Our microdroplet Megascale Detector (μMD) detects droplets on a
low frame rate camera by using modulated fluorescent emission from a modulated light
source to resolve overlapping fluorescent droplets and improve signal to noise ratio
(SNR) by 100x compared to conventional optical detection. Moreover, our μMD achieves
flow-rate invariant detection at rates as high as 160 mL/hr (106 droplets/sec) and a
dynamic range of 1:107 to 1:40 fluorescent: non-fluorescent droplets.

Fig. 5.1. Design Strategy of our Multiplexed Microdroplet Megascale Detector
(µMD). (a) Cross section schematic; a microcontroller strobes LED excitation to
modulate the fluorecent emission. (b) Each dye has its own MLS pattern. Droplets with a
mix of dyes emit both patterns. (c) We can resolve the presence of each MLS pattern in
low SNR, and when MLS overlap – to achieve high dynamic range and to identify mixed
dye droplets. (d) Phone based implementation that monitors 120 microfluidic channels
simultaneously.
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5.3 Background
Digital assays have met the demand for ultrasensitive detection, but their utility can
be greatly expanded by incorporating multiplexed detection of multiple biomarkers.
Multiplexed assays have demonstrated higher sensitivity and specificity for the detection
of cancers, genetic diseases, and infectious diseases than is possible using any single
biomarker

238,239.

To expand digital droplet based assays to multiplexed detection, there

are two main options: 1. Samples can be run one after another in series, which adds
additional labor costs, time and requires sample to be aliquoted, or 2. By expanding to
multiple color detection, it is possible to simultaneously monitor multiple biomarkers in
individual droplets, preserving precious sample, reducing assay time, and simplifying
use. Droplet assays can measure N>2 biomarkers, using only two colors, by using
endpoint fluorescence measurements in droplets where ratiometric combinations of two
reporter dyes at specific combinations signify a target. Multicolor digital assays have
proven useful in detecting, nucleic acids in digital PCR 180, proteins in digital ELISA using
barcoded fluorescent beads86, cell surface markers in droplets
system, wherein barcoded beads

240,

and in the Luminex

are used to detect multiple proteins 241. However,

current commercially available multicolor panels for digital assays, such as Quanterix’s
Simoa technology for single protein detection49,86, and Biorad’s multiplexed digital PCR
assay180, require complex optics and bulky machinery. Various microfluidic approaches
to miniaturize and increase the throughput of digital assays have been proposed,
including spatial modulation of fluorescent particles in flow to increase the SNR as well
as resolve multiple fluorescent families129,141, a highly parallel microfluidic chip that sits
directly on a CMOS which monitor droplets139, using a microlens array to monitor
multiple droplet channels133, a miniaturized confocal microscope observing a cuvette of
droplets135,and optical fibers integrated into a microfluidic chip242. However, these
167

approaches require complex fabrication processes, do not achieve a throughput
sufficient for ultrasensitive, multiplexed assays (<10k drops / sec), or use difficult to
miniaturize microscopy to readout the fluorescence.

Fig. 5.2. Optical and dye spectra. Components and dyes were selected to separate the
excitation and emission spectra for each of the LED/dye combinations to prevent
crosstalk.
5.4 Methods
Imaging Implementation
We have previously published on our cell phone based approach that addressed the
challenges of portability, high dynamic range, and high throughput required for droplet
assays237. Briefly, the microfluidic chip is made using standard photolithography to
create PDMS devices that are plasma bonded to glass. The PDMS chip contains n =
120 channels, through which droplets flow in parallel and are monitored by a cell phone
camera to achieve high flow rates.
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In our next generation device, which we herein report, we measure droplets using a cell
phone camera on the Galaxy S7 Edge using pro mode to fix the focus and settings 144.
The optics consist of a hobbyist-grade macro lens (Carlson Hookupz), followed by a dual
band emission filter (512 & 630nm, Edmund). The chip is illuminated from the side by a
green and blue LED (Luminus) that are coupled to maximize total internal reflection.
Each LED has its own bandpass filter (Green: 560DF15; Blue: 450BP50, Omega). (Fig.
2) To test the device, we used Dextran-FITC 10kDa (Sigma) and QuantaRed Enhanced
HRP substrate (Life) – a red Resorufin based dye used for immunoassays such as
ELISA. We combined the dyes at different ratios to generate three populations of
fluorescent droplets. Droplets were generated off-chip using a parallelized droplet
generator130, to ensure monodispersity, and then added to a suspension, which includes
droplets that contain fluorescent dye and those that contain only water. For the oil
phase, we used Biorad Oil and for aqueous we added dye in the concentrations
specified into a 1% PBS solution. For the Resorufin spiked droplets, we mixed the
substrate as specified by the manufacturer and added HRP until the product was
saturated.
Droplet Patterning and Detection
The key innovation to achieve multicolor droplet detection is the modulation of each
dye with its own excitation LED. Each LED-dye set uses a unique pseudorandom
sequence. The modulated excitation light in time patterns the droplet streak in space
(Fig. 1b), which allows multiple overlapping droplets to be resolved. To extract the
individual droplets, we correlate the image streak with the expected modulation pattern
m, to generate the correlation vector Ψ(X) = ∫Sn(x)m(x+X)dx = Sn ⊗ m. We chose to
pattern the droplets using MLS sequences with |m| = 63 bits, where each bit
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corresponds to 10 pixels. Thus, 63 bits would correspond to 630px, or 1/3 of a 1920px
wide video frame. To create a set of MLS with minimal auto-correlation and cross
correlation from each other, we followed the process in MacWilliams and Sloane
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to

create a pseudorandom vector with 212-1=4095 elements, that was folded into a 63*65
matrix, and chose the first two rows to select the two MLS patterns.
The workflow (Fig. 3) to detect droplets is as follows: (i) The video is broken up
into images and each image is separated into two frames, based on the camera’s red
(CMOS-R) and green (CMOS-G) sensors. (ii) Each frame is segmented along the x-axis
to generate 1D signal vectors

that correspond to the n = 120 microfluidic

channels. (iii) To simplify the hardware of the system, we do not control the droplet
velocity v or phase θ, relative to the MLS excitation, of the passing droplets, and instead
use cloud computing to computationally detect droplets with unknown phase and
velocity. We generate a 3d matrix by correlating each of the modulated signals with
expected emission patterns that scans the range of velocities and phase at which the
LED strobes [
optimal phase

and
and velocity

]. (iv) By selecting the

of every kth droplet, we pick out the maximum

correlation peaks [

] and record the locations of the peaks

that cross a defined threshold from

and

intensities R,G at each of the peak locations,

, respectively. By comparing the
, we identify which family of dye

combinations the droplet contains and report the results back to the smartphone via a
custom app. (v) The software is available as an Android App to make the system truly
portable by allowing the user to record the video, send the data to Matlab Mobile with
predefined code that remotely analyzes the data, and receive the results on the
smartphone.
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In the case of a droplet that contains both FITC and QuantaRed dye, we observe
peaks in both ΨR and ΨG. As expected, R and G match in droplet velocity (vc) and
location (xk), as seen in the 3D/2D plots of Ψ.(Fig 3c, iii-iv). For droplets that contain
only QuantaRed, we observed peaks only in ΨR and for droplets that contain only FITC,
we detected peaks in ΨG only.

Fig. 5.3. Software Workflow for Phase and Velocity Invariant Detection of
fluorescent droplets. (a) Workflow for detecting droplets, with lock-in detection that
scans for the emitted fluorescence as a function of droplet velocity and phase at which
the LED pattern starts. (b) Sample workflow for a single droplet that contains Resorufin
and FITC. Images from the video are filtered into CMOS-R & -G frames, and are
partitioned into 1d vectors (ii). We generate a 3d correlation matrix with all phases and
velocities for a droplet (ii), and select the optimal correlation for each MLS (iv). From
these results, we use the location of the correlation peaks to determine which population
a droplet belongs to. The cell phone records the video, while the data is processed using
cloud computing, and returns the results on the Android using Matlab Mobile and a
custom app.
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5.5 Results and Discussion
Simulation for Multicolor Detection
Ideally, each of the dye emission MLS patterns would only show up in the respective
CMOS channel, where the emission from Resorufin would only show up in the CMOS-R
and emission from the FITC would only show up in CMOS-G. However, we observed
non-zero cross talk between the channels, where a droplet that contained only FITC had
some signal in the CMOS-R channel and a droplet that contained only QuantaRed had
some signal in CMOS-G, due to the broad tail of the emission from both dyes (Fig. 2).
To measure the impact of crosstalk on the ability to resolve droplets, we simulated the
total signal in a given 1D vector

, where

represents the amount

of SG that leeches into the SR channel. We scanned the length of the MLS, |m|, and the
crosstalk intensity, , affect the peaks R and G for a mixed droplet. When

= 0, there is

no crosstalk and depicts an ideal scenario. In Fig. 4a, we demonstrate that the ability to
resolve droplets decreases with crosstalk and increases with the number of bits. In Fig.
4b, we observe the impact of MLS length, crosstalk, and noise on the ability to group
multicolor droplets. Increasing |m| results in a tighter grouping of droplets, while
increasing

causes a shift towards the channel where the crosstalk originates from.

Decreasing the SNR causes the scatter to increase. A combination of poor SNR with
substantial crosstalk can shift and spread out the populations of droplets to a point
where the resolved droplets cannot be grouped. However, this occurs at -30dB SNR
which is much lower than the typical >0dB SNR levels observed for droplet assays[4].
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Fig. 5.4. Simulation for Multicolor Detection. (a) We scan the impact of crosstalk (α)
and the number of bits (|m|) on the ability to resolve droplets (R/G). As crosstalk
increases from the green channel into the red, the ability to resolve the green droplet
weakens. Right: As |m| increases, scatter reduces and droplets separate better. (b)
Increasing crosstalk results in a shift, while decreasing SNR increases scatter.
Multiplexed detection of droplets with two dyes at various ratios
To experimentally evaluate our approach, we generated three populations of
monodisperse 40 μm diameter droplets: 500μM FITC droplets, saturated Resorufin
droplets, and one that contains both dyes. We spiked 10 μL of these droplets into 10mL
of an emulsion with empty droplets, and thoroughly mixed the droplets to create a
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homogenous population. We ran this suspension through the μMD at a flow rate ɸ = 70
mL/hr while recording in Samsung 7 Edge’s Pro mode with the following settings: a
frame rate of 1920x1080p resolution at 30 fps, ISO = 2000, Exposure = 0, aperture =
1/30, metering mode set to Matrix, and a fixed focus determined by the macro lens. The
field of view was ~12mm x 7 mm, and spherical aberrations from the lens were corrected
with Matlab’s computer vision toolbox.
We analyzed the computed R and G spread of the scatter for each population and
showed a sample of N = 50 droplets (Fig. 5a). The scatterplot shows that we can
separate all three populations. The centroids for Resorufin, FITC, and mixed populations
with scatter, r, defined as the average distance from the centroid were: [xR=0.58,
yR=0.08, rR =0.09];[xF= 0.35, yF=0.64, rF =0.22];[xRF=0.73, yRF=0.40, rRF =0.14]. We also
calculated the crosstalk defined as the total intensity in the “incorrect” channel divided by
the intensity in the “correct” channel. For Resorufin, the crosstalk was 17 ± 3%, while for
FITC the crosstalk was 49 ± 17%. We used this measurement to correct for crosstalk by
a linear transformation where the coefficient of correction matched the calculated
crosstalk (Fig. 5b). As expected from simulation, scatter was larger in populations that
had more noise and crosstalk. Interestingly, when we add the centroids based on the
concentrations for a theoretical mixed droplet centroid: (xR+0.5*xF, yR+0.5*yF), or (0.69,
0.40), we find that it nearly matches the calculated (xRF,yRF) at (0.72,0.40). The scatter
resulted from nonuniform excitation as the LED intensity decreased further away from
the source, which can be corrected in software. Crosstalk between fluorescence signals
can be further reduced by redesigning the filters, at the expense of a decrease in signal
to noise (Fig. 2).
Using our platform, we demonstrate that we could detect three distinct groups of
droplets, defined by their unique combination of the two dyes. Moreover, using a
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computational model, we showed that it is possible to further expand to a linear
combination of droplets with dye concentrations βcR+ γcG, where βc and γc represent the
concentration of each dye within a droplet – as has been previously demonstrated in
commercial N-plex assays[4]. In addition, we can expand our platform to include
additional LEDs, beyond the two demonstrated in this manuscript, each patterned with
its distinct MLS patterns. Using this approach, the highly multiplexed molecular
diagnostics that are emerging to diagnose cancer, infectious disease, and trauma can be
miniaturized and made accessible for clinical use.

Fig. 5.5. Experimental Verification of µMD. (a) Classification of Resorfuin, FITC, and
mixed droplet populations. (b) Linear transformation correcting for the crosstalk of the
FITC droplets results in tighter scatter groups.
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CHAPTER 6: FUTURE WORK
While the µMD is currently functional for a duplex biomarker detection with digital
ELISA, there are several applications that could be expanded including with minimal
hardware change including: Digital PCR, multiplexed detection of biomarkers, washless
ELISA, and nanoparticle enhanced ddELISA.
6.1 Digital PCR
Introduction:
Droplet-based assays have been used extensively for nucleic acids due to their
sensitivity for amplifying single molecules of DNA, RNA; and their robustness to reaction
conditions since only endpoint measurements are necessary16569. Similar to ddELISA,
ddPCR has enormous potential for early detection, and differentiating small fold changes
compared to traditional PCR; yet the equipment is often limited due to cost or bulkiness
or suffers from poor dynamic range in static array-based digital PCR deices.
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Figure 6.1. a. Comparison of traditional and digital PCR. Typical commercial digital
PCR assays such as Biorad’s system come in several parts for each function of the
workflow. Manual intervention is necessary for steps, and the slow throughput requires
overnight runs or suffers from low dynamic range. b. The µMD integrates all of this onto
one chip, where droplets are rapidly generated in parallel, thermocycled, and imaged
after. The parallel approach speeds up the process, while minimizing manual labor and
any steps that could cause contamination.

Figure 6.2 Components and workflow for integrated digital PCR. a. The major
components are the droplet generators followed by a compact 3d chip for thermocycling.
The 3d component is sandwiched by two peltiers on either side for rapid heating and
cooling, while an app detects droplets (inset: setup in lab). b. App analyzes the video on
the cloud by finding signatures that identify positive droplets. c. Integrated workflow
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shows droplet generation, a droplet fluorescent through RPA, and finally what the
droplets would potentially look like under the cell phone detection system.
To address this challenge, we began developing the integrated microscale mobile
droplet detector (µMD) – an integrated sample to answer to droplet based platform that
generates droplets in parallel, incubates them in a delay line for 10 minutes to amplify
target nucleic acids via recombinase polymerase amplification (RPA)243, and detects
droplets on a cell phone camera that is linked to cloud computing. The key innovation of
our platform that enables high-throughput is the parallelization of both the generators
and detectors, as well a rapid and robust isothermal amplification scheme that obviates
the need for bulky thermal cyclers. Using this approach, the µMD demonstrated that
isothermal amplification using Recombinase Polymerase Amplification (RPA) could be
possible by amplifying targeted strands and measuring their fluorescence after a delay
line. The device footprint was less than 100 cm2. In addition, thermocycling approaches
were also tested for traditional digital PCR since this technique could measure a wider
range of RNA and DNA targets that are not possible by isothermal amplification. By
miniaturizing and integrating droplet-based diagnostics into a handheld format, the µMD
platform can translate ultra-sensitive droplet-based assays into a self-contained platform
for practical use in clinical and industrial settings.

Table 6.1 – Digital PCR Technologies
Ref.

Throughput

Droplet
Volume

Method of
Thermal

Material

Method of Detection

125 to 250
k/s based on
4-8s
exposure

50 pL

Thermoelectric
Cooler,
Copper, Si
wafer, PDMS

PDMS

Wide field 21 MP DSLR
camera

Continuous
Hatch51

178

Schaerli65

Flow rates
~160ul/h;

40um to
150um; 33.5
pL to 1.76nL

Peltier module
with copper
rod at center;
spatial

SU8
embedded
in PMMA

Droplets were collected,
opened for gel
electrophoresis

4.7*106/mL
Beer et al66

Generate
1k/s and
then stop
while it
cycles.

10 pL

Peltier
temporal
heating

.5 mm thick
silicon
wafer a
anodic
bonded to
.5mm
coverslip

Nikon microscope w/ 5k
fps camera.

Kiss67

500/s

65 pl;
observed 14k
droplets per
cycle at 11
points

Spatial
heating; two
heaters at 95
and 65c zone;
55 s cycles/ 35
min

PDMS;
incubation
channels
260um

Droplets flash frozen and
analyzed on gel and
fluorescence microscope

Terazono68

2.2k/3.5 min

20-30um
droplets
made with
micropipetting 1030uL at a
time

Single
monolayer of
droplets
heated w/ IR
laser; 3.5min
for 50 cycles

Droplets
were
covered w/
mineral oil
and heated
on glass
base dish

Inverted microscope,
laser,

Biorad

1.92 mL can
be loaded
on
thermocycler
at once…

1 nL; 1 k/s

Off chip
thermocycler

Well plate
with
collected
droplets

Dual laser

Raindance

400 uL sets

5 pL; 1 k/s

Rane69

1M/110 min;
10uL per
110min

8 pL; 1-2
ms/droplet

Peltier heater
with water
cooling

Li70

27,000

314 pL

Peltier heater
with copper
chamber, PWA
chip, and
glass; 10
min… 30 min
for entire
procedure at
39C

Off Chip

Dual laser

Isothermal

Static array

SlipChip48

1550
reaction

9 nL each;

39C on flat
metal adapter;
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glass,
pdms,
coverslip

Custom built optical dual
fluorescence

Wide field image
microscopy

Glass

Leica DMI 6000 B epi-

wells

1550 wells/hr

plate reader
with
temperature
controlled at
25°C. 1 hr at
39C, 30 min at
42C

fluorescence
microscope (Leica
Microsystems, Germany)
with a 5X / 0.15 NA
objective and L5 filter

Schuler71

Volume
calculated
from given
dimensions:
~30000
120um dia
droplets;

0.9048 nL;
volume of
chamber
where
droplets form
is 27 µL

Labdisk player
with built in
heater; 30 min
for entire thing

Lab disks
were micro
milled in
PMMA – at
foundry
service

Stroboscopic setup for
droplet dia only;
fluorescence imaging
with Lavion bioanalyzer

Kang72

100 kHz

10 kHz

Red/Green
colors;

8 pL

Rotating cuvette with
mini confocal detector for
DNAzyme detection

Several digital PCR commercial platforms already exist that demonstrated several
advantages of digital PCR when compared to standard qPCR. These advantages
include robustness to background, absolute quantification where every single nucleic
acid target is counted rather than compared to standards, and endpoint measurements
that do not require as much optimization when compared to tracking PCR fluorescence
in traditional qPCR systems. While these commercial assays such as Biorad and
Raindance demonstrated great strides in digital PCR, they were limited to lab facilities
that could afford the equipment and were low throughput – relying on overnight runs for
their droplet generation to analysis workflow.
Several techniques to miniaturize the platform using microfluidics are described in
Table 6.1. Continuous flow digital PCR was first demonstrated in several chip materials
including glass, silicon, and PDMS. Continuous flow heating consists of two major
methods:

cycle

the

chip

through

the

temperatures

required

using

rapid

heating/cooling6667 or using spatial heating65 that control the temperature of the surface
at different regions of the chip and as droplets flow between regions, the droplets also go
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through various temperatures. Beer et al66 and Kiss et al67 first demonstrated that by
rapidly heating and cooling a chip, and monitoring several locations for droplet
fluorescence, digital PCR could be done in continuous flow. However rapid heating and
cooling of large chips often require bulky equipment since the thermal load does not only
consist of the channels where the droplets travel through, but also the entire thermal
mass of the glass, silicon or PDMS chip. With insulated materials, this can become
problematic and thus low throughput. A different strategy was employed by Schaerli with
spatial modulation, where a Silicon and SU8 chip hybrid had different regions of cool and
hot regions for amplification.
Design and Methods
In order to address the problem of the large thermal mass that is often cycled in
many of these setups and the inherent low throughput nature of these devices, we built a
thermocycler with a copper chip that was less than 200um in height. In addition, we
wanted the chip to be as thermally conductive as possible, which meant materials like
PDMS or thick glass would pose obstacles in rapid thermal cycling. We used COMSOL
to simulate several materials with different thicknesses to find out how long it would take
for droplets and the carrier oil to heat up from room temperature to the targeted
temperature. These simulations showed that PDMS and thick glass would be poor
choices for the design. We also tried using PDMS experimentally and found that
problems with evaporation and gas bubbles was a major issue despite papers
demonstrating success with degassing or using thin glass slides to prevent evaporation.
Silicon was also explored but the expensive manufacturing with deep reactive ion
etching, and the eventual need to have a compact footprint by stacking in 3D made this
not practical since the bonding between several layer would get complex and have a
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high risk of failure. Figure 6.3 shows the final design choice with a copper-based chip
that was stacked in 3d to have a compact yet large volume where droplets could cycle
rapidly.

Figure 6.3 Heating component for on chip isothermal amplification. a. The chip was
fabricated using both copper and thin mylar sheets that acted as a 3d reservoir for
droplets to travel through. b. Ten of these were stacked on top of each other, with
peltiers sandwiching both sides to keep the temperature at 37C. As room temperature
liquid entered, it spent several minutes inside the delay line where the 37C for isothermal
amplification was reached. c. COMSOL simulation shows how long it takes for room
temperature liquid to reach the intended temperature, while (d) shows the results of
spiking in varying concentrations of target templates. Droplet homogeneity was an issue
due to heating, but surface treatment and degassing of the devices should fix these
issues.
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In order to regulate the temperature, we used peltiers designed for high
temperatures and used an Arduino that measured the surface using thermocouples and
an H-bridge to reverse the current and cool the system. Heatsinks were added so the
peltiers did not lose efficiency over time; yet one issue was where the thermocouple
probe would be placed. Surface temperatures overestimated the liquid interface, so to
measure the effect of the surface temperature and the actual temperature of the liquid,
we used a Rhodamine calibration curve to relate the surface temperature to the liquid
temperature. We first measured the Rhodamine and its fluorescence at various
temperatures at steady state and then measured how the surface temperature changed
with the Rhodamine and optimized by thickness and channel height until the Rhodamine
followed the surface temperature quickly, covering about 4 cycles in 2 minutes.

Figure 6.4. Rapid on chip thermal cycling. a. A similar approach can also be applied
for digital PCR rather than just isothermal applications. b. A larger heatsink with a
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copper chip is used for rapid thermal cycling. c. Rhodamine dye was used to first
calibrate the surface temperatures at 30C and 75C. These fluorescent measurements
were associated with surface temperatures, and then probe surface temperature was
compared with the fluorescent signal from the Rhodamine. The graph shows that the
liquid closely follows the surface temperature, but over time can begin to lag and not
cool as effectively. COMSOL simulations also demonstrate how fast temperature should
change in the liquid as a function of surface temperature.
However, even with the thermal cycling, this did not seem fast enough, so we
looked at alternatives that would simplify the heating but still enable ultrasensitive
detection. RPA244 was previously demonstrated to be a robust isothermal amplification
that only requires 37C to amplify fluorescent signal in the presence of target DNA. While
existing commercial kits focused on bacterial nucleic acid targets, several labs have
developed RPA for digital assays covering a wider range by carefully designing
primers702432457148246. While RPA also was harder to control due to primer design and
nonobvious correlations between the speed and efficiency of the amplification 247, we
demonstrated that RPA could be done in a continuous flow system.
Biorad Oil for Evagreen was used as the continuous phase, a rehydrated pellet
from the RPA kit was used for the dispersed phase. A serial dilution of the target DNA
was mixed in with each of the rehydrated pellet solution, which was then formed into
droplets through a parallelized droplet generator. Since the droplets only had to be held
at 37C for a few minutes, the reaction could be observed immediately after in a
microscope setup. Figure 6.3d shows the results of the onchip amplification when
observed on a microscope, with higher concentrations leading to a higher fraction of
fluorescent droplets. While this assay was not optimized for the loss of target molecules
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due to the sticky surfaces, improvements in the non-stick surface treatments from ELISA
would significantly improve the existing problems. Furthermore, multiplexing of
isothermal amplification has already been demonstrated and could be implemented to
cover a wider range of targets once primers have been verified248–250.
6.2 Higher order multiplexing for ddELISA
In order to detect multiple biomarkers simultaneously based on the ddELISA
approach, there were several options for the design. The first is to have separate
microfluidic channels each with its own inlet so that biomarkers are separated spatially.
Here one bead color can be used, and each inlet would identify which biomarker was
present based on the number of fluorescent droplets counted. While the approach is
simpler, the drawbacks are that the sample has to be split into as many biomarkers to be
measured. If the sample is limited or precious, this can be an issue. Next, from an
engineering perspective, having 100 inlets with tubing for each would also make this
impractical even if the oil and substrate inlets could be shared; limiting the amount of
inlets to about 10 bead samples practically if we wanted to avoid connection complexity.
The second approach uses multiple excitation and emission filters for each bead
color. While this requires more complex harder, the limitations here stem from the trade
off between the amount of narrowband excitation and emission sources that can be
purchased. In addition, as the bands become more narrow, the amount of light for each
color will also be decreased, reducing the electrical signal generated by the pixels. If the
narrowbands are not tight, cross talk will severely reduce the ability to classify each bead
population.
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Figure 6.5 Higher order multiplexing strategy for color coded-beads. a. A similar
strategy from the duplex ddELISA is employed, except this time there are three
excitation sources each with a unique MLS. b. A color coded bead array is generated
based on various combinations of dye concentrations. One color indicates the presence
of a protein, whereas each color-coded bead is uniquely coated with capture antibody for
a single protein target. c. Droplets that contain a protein will fluoresce, while those that
do not remain blank.
Therefore, since we began with a cell phone-based approach and wanted to limit
hardware complexity, we chose a higher order multiplexing method that only relies on
three excitation sources, and a bandpass filter that fits the given ranges of emission
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sources. In order to do this, we had to select beads that emitted in two colors at different
intensities, where each combination of intensity would map out to a different target
protein, and a final color that would identify if a target protein was present or not inside a
droplet. This three-color system would be able to resolve as many populations of
biomarkers as long as the bead populations separated into tight clusters in 2d map.
While Luminex beads are the dominant player in this multiplexing bead approach, their
red and infrared emission wavelengths were not compatible with our setup.
Therefore, we choose to use PolyAn beads that were fluorescent with blue and
green lasers and had to shift to a UV fluorescent dye. These beads come in 12 distinct
populations, with 6 sets of fluorescent beads at various combinations of dye. Therefore,
each bead color would produce one MLS peak, and the third color would detect the
presence of a protein. The first iteration was running beads through at high flow rate and
measuring their MLS peaks for each wavelength of the bead dye. We observed that
there were several causes for large scatter in the correlation 2d indexing plot: (1) phase
variation from where the MLS starts, (2) excitation variation since the laser diodes have
nonuniform excitation, (3) beads travel at different velocities, (4) high pass filters in the
code, (5) software for normalizing the peak, and (6) crosstalk between signals.
In order to address the phase variation and get better sensitivity, we switched from a
cell phone-based detector to the FLIR machine vision camera (Grasshopper 3). The
FLIR 3 camera was swapped in, and this had several advantages: (1) higher sensitivity,
(2) control of parameters that were automated in the cell phone, (3) a smaller angle of
incidence which allows optical filters to work more effectively in narrow bands, (4)
removal of any optical aberrations that required software correction previously, and (5)
triggering of the recording frame in phase with the modulation of excitation light. Higher
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sensitivity allowed dimmer droplets and substrates to be resolved in a dynamic range
that covered the dimmest bead component to the brightest while flowing, without
saturating the pixels. In order to address excitation variation, a background frame with
the light intensities were used to first subtract and divide a real frame analyzed to
normalize each frame for nonuniform intensity. Bead velocities, high pass filters, and
bead length normalization were all related and in order to fix this, we first measured how
the correlation peaks changed for different streaks of the MLS after passing it through
the correlation analysis. The data was then used to correct for variations by multiplying
by the inverse and reduce a theoretical scatter from +- 10% to +-1%. Finally, the
crosstalk was limited as much as possible by choosing the sharpest optical filters and
notch filters for the excitation, yet the fluorescent emissions of the dyes overlapped in
the same CMOS segment. Therefore, the MLS patterns were used to distinguish which
dye was present in the beads. The results of the correlation analysis and rectangles
representing the centroid with widths of two standard deviations are shown. While the
beads are currently still clustered, there are some obvious steps to improve this process.
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Figure 6.6 Color-coded beads resolved in µMD. a. Spectra from the company
showing two sets of six color coded beads, that are also separated by size. b. Beads
were run in flow cytometry. c. Setup with the FLIR camera, and three excitation sources
controlled by an Arduino that triggers the excitation and detection. d. Resulting
correlations of the beads in the µMD, with rectangles representing centroids and two
standard deviations in width and length.
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6.3 Washless ddELISA
One weakness in digital ELISA techniques, is that aggressive wash steps can cause
dissociation between proteins and antibodies that are bound. Additionally, even with a
fast workflow from when the sandwich is completely formed to detection, the incubation
times and wash steps needed for each prior step of the sandwich can be lengthy. While
doing these in parallel can reduce time, bead-based approaches require wash steps that
often include centrifuges, magnetic washes, or more inexpensive size based membrane
filters. Each of these systems has loss from beads or proteins from sticking to surfaces
or not resuspending back properly after each wash step.

Figure 6.7 Schematic of washless ELISA. a. Typical bead based digital ELISA often
requires (ii) capture beads to capture target proteins, (iii) bind detection antibody, and
(iv) label with an enzyme. Each step requires multiple wash steps that often use a
centrifuge or magnetic washer before they can be compartmentalized into droplets (c).
b. In washless ELISA, active enzyme is only completed in the presence of excess
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targets. Target protein compete with target attached to an enzyme fragment. When
excess target is added, the ED-target fragment can dissociate from the antibody and
complement with the EA fragment. Competition assays show lower sensitivity in bulk (d)
than the digital assay where single complemented enzyme can be measured (e).

A one step reaction process that removes the needs for beads or wash steps
could overcome this challenge. There are several enzymes that use complementation in
the presence of a target to turn active, and cause fluorescence. This was demonstrated
with Luciferase, HRP, and B-Gal; however there was no commercial kit that allowed us
to test this. The principle of such an assay would require no washing since the two
halves would only join and turn active in the presence of a target, and could directly be
loaded into droplets after incubation. In order to test this with a similar technology called
the HitHunter cAMP assay that uses enzyme fragmentation technology for cAMP
(Figure 6.7). We tested this kit in bulk first, and then in droplets and measured
fluorescence when enzymes complemented successfully. There were some issues in
terms of running the kit completely with target proteins and inhibitors, so there was
significant loss. An additional issue is that the kit is only available for cAMP which may
not have potential as a significant diagnostic marker and is rather used for cell based
studies. Several labs have been developing fragmentation technology that could be
created for any target and are hopeful that this technology would enable a bead-free
washless digital ELISA.
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6.4 Nanoparticle enhanced ddELISA
Digital ELISA is currently severely limited by the antibodies that are available to
form a strong sandwich complex that can withstand various wash steps. Digital ELISA is
only possible when both the capture antibody and detection antibodies have low Kds,
allowing a single protein molecule to bind and stick to the bead surface. For the capture
antibody, this problem is not as severe since the entire capture bead is coated with
antibodies, and if a protein molecule dissociates, it has a chance to attach to a
neighboring antibody, termed avidity effects. However, when this happens with the
detection antibody, the problem is that there is only one detection antibody per protein
molecule. If the detection antibody dissociates either due to kinetics or from aggressive
wash steps, this will result in a lower sensitivity. Additionally, finding a sandwich pair that
has effective antibodies for digital ELISA is a limiting step in establishing assays that can
detect single proteins, where a low Kd antibody might not even be available.

Table 6.2 Bulk Nanoparticle enhanced ELISA
Ref.

Method of Verification and Improvement in Results

Zhan251

•
•
•
•
•

Bill252

Bang253

•
•
•
•
•

Five anti-RSV–HRP molecules for each AuNPs.
Improved LOD of conventional ELISA probe by 50 times.
6x improvement in color signal development from 15-30 mint o 5 min
Two-step detection assay that utilizes HRP-conjugated secondary IgG;
150 nm diameter nanoshells (NS) composed of 120 nm silica cores and 15
nm thick gold shells
13 fold increase in sensitivity
40x more conjugated antibodies were required to detect EGFR
Binding affinity of affibody functionalized gold nanoparticles of ~500 pM,
exceeded that of the anti-NS1 affibody dimer (Kd = 5 mM) by 10000 times.
14.2 fold improvement in sensitivity
Average of 150 affibodies per gold nanoparticle
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Figure 6.8 Enhancement from nanoparticle based digital ELISA. a. Traditional plate
based ELISA suffer from poor sensitivity. b. Digital ELISA measures the end point
reactions of single protein molecules in millions of tiny compartments where the
amplified dye can be concentrated for a strong signal. c. When the detection antibody is
replaced with a nanoparticle containing multiple detection antibodies, the higher number
of enzymes will speed up the reaction for a stronger signal compared to digital ELISA.
d,e. In digital ELISA, the protein has multiple chances to bind to neighboring capture
antibody, but only one detection antibody per captured protein. If the antibody weakly
binds, washing or dissociation will reduce total protein counted. f,g,h. In nanoparticle
enhanced ELISA, there are multiple chances for detection antibody to bind to the
protein, allowing a higher rate of proteins to be counted.
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We propose that nanoparticles covered with detection antibody can overcome
this limitation by enabling the avidity effects to the detection antibody. A nanoparticle
covered with detection antibody has the following advantages: (1) if the nanoparticle
dissociates, neighboring antibodies could rebind to the protein and (2) additional biotin
groups from multiple detection antibodies would capture more HRP/single protein
molecule. Additional HRP enzymes would result in faster signal generation, and avidity
would enable more sensitive measurements. Several groups have shown that this
enhancement has improved bulk ELISA by several orders of magnitude, allowed lower
levels of reagents, and lower false positive signals.
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